MikeLigalig.com

Florida Poly launched the Health Systems Engineering (HSE) program, which is the only undergraduate-level concentration of its kind in the state of Florida.

LAKELAND, FLA. (PRWEB) DECEMBER 01, 2020
Students with a love of STEM and an interest in health care can prepare for a career that prioritizes both with Florida Polytechnic University's new Health Systems Engineering (HSE) program, which offers the only undergraduate-level concentration of its kind in the state.
"Anyone who is frustrated with the current health care state and who would like to learn how to use their STEM skillset to transform health care delivery could benefit from HSE," said Dr. Grisselle Centeno, director of the program and professor in the Department of Data Science and Business Analytics. "This new program uses engineering tools and methods to improve efficiency and productivity, and studies health care as a holistic complex system."
The HSE program allows students pursuing a degree in data science or business analytics to declare a concentration in HSE. Students majoring in computer science, or electrical, mechanical, or computer engineering can also benefit from this program by pursuing an HSE certificate.
Career opportunities include positions in systems engineering in health care, health informatics, health data science, medical device development, and medical supply chain management.
"Health care captures 18% of the national gross domestic product, equivalent to $3.5 trillion," Centeno said. "There are many challenges and therefore opportunities to improve health systems – that is hospitals and clinics, which constitute about 80% of that 18%."
In addition to its coursework, the concentration brings in a variety of guest speakers such as physicians, nurses, and health care consultant to discuss the importance of data, process improvement, and other relevant issues in the health care industry.
"Given all the support we're getting from industry and interest in opening doors for our graduates, we hope to grow our program quickly," Centeno said.
Sophomore and data science major Michael Ortiz, from Kissimmee, Florida, said he is eager to declare the concentration next semester.
"What motivates me is being able to wake up every morning and put my skills to use in a field that can really help people, not just businesses or profit margins," said Ortiz.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

TVT and GLAMS are used by the world's leading Life Science companies. Using Schlafender Hase's TVT Connect, the company's new Application Programming Interface (API), GLAMS is configured to fully integrate TVT with all of its features.

DUBLIN, IRELAND AND FRANKFURT, GERMANY (PRWEB) DECEMBER 01, 2020
Perigord Life Science Solutions and Schlafender Hase have announced that TVT will be integrated with GLAMS. Perigord developed GLAMS (Global Labelling Artwork Management System) as the only AMS specifically designed to meet the needs of the highly regulated Life Science industry. TVT, Text Verification Tool, is an automated proofreading solution. It was originally developed to meet the labelling and packaging needs of the highly regulated pharmaceutical industry. Today TVT and GLAMS are used by the world's leading Life Science companies. This combination of GLAMS and TVT further supports GLAMS' leadership position as the most powerful Life Science AMS system on the market.
"Across our Global Centres of Creative and Packaging Excellence we adopted TVT early on into our proofreading and approval workflows," stated Suzanne Ivory, Chief Operations Officer, Perigord Data. "Sharing many clients with Schlafender Hase, we are uniquely placed to understand and anticipate the future market needs for end-to-end proofreading verification technology. Aligned to our product and R&D road map, we believe this integration further strengthens GLAMS' leadership position as the go-to platform for AMS and CMS systems for the Life Science industry." Sam Cole, Director of Client Services, GLAMS, pointed out that GLAMS and TVT are among the most widely used artwork management and comparison solutions deployed across the Life Science sector today. "This additional integration of TVT ensures all our Life Science customers have all the leading comparison tools on the market available within one system. With proofreading a key component of artwork management, this integration will ensure our GLAMS customers can select all document versions, compare, verify, and control changes without the need to flip from one system to another. It is this and the other functionalities built into GLAMS that makes the management of artwork workflows more efficient, and safe."
"Perigord has in-depth knowledge of how the Life Science industry works and what it needs to be successful," said Frank Hessler, Managing Director of Schlafender Hase. "Perigord also knows the strengths of TVT and how it can be best used as a key element in the AMS value chain. Our common focus on innovation and quality, combined with our experience and expertise, will bring benefits to customers of both companies."
Pharmaceutical packaging is a critical part of patient communications. Efficiently managing quality and compliance of packaging content is critical, complex, time-consuming, and prone to error. These errors can affect patient well-being, access to medicine, product success and business sustainability. Proofreading is a key component of artwork management. Using Schlafender Hase's TVT Connect, the company's new Application Programming Interface (API), GLAMS is configured to fully integrate TVT with all of its features. GLAMS and TVT are among the most widely used artwork management and comparison solutions deployed across the Life Science sector today.
About Perigord
Servicing the Life Science industry from our Global Centres of Creative and Packaging Excellence in Europe, Asia and North America, Perigord helps Life Science companies design, manage and deliver their packaging, marketing communications and digital assets around the globe. Services cover five core disciplines: Strategic Consultancy, Packaging Artwork and Labelling, Creative and Digital, Strategic Outsourcing – BPS, and Software Solutions. All services provided by Perigord, both regionally and globally, are certified to ISO 27001; ISO 9001:2015, PS 9000:2016 and are compliant to 21 CFR Part 11 & Eudralex Volume 4, Annex 11. Beyond these global standards, Perigord is audited on a rolling basis by our customers: in 2019, Perigord was audited by 15 of the top 20 global Life Science companies passing all audits with distinction.
For more information:
mediarelations@perigord-as.com
http://www.perigord-as.com
About Schlafender Hase
Since Schlafender Hase introduced TVT, the Text Verification Tool, this software has taken the lead in providing intelligent, automated text and graphic proofreading solutions for the most highly regulated industries. Schlafender Hase's clients include the world's leading pharmaceutical and medical device companies. Schlafender Hase is currently expanding its focus to bring the same time-saving and increased productivity benefits gained by this sector to pre-media, consumer packaged goods (CPG) and fast-moving consumer goods (FMCG) clients. The company recently introduced TVT Connect, a platform which makes it possible to easily integrate TVT with any information management system. Schlafender Hase is proud to be known for product quality, service excellence and customer success. Founded in 2001, the company is headquartered in Frankfurt, Germany, with a North American division in Cambridge, Massachusetts.
For more information:
tvt@sh-p.de
http://www.schlafenderhase.com

Perigord knows the strengths of TVT and how it can be best used as a key element in the AMS value chain. Our common focus on innovation and quality, combined with our experience and expertise, will bring benefits to customers of both companies.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Nashville-based CBD brand providing relief for the holidays by offering nearly 45 percent discount on popular starter product bundle

NASHVILLE, TENN. (PRWEB) DECEMBER 01, 2020
Also Organics, maker of alternative personal wellness products, is celebrating the holidays with a seasonal promotion for its popular and already-discounted CBD Starter Pack. From now until December 25, 2020, gift givers or those seeking organic and holistic alternatives to help relieve effects of anxiety and calm uneasy nerves during the holiday season and beyond can save an additional 25 percent off the purchase price of the brand's favorite CBD Starter Pack by using promo code HOLIDAY25. Orders placed by Wednesday, December 16, are guaranteed to arrive before Christmas.
"The holidays are often a stressful time for many, and with this year's happenings bringing extra feelings of uncertainty and anxiety, our team wants to make natural options readily available for those seeking relief," said Matthew 'Chewy' Smith, founder of Also Organics. "Whether using alternative products yourself or purchasing as a gift for loved ones, we hope our CBD products can help create a sense of calmness and wellbeing after a chaotic and unsettling year."
Also Organics' CBD Starter Pack makes it easy for those new to CBD and veteran users alike to try and enjoy a few best-selling products from the brand at a highly discounted price. The bundle includes:

1000 mg CBD Tincture: full-spectrum, whole-plant CBD tincture that delivers a calm sense of wellbeing. Specially formulated with organic MCT oil and phyto-rich hemp oil, one 33 mg dose helps relieves anxiety and stress, and promotes focus and healthy sleep cycles.

500 mg Skin Balm: provides powerful therapeutic agents like organic beeswax, CBD oil and eucalyptus oil to quickly soothe and protect dry and sensitive skin. The unique formula delivers unparalleled absorption and zero toxins that is safe for lips, face, hands, and the whole body.

10 mg CBD Gummies: mixed fruit CBD gummies are great for creating a calm sense of wellbeing, relieving anxiety and stress, and improving overall body function. are great for creating a calm sense of wellbeing, relieving anxiety and stress, and improving overall body function. A daily 10 mg organic hemp gummy infused with vitamins can help relieve the effects of ADD, ADHD & ASD.

Naturally occurring cannabinoids, like CBD and CBG (cannabigerol), work with the built-in endocannabinoid system (ECS) of humans to help regulate both central nervous and immune systems. The entire Also Organics portfolio, which includes tinctures, gummies, gel caps, balms, salves and lotions, is non-psychoactive and made with US-grown hemp and organic ingredients. Additionally, the products are vegan, kosher-certified, non-GMO and free of gluten, dyes, paraben and fragrances.
Also Organics is committed to educating its customers on the complex qualities and potential therapeutic benefits of the hemp plant by offering publicly available insights and helpful facts featured on its website and social media properties. More information and the Also Organics product line is available online and in select medical clinics, wellness boutiques and retailers.
ABOUT ALSO ORGANICS:
Based in Nashville, Tenn., Also Organics creates personal wellness products with the finest, full-spectrum, whole plant CBD (and CBG) – all made from 100% American grown organic hemp. Also Organics offers a wide range of products including tinctures, gummies, gel caps, balms, salves, lotions and more. The Also Organics team believes there's always more – to see, experience, and discover. The Also Organics portfolio is designed to unlock one's potential and find balance in an increasingly chaotic world. For more information about Also Organics, visit http://www.alsoorganics.com. Also Organics can be found on Facebook, Instagram, and Twitter.
Media Contact:
Tiny Mighty Communications



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Warriors Heart Foundation names U.S. Army Master Sergeant (ret) Teddy Lanier and Warriors Heart Alumni as the new Executive Director with a mission to "unite the power of social responsibility, sustainability, and the healing of our warriors."

SAN ANTONIO (PRWEB) DECEMBER 01, 2020
In sync with Giving Tuesday, Warriors Heart Foundation announces Warriors Heart Alumni and U.S. Army Master Sergeant (ret) Teddy Lanier is the new Executive Director of the Warriors Heart Foundation. The Warriors Heart Foundation is a 501(c)(3) that accepts deductible donations that help fund warriors (active-duty military, veterans, first responders and EMTs/paramedics) in their healing from addiction, PTSD, mild TBI, trauma, suicide, depression and co-occurring issues.
The Warriors Heart Foundation helps subsidize the cost of treatment for Warriors who do not have insurance benefits, including VA benefits. Most funding goes towards treatment services at the Warriors Heart Facility (a separate entity from the foundation), but also covers funding for other verified programs. With the unacceptable averages of 20 veteran suicides per day and 1 law enforcement officer every 62.5 hours in the U.S., the goal is not to turn anyone away for financial reasons.
Former Special Forces and Warriors Heart Co-Founder Tom Spooner shared, "We are grateful to the community for their continued support, and to Teddy Lanier for assuming this new leadership role as the Warriors Heart Foundation Executive Director. He is recognized as a role model and hero, who speaks regularly about his long journey home."
After serving on the Warriors Heart Foundation Board for the past three years and as a Warriors Heart Alumni in long-term recovery for the past 3.5 years, Lanier has dedicated his life to healing fellow warriors. With gratitude, Lanier explains, "Warriors Heart and a private donor saved my life, and gave me the tools to live. Leading the Warriors Heart Foundation is a great opportunity to 'Pay It Forward' to the next person, and save as many lives as possible."
The Warriors Heart Foundation supports programs that give individuals and communities the tools to rebuild their lives and become self-sufficient. Donations help:

Subsidize funding for chemical dependency and PTSD treatment that includes detox, in-patient residential treatment services, intensive outpatient program (IOP), one-on-one therapy and sober living.

Fund ESA or Service Dogs for warriors that includes trained emotional support animals that provide a specific service to a warrior.

Fund Sober Living housing for warriors who need continued support where there is structure after treatment while going back to school, volunteering and/or receiving outpatient treatment.

Promote behavioral health education for veteran, law enforcement & firefighter resources for what to look for with chemical dependencies and PTSD.

In-kind donations also support warrior healing, which may include donations of wood, building materials, steel, metal and wood shop equipment, volunteer work, products and other partnerships. Current foundation partnership programs include the Gary Sinise Foundation, Black Rifle Coffee Company, U.S. Elite Footwear and an MTM l Watch Limited Edition Series.
Lanier encourages everyone to get involved in the healing of our protectors by donating to Warriors Heart Foundation, listening and/or honoring those who have served.
MEDIA CONTACT for Warriors Heart:
Liz Kelly: 310-987-7207
ABOUT TEDDY LANIER: Warriors Heart Foundation Executive Director and Master Sergeant (ret) Teddy Lanier served for 22 years (1989-2011), including 10 years in the U.S. Army and 12 years in Special Forces. Lanier is honored to be the new Warriors Heart Foundation Executive Director to help fellow warriors win their "War At Home" against drug and alcohol addiction, PTSD and co-occurring issues. Lanier was deployed five times to combat in Iraq and Afghanistan, and adjusting back to civilian life brought many challenges. Lanier overcame a 17-year opiate addiction after attending Warriors Heart residential treatment program in April 2017. To give back, Lanier is speaking publicly about his story. Teddy says, "If all I do is save one person, then I am happy to share my story with the world." Lanier has shared his story on the TODAY Show, WRAL NBC News Raleigh, Dr Drew Midday Live and more. https://www.warriorsheartfoundation.org/board-of-directors/
ABOUT WARRIORS HEART FOUNDATION (Bandera, Texas)
Warriors Heart Foundation is a 501 (c)(3) that accepts donations to help heal our protectors with their peers. One of the missions of the foundation is to provide financial aid through hardship grants that assist in covering the cost of treatment at Warriors Heart to help our military, veterans and first responders get the treatment they have earned and deserve. https://www.warriorsheartfoundation.org
ABOUT WARRIORS HEART (Bandera, Texas near San Antonio):
Warriors Heart is the first and only private accredited treatment program in the U.S. exclusively for "warriors" (active duty military, veterans, first responders and EMTs/paramedics) faced with the self-medicating struggles of alcohol addiction, prescription and drug addiction, PTSD (post-traumatic stress disorder), mild TBI (Traumatic Brain Injury) and other co-occurring issues in a private, 60-bed facility on a 543-acre ranch. Along with a minimum 42-day peer-to-peer residential treatment program, Warriors Heart gives "warriors" the option of Detox, Day Treatment, Outpatient, and Sober Living (60-day minimum). Warriors Heart's work has been featured on the TODAY Show, CBS Health Watch, FOX 11 Los Angeles, National Defense Radio Show and in TIME, Forbes, The Chicago Tribune, Addiction Pro magazine, San Antonio Business Journal and many more. There is a 24-hour Warriors Heart hotline (844-448-2567) answered by warriors. https://www.warriorsheart.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Strategic combination strengthens Aprio's growing National Dental Practice

ATLANTA (PRWEB) DECEMBER 01, 2020
Aprio, LLP, a nationally recognized, top 50, CPA-led business advisory firm headquartered in Atlanta, announced today that it has combined with Charlotte-based Stowe & Stowe, Certified Public Accountants (Stowe & Stowe), forming a dental segment serving more than 400 dental practices nationwide.
Stowe & Stowe is a leading dental accounting firm in North Carolina and deeply rooted in the accounting industry. This strategic combination complements and expands Aprio's existing dental practice while providing Stowe & Stowe clients with comprehensive financial, accounting, tax and advisory services to help them thrive at all stages of practice ownership.
Aprio's National Dental Practice, led by Brad McKeiver, is a single-source growth partner for dental practices of all sizes. McKeiver has been serving the needs of dental clients for over ten years and is a recognized thought leader in the dental industry.
"The combination with Stowe & Stowe, along with the recent addition of Nashville-based firm WSW CPAs, furthers Aprio's strategic regional growth plans and strengthens our national dental segment," said McKeiver, Partner-in-Charge of Aprio's National Dental Practice. "We are thrilled to expand our reach and bring Aprio's sophisticated and specialized financial planning, tax and consulting services to dental practices nationwide."
Tom Stowe, principal & founder of Stowe & Stowe, will join Aprio as a partner working alongside McKeiver in Aprio's National Dental Practice. Stowe has more than two decades of experience partnering with dental clients across the Southeast.
"Having known Brad for many years, I'm excited to join forces with Aprio and impact our clients by helping them make sound business decisions," said Stowe. "Aprio provides solutions to grow the profits of dental practices, meeting dental clients where they are today and propelling them to what's next for tomorrow."
Aprio's full suite of dental offerings includes traditional tax and accounting services, business planning, due diligence and financial management. Additionally, Aprio's dental practice provides dentists with managed accounting services and real-time access to their financials through a customized dashboard. Using Aprio's technologies, dentists can harness the power of timely, accurate and meaningful financial insights to make better, faster business decisions so they can stay focused on providing the best care to their patients.
For more information about Aprio's National Dental Practice, visit https://www.aprio.com/industry/dental.
About Aprio
Aprio is a premier full-service, CPA-led business advisory firm that advises clients and associates on how to achieve what's next. Aprio's associates work as integrated teams across advisory, assurance, tax, cloud accounting solutions and private client services, bringing the best thinking and personal commitment to each client. Across practices, Aprio brings together proven expertise, deep understanding and strategic foresight for industries including Manufacturing and Distribution; Non-Profit and Education; Professional Services; Real Estate and Construction; Retail, Franchise and Hospitality; and Technology and Blockchain. In 65 years, Aprio has grown to over 600 team members. To serve clients wherever life or business may take them, Aprio's teams speak more than 30 languages and work with clients in over 40 countries. The firm is headquartered in Atlanta, Georgia. For more, visit https://www.aprio.com.
About Stowe & Stowe
Stowe & Stowe, CPAs is a certified public accounting firm located in Charlotte, North Carolina, specializing in dentistry. Stowe & Stowe provides a full range of both personal and professional services to help dentists meet their tax, accounting, financial, practice management and marketing needs. Stowe & Stowe's unique knowledge of the dental profession enables specialized service, allowing clients to spend more time with patients and less time crunching numbers.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

This is the first and only CBD brand created by a leading Gerontologist and formulated for the unique needs of midlife and active seniors.

POLAND, OHIO (PRWEB) DECEMBER 01, 2020
Ohio-based Sapphire Essentials announced today the full launch of their unique CBD product line, designed specifically to meet the needs of active adults and seniors. Sapphire products are made in the USA and use a proprietary & organically-grown hemp plant which delivers a broad spectrum, phytocannabinoid-rich and 100% THC-free CBD complex.
Sapphire Essentials was founded by nationally recognized healthy aging expert Dr. Jim Collins. As a Gerontologist focused on wellness and health care for seniors and older Americans, his 30-year plus career has spanned everything from Geropsychiatry to home health regimens for active seniors.
"I have been passionate about helping older and aging Americans. Members of this community, often overlooked by both traditional and holistic medicine, struggles daily with numerous physical and emotional health conditions. But they should not have to," said Collins. With a burgeoning marketplace full of hemp-based "cures," Collins differentiates his line. "While many CBD supplements are created with industrial hemp, and produce lower amounts of CBD, their end crop doesn't yield the best medicinal outcome. We cultivate a proprietary strain of hemp specifically bred for the most medicinally concentrated cannabinoid strains of medical cannabis—without causing a drug high. You enjoy the benefits without the worry."
Sapphire Essentials stands by their quality and can prove the standards they set make a difference. That starts with the type of cannabis used to make their products. Grown in the United States, their hemp is fully licensed and registered with the Colorado State Department of Agriculture. It is Non-GMO, GMP compliant, eco-friendly, solvent-free, lab tested and grown without pesticides. But Dr. Collins goes even further, asking those interested to do their homework, research the possible benefits of CBD, and read results on Sapphire Essentials' website from third party testing of his products.
Dr. Collins also enlisted the help of another powerful voice in medicine. Dr. Leonard Wisneski, MD, has extensive knowledge and interest in the benefits of CBD and therapeutic applications involving the endocannabinoid system. With thirty years in the clinical practice of endocrinology, Dr. Wisneski is a recognized leader globally in the field of integrative and whole person health. His role at Sapphire Essentials is as a medical and scientific advisor.
"From my work with NIH, fellowships, time as an adjunct professor, and work with patients, I can easily marry the thought processes and results of cutting-edge research with that of the traditional doctor-patient experience. So, I understand how doctors treat aging issues and where science can go to do even more. I am proud to partner with Sapphire Essentials to help the aging community explore the possibilities for living a better life," said Dr. Wisneski.
Every Sapphire Essentials product is fully lab tested and certified. Certificates of testing and information can be found on our website at http://www.sapphire-essentials.com. We are proud to offer consumer and wholesale partnerships on the website as well.
About Sapphire Essentials
Sapphire Essentials believes that everyone should be able to afford CBD supplements for their health and wellness. Our goal is to maximize quality of life organically for as many people as possible. Sapphire Essentials was created by a Gerontologist, licensed social worker, and a leader in senior care and we understand that older adults struggle daily with a number of physical and emotional health conditions. And while federal regulations will not allow us to state that CBD may help with specific ailments, we encourage everyone to do their research and become more educated on the possible benefits of CBD. For more information about Sapphire Essentials or our team, please visit http://www.sapphire-essentials.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Dr. Julianne Arena of Plymouth, MA brings Cliovana to Waves of Awakening Center for Personalized Medicine - the first completely non-invasive treatment designed specifically to improve women's arousal levels and their orgasm frequency and intensity.

PLYMOUTH, MASS. (PRWEB) DECEMBER 01, 2020
A prominent leader in female health, Dr. Julianne Arena, of Waves of Awakening Center for Personalized Medicine, is adding this first-of-its-kind treatment for women to her integrative medical practice.
Waves of Awakening offers a personalized, integrative and functional approach to healthcare delivered by qualified, compassionate, and experienced providers. Their purpose is to provide patients the opportunity to improve their overall health and well-being.
Dr. Arena describes Waves of Awakening as a practice created by women warriors of healthcare and change. "I have always had an interest in the art as well as the science of healing. In May of 2016, I went to a conference on Integrative Medicine in Women's Health. I could not believe there was so much out there that I hadn't learned in conventional medical training to help my patients, my family and myself. My passion for healing was reignited and for me, there was no turning back."
Cliovana is a simple, completely non-invasive way to increase women's arousal levels and their orgasm frequency and intensity. Cliovana does not use lasers, scalpels or needles, so there are no dangerous side effects. Many women want to get more out of sex but they want to do it in a way that respects their body. Cliovana is the perfect solution because it enhances arousal at the cellular level, and causes your body to do more of what it does naturally - regenerate cells.
So how does Cliovana work? The body is always regenerating cells. Cliovana stimulates the body to do more of that, specifically in the genitals, and can lead to an increase in women's long term sexual responsiveness. The technologies employed by Cliovana have been used for decades, all over the world, for a variety of health issues. The treatment is a total of four sessions at less than 10 minutes each, over the course of 2 weeks. Because it is 100% noninvasive, there is zero downtime.
Waves of Awakening is the first medical practice in Massachusetts to offer Cliovana treatments. Patients can find more information about the treatment as well as schedule a free consultation at https://www.cliovana.com
Learn more about Cliovana
https://cliovana.com
practitionerinfo@cliovana.com
1-888-583-5134
@cliovana
About Dr. Julianne Arena and Waves of Awakening Center for Personalized Medicine
Dr. Arena received her undergraduate degree at Harvard University and graduated from Boston University School of Medicine. She completed her residency in Obstetrics and Gynecology at Baystate Medical Center in Springfield MA. She then practiced conventional medicine as a board certified Ob/Gyn physician for 15 years before she had her own awakening.
Dr. Arena's patient population includes young teens through and past menopause for well gynecology care and pap smears as well as those that want to address issues related to the thyroid, digestion, stress, infertility, weight, adrenals, hormone imbalance and sexual health



START your own Wordpress site, business or personal website, or online store at www.siteground.com

This online event, 4th in the series scheduled on December 3rd, facilitates academic and industry collaboration across healthcare verticals in response to the evolving COVID-19 global pandemic

YORBA LINDA, CALIF. (PRWEB) DECEMBER 01, 2020
LabRoots, the leading scientific social networking website offering premier, interactive virtual events and webinars, today announced the last event as part of its ongoing free Coronavirus Virtual Event Series hosted on December 3rd, 2020, covering the impacts of the coronavirus disease. The preceding events with on demand presentations (April 2, June 17 and September 17) held record attendance, and this upcoming conference promises to generate resumed hot topics and expanded awareness.
The virtual stage comprising over 12,000 research scholars, healthcare and medical experts, clinicians, top scientists and epidemiologists, and industry and academia professionals from around the world, features a jam-packed agenda highlighting wide-ranging topics.
Key sessions include, transmission dynamics of SARS-CoV-2: Inference and Projection, the Immunology of COVID-19, via a joint panel session sponsored by Nanostring Technologies to better understand the current knowledge on the dynamics of the immune response, followed by a second panel opportunity on Advancing SARS-CoV-2 Testing Today and a New Serology Approach for High Throughput Screening, sponsored by LGC Seracare. Moreover, Dr. Linfa Wang, Professor and Director, Emerging Infectious Diseases, Duke-NUS Medical School will provide a review of major emerging zoonotic virus outbreaks, in addition to other notable speaker presentations on COVID-19 RNA and DNA vaccines; an Iterative Approach to Structure-based insilico to in vivo Development of Combinatorial Anti-SARS-CoV-2 Therapy; Development, assessment and commercialization of serological SARS Cov-2 tests; NGS Workflows for Studying Infectious Disease; Putting Covid-19 into Context; and Immunity, Aging and COVID-19: where do we stand, naming other talk titles.
With rapidly shifting developments and advancements, it's important to unveil such valuable insights from the following prominent speakers through their keynote deliveries:
Monica Gandhi, MD, MPH, Professor of Medicine and Associate Chief, Division of HIV, Infectious Diseases, Global Medicine, UCSF, Director, UCSF-Gladstone Center for AID Research (CFAR) – "Facial Masking for COVID-19: Transmission, Severity and Immunity."
Matthew J. Memoli, MD, MS, Director, LID Clinical Studies Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) – "Prevalence of SARS-Co-V-2 Immunity in Those Undiagnosed with COVID-19 in the U.S." discussing immunity, antibody testing and the meaning of these tests and the findings of the NIH serosurvey in terms of immunity by geography and demographic groups.
Ali H. Mokdad, PhD, Chief Strategy Officer, Population Health, University of Washington, Director, Middle Eastern Initiatives, Professor, Health Metric Sciences, Institute for Health Metrics and Evaluation, School of Medicine – "COVID-19 Projections for the United States," revealing the drivers of COVID-19 surge, the projected numbers of cases and deaths, and the measures to contain the virus.
"Non-pharmaceutical interventions for COVID-19 prevention (facial masks, social distancing, hand hygiene, and ventilation) have been pivotal for prevention efforts to date and will continue to play a role in COVID-19 mitigation as we go through the process of achieving equitable distribution of a safe and effective vaccine," commented Dr. Monica Gandhi, Infectious Diseases Doctor, Professor, and Director of the UCSF Center of AIDS Research at UCSF." Gandhi added, "Facial masking is a cornerstone of the COVID-19 pandemic control but has had controversy. This talk will go over the epidemiologic data on facial masks curbing SARS-CoV-2 transmission, the physical sciences data on how masks protect both you and others, and the role of NPIs in reducing viral inoculum which may reduce the severity of disease if infected."
Matthew Memoli, Director, LID Clinical Studies Unit, Laboratory of Infectious Diseases, NIAID/NIH said, "Respiratory viruses like COVID-19 and Influenza challenge scientists to explore the complexity of the immune response and correlates of protection. Broad investigation using translational studies in humans are imperative to our efforts to design efficacious, balanced countermeasures in an informed way that will lead to significant success in limiting the deleterious impact of these infections without destroying society or removing our humanity."
"We have been fortunate to have various informative and enlightening discussions shared by renowned experts tackling some of the biggest questions facing the world today over the duration of our Coronavirus Virtual Event Series this year," said Greg Cruikshank, Chief Executive Officer of LabRoots. "During this COVD-19 pandemic and other future events, LabRoots will continue to be a source of bringing educational content to the forefront to empower the life sciences community, while presenting lessons learned and best practices for mitigation, preparedness, response and recovery strategies making a larger impact in the response to COVID-19 and human health, now and in the future."
Produced on LabRoots' robust platform while connecting across all desktop and mobile devices, the interactive environment is complete with a lobby, auditorium, poster hall, exhibit hall (driving innovations and highlighting the latest products and technologies), and networking lounge (encouraging collaborations), providing a one-stop learning experience for all attendees. By participating in this virtual event series, you can earn 1 Continuing Education credit per presentation.
For more information or to register for the event, click here. Participants can follow the conversation online by using #LRcoronavirus.
About LabRoots
LabRoots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, LabRoots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Dr. Keegan's proven experience with building innovative life science companies will help guide Carterra as it expands its unique protein and antibody characterization platform globally with additional products, assays, and analytical capabilities.

SALT LAKE CITY (PRWEB) DECEMBER 01, 2020
Carterra Inc., the world leader in high-throughput antibody screening and characterization, has announced that Joseph D. Keegan, PhD has been appointed as Executive Chairman of the Board of Directors.
Dr. Keegan has been a member of Carterra's board for the last five years and has over 30 years of experience leading public and private life science platform companies. As CEO of ForteBio, Inc., he established product development and commercial strategies that resulted in its rapid growth and acquisition by Pall Corporation. During his nine-year tenure as CEO of Molecular Devices Corporation (MDC), he grew the company's revenues through internal growth and acquisitions. In early 2007, he oversaw the acquisition of MDC by MDS Corporation for $615M.
"We are pleased to welcome Dr. Joe Keegan as Executive Chairman at this exciting time in the growth of the company," said Josh Eckman, Carterra's Chief Executive Officer. "Our flagship platform, the Carterra LSA, is disrupting the traditional antibody discovery workflow and playing a key role in speeding the development of biotherapeutics for a variety of diseases, including COVID-19. Dr. Keegan's leadership experience in analytical instrumentation will be significant to our continued growth and success."
Dr. Keegan holds a B.A. in Chemistry from Boston University and a Ph.D. in Physical Chemistry from Stanford University. He currently serves on a number of Boards of Directors, including those of Bio-Techne and Interpace Biosciences. Dr. Keegan's proven experience with building innovative life science companies will help guide Carterra as it expands its unique protein and antibody characterization platform globally with additional products, assays, and analytical capabilities.
"I am excited about assuming the role of Executive Chairman at Carterra," stated Dr. Keegan. "I look forward to working alongside my fellow board members and company leadership to bring the world's highest throughput, lowest sample consumption and most multiplexed label-free biosensor platform to every corner of the globe."
About Carterra, Inc.
Carterra is the leading provider of high throughput technologies designed to accelerate and improve the discovery of novel therapeutic candidates. Carterra's LSA instrument, software, and consumables for monoclonal antibody (mAb) characterization deliver up to 100 times the throughput of existing platforms in 10% of the time while using only 1% of the sample required by other systems. The LSA combines patented microfluidics technology with real-time high throughput Surface Plasmon Resonance (HT-SPR) and industry-leading data analysis and visualization software to revolutionize mAb screening. Carterra, Inc. is based in Salt Lake City, Utah, and has Customer Experience Centers in San Francisco, Salt Lake City, Boston, and Munich, Germany. For additional information, please visit http://www.carterra-bio.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

clEAR, a leading provider of hearing healthcare, announces a category-defining digital therapeutic for hearing loss coined Amptify. Amptify enables organizations to offer comprehensive, evidence-based hearing healthcare to their populations.

ST. LOUIS (PRWEB) DECEMBER 01, 2020
Amptify, the world's first digital therapeutic for hearing loss, is groundbreaking in what it offers to those seeking hearing loss solutions for their patients or managed care populations. Currently, hearing loss treatment consists of diagnostics and hearing aid distribution with little or no follow-up hearing loss therapy, support, or counseling -- all of which are clinical best practice. Amptify was created by audiologists, academics, and technologists to provide an innovative pathway for hearing healthcare professionals and managed care organizations to offer best practice hearing loss treatment in a way that is clinically feasible.
Amptify participants experience a merging of digital health and aural rehabilitation that supplements their hearing instruments and produces a scientifically-backed and patient-proven therapy for hearing loss. Sponsored participants can access Amptify by downloading the iOS or Android app, which include clinically validated auditory and cognitive training video games. These games have been shown to develop speech perception skills, increase listening confidence, and enhance conversational fluency.
Amptify participants also gain access to interactive hearing health lessons, a managed peer-support community, and a certified Amptify Hearing Health Coach. Coaches provide one-on-one support and encouragement, track participants' weekly training and curriculum progress, and provide personalized assistance and guidance on how to improve and reach each participant's hearing goals.
In the United States, one in three people over the age of 65 has hearing loss. Unfortunately, people who suspect hearing loss wait about 7 years before seeking treatment. As a result, they increase their risks for experiencing adverse social, medical, and vocational consequences. Untreated hearing loss can lead to social isolation, depression, early retirement, and cognitive decline. Those with untreated mild hearing loss have a higher probability of suffering Alzheimer's disease and related dementias than those without hearing loss. Correspondingly, healthcare costs are 46% higher for those with untreated hearing loss. If people receive treatment earlier, they may reduce their risk of adverse consequences including dementia progression.
Professor Nancy Tye-Murray, clEAR Co-founder and CEO, is a prolific researcher and strong proponent of incorporating aural rehabilitation into routine audiology practice. She says, "I've spent my entire professional career making it possible for clinicians to provide quality aural rehabilitation in a way that is both economically and practically feasible. Amptify completes the hearing healthcare journey --- after diagnostics and the hearing aid fitting, clinicians can now efficiently and easily provide aural rehabilitation with Amptify. And, people can get the complete hearing therapy they deserve."
Amptify targets three customer bases - enterprise clinical hearing care providers, employers who want to improve their employees' hearing health, and hearing aid manufacturers who wish to incentivize purchases and adherence to their hearing aids. Amptify's pricing varies based upon feature set and population size. For organizations sponsoring 100 participants, plans start at $49 per participant per month.
"The field of audiology is rapidly changing in line with movements in the greater digital and telehealth industries. Due to regulatory, technological and demographic alignments, the hearing healthcare space is ripe with opportunities to improve patient care with digital health tools. Amptify is well positioned to realize great growth based on these trends." added clEAR President and COO Chris Cardinal.
For detailed information on Amptify including its clinical research, contact Chris Cardinal and visit https://amptify.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Grant to support expanded services to vulnerable seniors during the COVID-19 pandemic

MINEOLA, N.Y. (PRWEB) DECEMBER 01, 2020
The Huguette Clark Foundation announced today that it has awarded a second grant to the Family and Children's Association (FCA) of Long Island to support its Safe Observant Seniors (SOS) program. The $50,000 grant is the largest award by the Foundation to date and reflects the success of the SOS program in its first year and the urgent need to address the rise in senior exploitation during the COVID-19 pandemic.
The SOS program is part of Nassau County's first elder abuse multi-disciplinary team, which coordinates case management and counseling, Adult Protective Services, the District Attorney's office, legal and medical representatives, and law enforcement to help the victims of elder exploitation.
The COVID-19 pandemic has increased the isolation of seniors and made them more vulnerable to crime. Felony arrests in crimes against seniors compared tripled as of August 2020 compared to a year earlier, according to the Nassau County District Attorney's office. As a result, the Foundation believed it was essential to fund direct services to victims of elder exploitation.
Since its inception in 2013, the Foundation has developed a reputation for funding innovative programs to address elder abuse, using relatively small, targeted grants to achieve outsized results. The Foundation's support helped FCA attract and secure additional sources of funding for the SOS program.
"Programs like SOS provide vital support to seniors at a time when they suffering from the effects of the COVID-19 pandemic," said Ian Clark Devine, president of the Huguette Clark Foundation. "We are pleased to support the SOS program for a second year so that it can expand its services to seniors. Its record demonstrates that a multi-disciplinary approach can be very effective, and we hope it can be a model for other communities."
Dr. Jeffrey Reynolds, FCA President & CEO, said: "This grant is critical to FCA's efforts to protect and serve Long Island's lonely, isolated and vulnerable seniors, all of whom are at much greater risk for exploitation during the COVID-19 crisis. We are grateful for the Huguette Clark Foundation's continued support and we look forward to building on our successes as we head into 2021."
About the Huguette Clark Foundation
The Huguette Clark Foundation for Protection of Elders was created by members of the Clark family to honor their late aunt, Huguette Clark, who was victimized by her caregivers and advisors for more than two decades. The Foundation supports innovative organizations and programs to fight the financial abuse of elders, addressing needs often overlooked by traditional programs. The Foundation's strategy is to make targeted early-stage grants to develop programs that later can be scaled or replicated for broad impact. Grants are related to the abuse that Huguette Clark herself suffered, specifically the prevention of undue influence, manipulation and financial exploitation by institutions and professionals.
The Huguette Clark Foundation, a tax-exempt public charity, has awarded grants since 2013 to support innovative education and advocacy programs to combat elder exploitation. Earlier grants provided financial support for programs to train Adult Protective Service workers; help banks implement federal guidelines for sharing customer information with investigatory agencies in cases of suspected elder financial exploitation; and develop model civil statutes to help victims of financial exploitation seek justice, recover assets and rebuild their lives. For more information, please see: http://www.huguetteclarkfoundation.org.
About FCA
FCA is a nonprofit agency helping more than 30,000 Long Islanders each year. For over 135 years, the organization has worked to protect and strengthen vulnerable children, seniors, families, and communities on Long Island.
FCA believes in the potential of Long Island - a place where no child, senior, family or community is left to struggle alone with barriers to health care, education, employment, or economic prosperity. Long Island continues to be one of the greatest places in the world to live and raise a family for many; FCA exists to ensure that be the case for all.
For more information about FCA, please visit: http://www.fcali.org.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Leading Software-as-a-Service provider for the healthcare market certifies its alliance with the industry leader in evidence-based guidance

TUCSON, ARIZ. (PRWEB) DECEMBER 01, 2020
MCG Health, part of the Hearst Health network, announces HealthTrio, an innovator of healthcare digital-experience solutions, is now a certified strategic alliance partner following the integration of their HealthTrio Authorizations with MCG's Cite AutoAuth solution. The combination of these platforms allows for the incorporation of medical policy directly within a healthcare provider's authorization workflow, streamlining manual prior authorization reviews, and automating steps in the overall process.
Within the healthcare industry, the prior authorization process can be costly, time-consuming, and often overly complex for providers and payers alike. These challenges can cause delays in care delivery and frequently lead to administrative inefficiencies in payer-provider communication. However, HealthTrio and MCG are on a mission to streamline and transform the prior auth workflow by integrating their respective technologies. Their combined, web-based solution facilitates automated, evidence-based reviews to support optimal clinical efficiency. Located within HealthTrio's provider portal, HealthTrio Authorizations incorporates a payer or health plan's custom rules and MCG's industry-leading, evidence-based clinical content directly into the submission process. This helps improve up-front information gathering from providers and reduces manual workflows for the payer's staff. Leveraging this powerful combination, healthcare providers can easily include the results of their medical review within the authorization request, allowing payers, in most cases, to automatically return the authorization determination without manual process steps or duplicative reviews.
"MCG Health is well-recognized across the industry as a gold standard of clinical excellence, and we're very proud of our partnership," said Dominic Wallen, President and COO of HealthTrio. "By joining forces, our combined solution improves quality, decreases time-consuming manual processes, and reduces unnecessary cost for both payers and providers."
"MCG is proud to partner with HealthTrio to incorporate evidence-based guidance into the prior auth process," added Jon Shreve, MCG's President and CEO. "The integration of HealthTrio Authorizations and MCG Cite AutoAuth will help providers and payers support timely clinical decisions that will ultimately be a benefit to the patient."
About HealthTrio
HealthTrio provides digital engagement solutions that optimize self-service, value-based care, healthcare consumerism and real-time data integration. Our selection of tools is as broad as the markets we serve – from everyday tools such as eligibility, benefits and claims to advanced features supporting provider quality performance, cost transparency and automated authorizations. With in-depth security capabilities, HealthTrio's platform extends beyond the traditional member, provider, employer and broker access to include guests, caregivers, community-based organizations and a variety of other user types. For over twenty years, HealthTrio has supported health plans, administrators and integrated delivery networks to decrease costs, increase access and improve health outcomes. For more information, visit healthtrio.com or contact us at learnmore@healthtrio.com.
About MCG Health
MCG, part of the Hearst Health network, helps healthcare organizations implement informed care strategies that proactively and efficiently move people toward health. MCG's transparent assessment of the latest research and scholarly articles, along with our own data analysis, gives patients, providers, and payers the vetted information they need to feel confident in every care decision, in every moment. For more information visit http://www.mcg.com or follow our Twitter handle at @MCG_Health.
About Hearst Health
The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person's health journey. Each year in the U.S., care guidance from Hearst Health reaches 85 percent of discharged patients, 205 million insured individuals, 103 million home health visits, and 3.2 billion dispensed prescriptions. The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase, and MHK (formerly MedHOK). Hearst also holds a minority interest in the precision medicine and oncology analytics company M2Gen. Follow Hearst Health on Twitter @HearstHealth and LinkedIn @Hearst-Health.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Metagenomics Leader Recognized by CAP based on On-Site Inspection

SAN FRANCISCO (PRWEB) DECEMBER 01, 2020
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to IDbyDNA Inc., the company revolutionizing the use of metagenomics to improve health by decoding the unknown, based on results of a recent on-site inspection as part of the CAP's Accreditation Programs.
The facility's director, Robert Schlaberg, MD, PhD, MPH, was advised of this national recognition and congratulated for the excellence of the services being provided. IDbyDNA is one of more than 8,000 CAP-accredited facilities worldwide.
"This recognition further demonstrates our commitment to the highest levels of metagenomic testing," said Dr. Schlaberg. "To be recognized for our excellence by the world's largest organization of board-certified pathologists serves as another confirmation that we're not only advancing our field with great work, but we're also doing it the right way."
IDbyDNA's Chief Executive Officer, Guochun Liao, PhD, MBA, added, "The value of an accreditation from CAP cannot be overstated for strengthening our positioning within our scientific community, as well as the business community and investors. Third-party validation is of the utmost importance in the scientific community and we're honored to receive it from CAP."
The U.S. federal government recognizes the CAP Laboratory Accreditation Program, begun in the early 1960s, as being equal-to or more-stringent-than the government's own inspection program.
During the CAP accreditation process, designed to ensure the highest standard of care for all laboratory patients, inspectors examine the laboratory's records and quality control of procedures for the preceding two years. CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, and overall management.
About IDbyDNA
IDbyDNA is revolutionizing the use of clinical metagenomics to improve health by decoding the unknown. IDbyDNA's product suite delivers unparalleled data analytics and industry-leading expertise to support medical laboratories with actionable infectious disease testing and pathogen surveillance. By profiling tens of thousands of microorganisms from any specimen with a scalable and intuitive approach, IDbyDNA empowers healthcare providers with greater depth and transparency for better identification of pathogens in order to accelerate triage and treatment and improve public health. For more information, visit http://www.idbydna.com or reach out to us on Twitter, Facebook, LinkedIn, Vimeo or YouTube.
About the College of American Pathologists
As the world's largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, read the CAP Annual Report at cap.org.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Upcoming free, educational webinars from Xtalks Webinars will feature topics on biomarkers, clinical trials, commercialization and HEOR, drug discovery & development, food, healthcare, laboratory technology, medical devices, pharmaceuticals and pharmaceutical regulations.

TORONTO (PRWEB) DECEMBER 01, 2020
Stay on top of current hot topics through free webinars presented by leading experts in pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field!
Visit http://www.xtalks.com to see our upcoming webinars:
BIOMARKERS
December 1- A Biomarker Journey in Immuno-Oncology Utilizing Immunohistochemistry
CLINICAL TRIALS
December 1- Digital Technologies for Assessing Patient Functioning in Multiple Sclerosis Clinical Trials
December 2- Case Study: Transforming Clinical Data Management from Legacy Processes to a Modern EDC Approach
December 3- The Value of Early Site Selection in Type 2 Diabetes Trials
December 3- Engaging Diverse Patient Populations in Rare Genetic Disease Clinical Research
December 4- Developing a Digital Protocol for Dermatology Trials: A Step-by-Step Guide to Optimizing Research for Patients and Clinicians
December 7- Risk-Based Optimization or Forecasting? The Impact on Clinical Trial Supply Planning
December 8- Meeting the Needs of Rare Disease Patients in Clinical Trials During the COVID-19 Pandemic
December 10- Designing a Successful Imaging-Based Pediatrics Clinical Trial
December 10- Enabling Decentralization with Patient-Focused eClinical Solutions
December 14- Strategic Comparator Sourcing in China: Optimizing the Clinical Supply Chain
December 15- Direct-to-Patient: Implementing Models for Continuous Treatment During the Pandemic and Beyond
COMMERCIALIZATION AND HEOR
December 7- Using R Shiny to Create Interactive and Web-Based Health Economic Models: Challenges and Opportunities
DRUG DISCOVERY AND DEVELOPMENT
December 3- Better Connections with Patients Using Data from Digital Pills
December 7- Strategies to Optimize Your Drug-Drug Interaction Program
December 10- Helping NASH Study Sites to Succeed: Insights into Operational Best Practices
December 11- Stabilizing the Unstable: Sample Stabilization Approaches for Unstable Compounds in Biological Matrices
December 14- Single-Cell Genomics Applications in Oncology Therapeutic Development: Resolving the Complexity of Cancer Heterogeneity
December 15- Maximizing Biorepositories for Research & Drug Discovery
FOOD
December 1- Wellness in a Bottle Series: What Do Consumers Want? (They Told Us)
December 4- Making Cultivation Financially Profitable and Optimizing Farm Potential with 'Smarter Sesame'
December 7- Blockchain for Business Partners: Three Examples of Technology and Channel Partners Innovating with IBM Blockchain
December 9- Food and Beverage Industry Outlook for 2021
December 16- 2020 Pandemic: Key Learnings for the Food and Beverage Supply Chain
HEALTHCARE
December 2- Test. Better. Enhanced NIPT Reporting for Patients with Positive Results
December 8- Muscle-Liver Crosstalk and Sarcopenia in Chronic Liver Disease: Novel Techniques and Clinical Evidence
December 9- Laboratory Analysis of the ePlex Blood Culture Panels for Timelier Diagnosis of Gram-Negative and Gram-Positive Bacteremia
LABORATORY TECHNOLOGY
December 16- Imaging AI and Machine Learning – Beyond the Hype
December 17- NeXT Liquid Biopsy: A High-Performance, Exome-Wide Liquid Biopsy Assay to Study Tumor Dynamics
December 17- Revolutionizing Risk-Based Monitoring Through On-Study Analytics
MEDICAL DEVICES
December 11- Introduction to the 3DEXPERIENCE License to Cure and its Applicability in Audit-Ready Medical Device Development
December 11- Selecting the Fast Path in Diagnostics Manufacturing Without Sacrificing Performance
December 17- The IVDR Journey: A Roadmap to Meet 2022 Deadlines
PHARMACEUTICAL
December 2- How to Maximize Pharmaceutical Supply Chain Efficiency and Security From Manufacturer to Patient
December 8- How Aseptic Filling Can Make Up Lost Time in a Drug Development Program
December 10- Pharmacovigilance Audit Failures: What's Still Going Wrong?
December 15- From Promise to Reality: MyoKardia and Medpace Talk Precision Medicine in Cardiovascular Disease
PHARMACEUTICAL REGULATION
December 2- Creating Efficiency with Metadata-Driven End-to-End Standards
December 14- Meeting Pharmacopeia Regulations & Controlling the Risk of Contamination in Pharmaceutical Waters
December 17- The RACE for Children Act: Early Global Impact and Ensuring Success with Pediatric Champions
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://www.xtalks.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

New playbook from Updox details implementation best practices based on survey of 3,000 healthcare providers and shares how leading organizations have successfully adopted virtual care solutions to transform their practices and see significant ROI

DUBLIN, OHIO (PRWEB) DECEMBER 01, 2020
Updox, the only place to manage healthcare communications across both in-person and virtual care, today released its Virtual Care Playbook: Four Steps to Connecting the Dots and Piecing Together Your Virtual Care Strategy. The COVID-19 pandemic has accelerated the consumerization of healthcare, and successful healthcare practices, health systems and pharmacies are not only implementing a variety of virtual care solutions to meet patient expectations, but are connecting the dots between them to create a streamlined virtual care experience. The Updox playbook -- which comes on the heels of Updox's Virtual Care Report and survey of more than 3,000 practices on their virtual care experiences -- provides healthcare organizations with strategies on how to implement an effective virtual care strategy, sharing the real experiences of Updox customers.
Prior to the current public health crisis, the majority of patients reported being unhappy with their healthcare experiences. While many health systems and other healthcare organizations historically relied on the telephone or patient portals to communicate with patients, studies show almost 50% were not using portals to access their medical records. Considering this, as we move toward a post-COVID world, the practice of healthcare must be reinvented in order to increase patient satisfaction and engagement.
"Patients today are demanding faster, more convenient access to healthcare. That's driving all practices, regardless of size, specialty, or location, to transform and modernize all aspects of care as patient preferences continue to shift," said Michael Morgan, CEO, Updox. "While nearly 94% of practices have reported using telehealth as a result of the COVID-19 pandemic, it's imperative that providers remember telehealth is just one piece of the puzzle. The next step is for all healthcare organizations to implement a custom virtual care strategy that is tailored to a practice's specific needs to create the ideal experience for their patients. Our playbook collects best practices across the full scope of healthcare to help providers and make that process as seamless as possible."
Seeking a way to save staff time and effort, Williamsburg Drug Co. adopted multiple Updox solutions -- including Secure Text, Broadcast, Video Chat, and more -- to ensure the pharmacy was running more efficiently. According to Adam Brown, CPhT, director of IT and CLIA Laboratory manager for Williamsburg Drug Company, "Everything we get from our individual Updox solutions add up to big savings. Leveraging Secure Text, for example, we have increased staff productivity by 30% while simultaneously reducing patient no-shows to zero. Utilizing electronic fax and forms has also made a world of a difference, as the pharmacy has saved roughly $1,000 a month on office supplies. Thanks to Updox, our pharmacy is more profitable and efficient than ever."
Furthermore, Bridgeport Family Medicine headquartered in Tigard, Oregon, has experienced rapid growth since being founded roughly six years ago -- even throughout the COVID-19 pandemic. With a staff of seven physicians serving more than 10,000 patients, the practice needed to implement innovative technology as it grew in order to continue delivering the deep personalized care its founders had always promised. With Electronic Fax, Bridgeport Family Medicine was able to alleviate the back-and-forth of a fax machine, saving up to $750 a month on the cost for hardware, phone lines, paper, toner, and shredding, while also reducing much of the administrative burden on its staff. Implementing Updox Video Chat, the practice was also able to continue serving its patients during the public health crisis without having to lay off staff.
To learn more about how Updox's complete communication platform can enhance your patients' experiences, boost office productivity, and drive organizational profitability, visit http://www.updox.com/healthcare-crm. To download the full Virtual Care Playbook and start connecting the dots and piecing together your own personalized virtual care strategy, click here.
About Updox
The only place to manage healthcare communications across both in-person and virtual care, Updox offers one consolidated inbox for healthcare providers to manage the entire patient journey and office productivity. Through an all-in-one platform, Updox provides a broad set of capabilities for virtual health, patient engagement, and paperless office efficiency that work together to reduce costs and drive revenue. Updox is integrated with more than 100 electronic health records (EHR) and pharmacy management systems and serves more than 560,000 users and 210 million patients. Updox customers also benefit from an engaged user community for benchmarking, idea exchange and networking. Learn how we simplify the business of healthcare. Visit http://www.updox.com or follow the company on Twitter, LinkedIn and Facebook.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Greater collaboration on a secure digital platform across 16 locations will improve continuum of care for patients

DETROIT AND ATLANTA (PRWEB) DECEMBER 01, 2020
Karmanos Cancer Institute is pleased to announce that it will begin using the OncoLens cancer treatment planning software platform to hold tumor boards and multidisciplinary case discussions. Implementing OncoLens will make it easier for providers to participate in multidisciplinary team discussions through a streamlined and accessible platform where members can review patient cases in real-time and asynchronously. Using this secure platform allows for the consolidation of clinical trial information, electronic medical records (EMR), images, lab results and other information into one environment. Follow up action items are recorded and can be managed through the platform.
Tumor boards are critical to Karmanos' multidisciplinary approach. These treatment planning sessions allow specialty providers from many disciplines to discuss and plan treatment for patients. Participants include oncologists, radiation oncologists, radiologists, pathologists, surgeons, pharmacists, specialized nurse practitioners, dietitians, social workers and genetic counselors. By holding tumor board meetings, Karmanos offers access to a team of experts without requiring patients to see multiple specialists. Rather, patient cases are discussed in one setting, where each specialist can weigh in, providing the best possible expertise and patient treatment. With 16 locations in the Karmanos network, accessible collaboration is imperative.
Before the implementation of OncoLens, Karmanos held tumor boards in person or via conference call. While this allowed for effective communication, the use of OncoLens will enhance the process and efficiency by integrating EMR and other data to be shared seamlessly in real-time for all to review. Additionally, whether held online or in-person, tumor boards have previously required that all providers attend simultaneously. With the implementation of OncoLens, specialists can offer comments and feedback asynchronously and engage with other team members before or after the meeting.
The OncoLens platform provides clinical decision support to automatically match patients with potential clinical trials that are pulled from the study information portal, based on the specific cancer type and tumor characteristics.
The OncoLens platform enables system-wide treatment planning and standardization of care across a network that is consistent with evidence-based and customized care pathways. It allows peer-to-peer collaboration and instant reporting to provide perspective into testing and treatment recommendations, adherence to quality metrics and improvement opportunities.
"We have learned a great deal about the value and ease that can be facilitated by digital communication platforms during the COVID-19 pandemic. Even before this, Karmanos sought to remove communication barriers between our providers to offer the best cancer care possible to our patients. Thanks to the specialized offerings provided by OncoLens, multidisciplinary teams throughout the entire Karmanos system will be able to collaborate seamlessly and share information, whether they are stepping out of surgery, sitting at a desk or commuting to the clinic," said Justin Klamerus, M.D., M.M.M., President of the Karmanos Cancer Hospital & Network.
"With OncoLens and Karmanos working together, we will drive increased care coordination among multi-specialty providers in the network and community, leading to better patient care and increased referrals. Each cancer patient's case will be visualized by their care team and expert physicians at Karmanos, with the relevant clinical, imaging, genomic and other data, irrespective of location or busy schedules and tracked to Karmanos' high-quality standards. We are excited to work with a partner like Karmanos that shares our mission to bring the best possible care to the patient," said Anju Mathew, CEO and Co-Founder, OncoLens.
Since its founding, OncoLens has offered a platform that can easily aggregate patient-specific data in a HIPAA-compliant manner across different EMR/clinical/genetics information systems. In addition, patient-specific clinical trials at a facility or its affiliates, NCCN/ASCO guidelines and the latest research are automatically identified for each case to support the care team in making the best decision for the patient. For large healthcare networks and institutions like Karmanos, OncoLens provides an inter-connectivity tool that breaks down the silos of healthcare delivery.
OncoLens serves more than 8,000 cancer care providers across the country today, including those from NCI designated cancer centers, academic institutions, integrated delivery networks (IDN) and community cancer centers.
###
About OncoLens
OncoLens is a care treatment planning platform designed specifically to help cancer programs collaborate effectively with multidisciplinary teams across their care networks and within the affiliates and communities they serve. Our solutions include virtual tumor board technology, workflow automation, survivorship care planning, and clinical decision support capabilities that ultimately lead to increased standardization across the network, higher quality of care, enhanced engagement with affiliates, increased referrals, and reduced costs through greater efficiencies. For more information on OncoLens, please visit http://www.oncolens.com. Follow us on Facebook, Twitter, and LinkedIn.
About The Barbara Ann Karmanos Cancer Institute
Karmanos Cancer Institute is a leader in transformative cancer care, research and education through courage, commitment, and compassion. Our vision is a world free of cancer. As part of McLaren Health Care, Karmanos is the largest provider of cancer care and research in the state of Michigan. For more than 75 years, our administrative and research headquarters, along with our premier specialty cancer hospital, have been located in downtown Detroit. Our 15 network sites throughout the state deliver market-leading cancer care and clinical trials conveniently to the communities where many of our patients live. Karmanos is recognized by the National Cancer Institute as one of the best cancer centers in the nation. Our academic partnership with the Wayne State University School of Medicine provides the framework for cancer research and education – defining new standards of care and improving survivorship. For more information, call 1-800-KARMANOS (800-527-6266) or visit http://www.karmanos.org. Follow Karmanos on Facebook, Twitter, LinkedIn and YouTube.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

FDA's BDD program targets novel devices with the potential to provide patients with a more effective treatment for life-threatening or irreversibly debilitating diseases. SFC's insulin pod promises to substantially improve the lives of patients with diabetes.

FAYETTEVILLE, ARK. (PRWEB) DECEMBER 01, 2020
SFC Fluidics, Inc. (SFC) is pleased to announce that its interoperable insulin delivery pod (the PandaTM), in late-stage development, has been granted Breakthrough Device Designation (BDD) by the Food and Drug Administration (FDA). The interoperable insulin delivery pod is intended for the subcutaneous delivery of insulin at set and variable rates for the management of diabetes mellitus in persons requiring insulin. SFC's pod and its indications for use met several criteria designated by the BDD Program, including the promise of providing more effective treatment and offering significant advantages over existing approved or cleared alternatives.
SFC's advanced microfluidic pumping system (ePump) is designed to provide accurate delivery of extremely small doses of insulin without the resolution limits inherent in other commercially-available delivery devices. SFC believes its technology will effectively eliminate 95% of over and under dispenses of insulin.
SFC's proprietary Dispense Confirmation Sensor (DCS) represents a differentiating technology that can detect flow or no flow conditions of insulin in real-time. The DCS will quickly signal a lack of dispense for any reason. Currently available insulin pumps struggle with occlusion detection, especially at low doses. Some insulin pump systems cannot identify an occlusion for 20 hours or more, a very dangerous condition for patients. The DCS technology can detect an occlusion in six minutes or less.
Improved accuracy, precision, and resolution of dosing along with real-time confirmation of insulin delivery will allow dosing schemes and alert/alarm settings to be customized by a physician for each patient.
Barry Ginsberg, MD, PhD, Consulting Medical Director for SFC Fluidics stated, "This pod is truly a breakthrough in its safety, immediately detecting the common blockages to pump flow and preventing traumatic insulin overdosing. It also provides exceptional dose accuracy. As we progress to the next level of integrated diabetes care, these features will allow improved therapy of diabetes, resulting in better blood glucose control and fewer diabetes complications."
"SFC is honored to receive the Breakthrough Device Designation. Being recognized by the FDA as the developer of a potentially game-changing device demonstrates promise for the future of our company's role in improving diabetes therapy," added Anthony Cruz, CEO of SFC Fluidics.
This work was supported in part by funding from JDRF, the leading global organization funding type 1 diabetes research.
SFC would also like to acknowledge the National Institutes of Health, including the National Institute of Diabetes and Digestive and Kidney Diseases, for help in funding various aspects of product development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
About SFC Fluidics, Inc.    
SFC Fluidics, Inc. has a mission to advance healthcare and improve quality of life through our enabling microfluidic technologies. The company's vision is to become a recognized global leader in drug delivery, with a focus on insulin, where our unique product lines improve lifestyle and affordability. SFC Fluidics is a VIC Technology Venture Development portfolio company. For more information, please visit https://www.sfc-fluidics.com/ or follow us on Twitter: @sfcfluidics.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

A shared vision of supporting recovery through a food-first approach to health and wellness.

TIOGA, TEXAS (PRWEB) DECEMBER 01, 2020
Internationally recognized residential treatment center Healing Springs Ranch (HSR) is partnering with Culinary Services Group, a wellness-focused food service provider. HSR treats adults recovering from addictions, substance abuse, and other related mental health issues through a holistic approach that includes a Nutritional Wellness Program.
Rachel H. Graham, CEO, and Co-founder of Healing Springs Ranch and Rich Valway III President and CEO of Culinary Services Group, believe their companies have a shared vision of supporting recovery through a food-first approach to health and wellness. Each believes food can be used to support healing alongside traditional treatment methods.
HSR believes that nutritional education for its clients is imperative in their path to recovery. Through this partnership, the center will gain access to a large network of dieticians, training resources, and added support. CSG's Chef Corey Warnsley believes that nutrition and exercise are valuable tools both during and after the recovery process because they support digestive health, balanced hormones, healthy brain function, and insulin regulation which are all key factors in well-being.
"By providing our clients with an enhanced specialized nutrition program as part of their recovery, we continue to add value to their treatment plan." said Rachel H. Graham. "The added value of tracking each meal to meet core nutrition parameters, and eating the right balance of nutrients will help clients feel better faster, both emotionally and physically".
Culinary Services Group will build custom menus that support the Nutritional Wellness Program's goals of organic, healthy dining. These menus will focus on locally sourced food by building relationships with local farmers markets and produce vendors. Using specialized software, CSG will be able to track and ensure each meal meets core nutrition parameters to support recovery. Menus will be analyzed daily to include the right balance of both macro and micronutrients to provide balanced nutritional support to clients throughout treatment. Studies have shown that those in addiction recovery often lack key nutrients such as zinc, B vitamins, and protein. These nutrients have been found to support serotonin and dopamine production.
"Healing Springs wanted to enhance their holistic approach and educational messages regarding the importance of eating high quality food and using healthy recipes for their clients", said Scott Alme, VP of Business Development. "Top Nosh is able to bring them a level of support and resources they didn't have previously".
About Healing Springs Ranch
Tucked away on 80 acres of beautiful and serene lakefront property north of the Dallas Metroplex, HSR offers a truly Integrated Addictions Model, which addresses the underlying issues and unresolved trauma behind most, if not all, self-defeating addictive patterns and co-occurring symptoms and diagnoses. As an industry leader, HSR is actively involved in conducting on-going research and publication. HSR's mission is to provide more integrated treatment by offering innovative and cutting-edge therapeutic modalities. HSR currently offers ETT (Emotional Transformation Therapy), Trauma Model Therapy, and the BALM (Be A Loving Mirror) family recovery program. Through research, education, and quality services, HSR strives to raise the bar for best practice standards, matching the advances in science and technology to address this national epidemic in both the mental health and addiction fields.
Life Works Wellness (LWW) is a sister company to Healing Springs Ranch) and a part of Elevate Global Partners family of wellness companies. LWW is a new company focused on helping individuals with life balance, optimal performance, purpose, healthy communication skills, and general personal growth.
About Culinary Services Group
Culinary Services Group is a food service company on a mission to transform healthcare dining services. CSG believes that senior living, residential treatment centers and community hospitals should have access to high-quality, restaurant style food at an affordable cost. Today, the company prides itself on using fresh, locally sourced food and crafting custom menus that are tailored to each community they serve through resident feedback, regional preferences, and health and nutritional needs. CSG partnerships include a network of dietitian support, culinary education, and employee training resources. The company is dedicated to operating safe, clean kitchens that meet and exceed the CMS guidelines. Follow the latest news and resources from Culinary Services Group on their company blog.
Media Contacts
Lorna Stegall
Media Relations
817.807.2257
Lorna.Stegall@HealingSpringsRanch.com
Karen White
Director of Marketing
443-952-8156
kwhite@csgfood.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this free webinar, the featured speaker will discuss today's in vitro diagnostics (IVD) regulatory landscape and the rapidly approaching deadlines to comply with the new In Vitro Diagnostics Regulation (IVDR). Overcoming the shortage of notified bodies (NB) will be explored, along with assessing product portfolios and quality systems. Planning and implementing technical file remediation, as well as managing the IVD lifecycle will also be discussed.

TORONTO (PRWEB) DECEMBER 01, 2020
Between the COVID-19 pandemic and BREXIT negotiations, the rapidly approaching deadlines to comply with the new In Vitro Diagnostics Regulation (IVDR) may have a profound impact on market access to products and, ultimately, patient outcomes. Now more than ever, in vitro diagnostic (IVD) manufacturers will need to prepare for the upcoming changes to the clinical and regulatory landscape.
Understanding current guidance and adapted regulations is the first step to navigating transformations that the diagnostics and broader healthcare industries are undergoing.
Join this webinar to learn about today's IVD regulatory landscape and discuss how manufacturers can develop strategies to ensure a successful transition to comply with the IVDR by the 2022 deadline.
Join Ashleigh Dawley, RAC, Manager, Regulatory Affairs, Regulatory, Reimbursement and Market Access from ICON plc, in a live webinar on Thursday, December 17, 2020 at 11am EST (4pm GMT/UK).
For more information, or to register for this event, visit The IVDR Journey: A Roadmap to Meet 2022 Deadlines.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

First Quarter 2021 Launch Driven By Life Sciences Investment Momentum Nationally and Demand for Portal Platform in the Midwest. Platform Provides Seed Capital, Best-In-Class Lab and Office Space, and Management Expertise to Select Early Stage Life Sciences, Medtech and Bioinformatics Companies.

CHICAGO (PRWEB) DECEMBER 01, 2020
Portal Innovations today announced the formal launch of its premier life sciences-focused venture development engine in Chicago's Fulton Market neighborhood, where it will provide the critical resources that early stage companies need in order to succeed. The launch comes one year earlier than planned, a direct response to increased life sciences investment opportunities and demand by scientists and entrepreneurs for seed capital, specialized lab space and management expertise in the region.
Portal is partnering with Trammell Crow Company, one of the largest commercial real estate developers in the United States, to catalyze the life sciences ecosystem at the Fulton Labs Campus in the newly opened Fulton Labs at West End and Fulton Labs at Aberdeen opening in early 2022. Portal Innovation's phase 1 lab launch will include 11,000 square feet of wet and dry lab and office space at Fulton Labs at West End beginning in the first quarter of 2021. Portal's phase 2 lab launch will include 35,000 square feet of wet and dry lab and office space at Fulton Labs at Aberdeen beginning in the first quarter of 2022.
Portal's unique venture assembly and investment platform will bridge the gap between scientific ideation and entrepreneurial realization for the life sciences, medtech and bioinformatics companies it carefully selects. The venture development platform will deliver seed capital, management expertise, access to a massive network of life sciences experts and investors along with best-in-class lab and office space to high-potential start-ups.
"Portal Innovations is catalyzing and leveraging a dynamic Midwest life sciences ecosystem to create a portfolio of successful companies developing breakthrough products to help patients," said John Flavin, chief executive officer and founder of Portal Innovations. "We are excited to launch our space at Fulton Labs, the nucleus of the region where the best life sciences companies will have an opportunity to start and thrive as they grow."
The market need and opportunity for start-up lab incubation has been gaining momentum for some time. Healthcare venture capital fundraising is on track to reach a record high with over $15 billion in venture financing so far in the first quarter of 2020, according to Crunchbase. This is a strong indicator of the need for the critical services early stage life sciences companies need, including seed capital, management expertise and best-in-class lab space.
"The Portal team has already made a tremendous impact on our company in a short time as demonstrated by our seed round extension and insights from its drug development team and expert network," said Cathryn Nagler., Ph.D., president of ClostraBio, a Portal Innovations portfolio company. "Having access to the amazing Fulton Labs infrastructure our region badly needs, one year earlier than expected, will further accelerate our anticipated development timeline."
"The Midwest is home to world-class universities, leading global healthcare companies and an unsurpassed pool of diverse talent. A shortage of seed capital and quality infrastructure to tie it all together have been needed to make it a world-class life sciences cluster," said Raju Prasad Ph.D., senior biotechnology equity research analyst at William Blair. "Portal's best-in-class lab facilities and venture development platform will help fuel innovation and keep Illinois' best and brightest entrepreneurs and scientists right here and also attract talent from outside of the region."
About Portal Innovations
Portal Innovations is a premier venture development engine that bridges scientific ideation in life sciences, medtech and bioinformatics through commercial proof of concept by delivering seed capital, specialized equipment and lab space and management expertise to high-potential early stage companies. For more information visit portalinno.com
About Trammell Crow Company
Trammell Crow Company (TCC), founded in 1948, is one of the nation's leading developers and investors in commercial real estate. The Company has developed or acquired 2,700 buildings valued at nearly $65 billion and over 590 million square feet. As of September 30, 2020, TCC had $14.8 billion of projects in process and $5.9 billion in its pipeline. It employs more than 550 professionals in the United States and the United Kingdom.
Trammell Crow Company's teams are dedicated to building value for its clients with professionals in 18 major cities throughout the United States and London. The company serves users of and investors in office, industrial, retail, healthcare, multi-family residential, through its operating subsidiary High Street Residential, and mixed-use projects. For those who occupy real estate, TCC can execute the development or acquisition of facilities tailored to meet the needs of its clients. For investor clients, the company specializes in joint venture speculative development, acquisition/re-development ventures, build-to-suit development and providing incentive-based fee development services.
For more information visit http://www.trammellcrow.com.
Media Contacts
Portal Innovations
John Flavin
(630) 297-1600
john.flavin@portalinno.com
Trammell Crow
Elise Maguire
(908) 216-6785
emaguire@trammellcrow.com
CG Life
Bill Rader
(312) 318-7054
brader@cglife.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Reconstructing the nipple-areola complex completes the sense of restoration that helps some women put cancer behind them.

NEW YORK (PRWEB) DECEMBER 01, 2020
December 2020 – More and more women who have lost a breast to mastectomy now choose breast reconstruction. Reconstruction can be performed either at the time of the mastectomy, called "immediate reconstruction," or later, called "delayed reconstruction." Breast reconstruction can also be performed either via breast implants or with a woman's own natural tissue. Using her own tissue to fashion a new breast, a procedure known as "autologous reconstruction," results in a soft, warm, natural breast that is sometimes difficult to distinguish from a woman's original breast, especially when a woman has had a nipple-sparing mastectomy. For women who cannot undergo nipple-sparing mastectomy, it is possible to reconstruct the nipple-areola complex. "Having a new breast with a nipple is important to many women," says plastic surgeon and breast specialist Dr. Constance M. Chen. Reconstructing the nipple-areola complex completes the sense of restoration that helps some women put cancer behind them."
Women who are considering a mastectomy that preserves the nipple-areola complex must be evaluated to ensure that there is no tumor tissue near the nipple and no symptoms such as discharge that might indicate the presence of disease in the nipple itself. Those who are not candidates for nipple-preserving surgery can consider nipple reconstruction, which folds and sutures a flap of skin from the surrounding breast tissue to form a mound in the shape of a nipple. Nipple reconstruction typically also requires tattooing several months after surgery to add color to the healed reconstructed nipples.
For women who would like to bypass surgical nipple reconstruction, there are also tattoo artists who specialize in tattooing the nipple-areola complex directly on the breast mound. This less invasive procedure has become increasingly popular as the techniques have become increasingly sophisticated, even creating a realistic three-dimensional effect. 3-D tattooing may be performed in the surgeon's office or by a trained tattoo artist in a shop or specialized medical center. It is generally performed several months after breast reconstruction surgery when surgical scars are completely healed.
"While a nipple tattoo cannot create an actual projection, a high-quality, detailed tattoo, designed for each woman, can appear to have dimension as well as the shading, shadows, and coloration of a natural nipple," Dr. Chen says. The practitioner consults with each patient to determine how to best match the nipple to her skin tone and to create the appearance she wants. The inks used are mixed to create the best color for each woman. When the tattoo is to be applied to only one breast, it can be designed to match the appearance of her natural breast. Depending on how much sensation a woman has in her reconstructed breast, the tattooing procedure may be completely painless or may be performed with a local anesthetic. Healing takes a week to ten days.
Finally, a prosthetic nipple can be used to place an extremely realistic nipple-areola complex on the breast. Usually made of silicone, the prosthetic nipple-areola complexes come in many different colors and projections, and are glued onto the breast mound. Women can swim and take showers with the prosthetic nipple on their breast, and then take them off to wash them with soap and water if they start attracting lint. They can then be reglued to the breast mound.
"The results achieved with prosthetic nipples can be truly impressive," says Dr. Chen. "For women who aren't candidates for a nipple-preserving mastectomy or who want to avoid the additional surgery of nipple reconstruction, a prosthetic nipple is a straightforward, non-invasive procedure that completes the breast reconstruction that restores a woman's self-image as she moves confidently forward."
Constance M. Chen, MD, is a board-certified plastic surgeon with special expertise in the use of innovative natural techniques to optimize medical and cosmetic outcomes for women undergoing breast reconstruction. She is Clinical Assistant Professor of Surgery (Plastic Surgery) at Weill Cornell Medical College and Clinical Assistant Professor of Surgery (Plastic Surgery) at Tulane University School of Medicine. http://www.constancechenmd.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The German unit of Europe's largest insurance group brings Binah.ai's award-winning technology to customers

TEL AVIV, ISRAEL (PRWEB) DECEMBER 01, 2020
Binah.ai, a leading provider of general health and wellness video-based monitoring tools powered by artificial intelligence (AI), today announced that Generali Deutschland, the German business unit of Europe's largest insurance Group, has adopted its award-winning technology to launch a new mobile application. The application is called VitalSigns&Care, and will put cutting-edge technology at the service of customers' preventive healthcare, thereby strengthening Generali's role as their life-time partner.
Binah.ai's technology will run through the Generali Deutschland app, allowing users to extract vital parameters that are key to one's health status such as heart rate, oxygen saturation, respiration rate and heart rate variability through the camera on their smartphone. In cooperation with global consulting firm, SDG Group, Generali Deutschland will complement Binah.ai's technology with additional access to a vast range of assistance and prevention services. The Generali app highlights the importance of prevention in healthcare, hugely heightened by the current COVID-19 pandemic, and will include additional tailor-made optional services such as useful advice on nutrition, preventive healthcare and work-life balance.
"The adoption of our technology by a leader like Generali in the insurance industry is a significant seal of approval around our vision for Binah.ai," said David Maman, Co-Founder and CEO of Binah.ai. "The German market is at the forefront of healthcare's digital transformation, and we look forward to witnessing the many advantages that our vital signs monitoring capabilities can provide to those who access the application."
Binah.ai's award-winning technology applies a unique mix of signal processing and artificial intelligence technologies to extract and analyze a video stream taken from the upper cheek region of a human face, and then converts it into medical-grade accurate vital signs measurements.
"We will introduce a disruptive innovation in the field of insurance for preventive healthcare and assistance," said Giovanni Liverani, CEO of Generali Deutschland. "As a trail-blazer in the global insurance market, Generali Deutschland will launch Generali VitalSigns&Care, a state-of-the-art app available for download on anyone's smartphone and capable of testing – just by using the camera – important vital parameters as well as enabling users to access assistance and prevention services when needed. With this new digital solution, we put advanced analytics and Artificial Intelligence to the service of our customers, in a way that is affordable, fast and easy. A new tool to promote prevention, which, as we learnt during the current Covid emergency, is of paramount importance, and to protect our customer's life and health."
"I am really proud to see that even in the unprecedented time we are living right now, we have been able to collaborate with Generali on a real extraordinary project. This project is a unique innovation in the field of digital preventive healthcare and artificial intelligence. Our partnership with Generali is fully aligned with our mission - inspiring innovation and supporting our clients, their clients and the whole community by taking full advantage of the advanced analytics."said Luca Quagini, CEO of SDG Group.
The app is expected to be available to German users via app stores in early 2021, with Generali exploring future options to extend the geographic scope to other markets.
For the Generali Deutschland press release, please go to: https://www.generali.com/media/News/Generali-VitalSigns-Care--the-new-app-that-puts-technology-to-the-service-of-preventive-healthcare
About Binah.ai
Binah.ai's award-winning technology delivers on the company's vision and mission to allow for basic and universally accessible health and wellness services for everyone, anywhere. We are accelerating the digital transformation of healthcare and wellness by converting any smartphone, tablet or laptop into a vital signs monitoring tool, delivered with medical-grade accuracy. Binah.ai's technology has countless use cases that span fields including telemedicine, remote patient monitoring, primary care, personal and corporate wellness, preventive medicine, virtual trials, nursing homes, insurance, in-car wellness and many more. Our technology is in use with leading global organizations that understand that latest technologies and connected services are the roadmap to personalized, streamlined, and universally accessible health services that empower both organizations, and personal users.
The solution is not a medical device and should be considered as a self-assessment tool only.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Most U.S. skilled nursing facilities fail to consistently meet staffing requirements mandated by the Centers for Medicare and Medicaid Services

NEW YORK (PRWEB) DECEMBER 01, 2020
SmartLinx Solutions, a leading provider of workforce management solutions dedicated to helping senior care providers navigate workforce challenges, including those stemming from COVID-19, today announced the SmartLinx Five-Star Predictor. The Five-Star Predictor gives long-term and post-acute care operators the power to proactively predict and improve their Five-Star Quality Ratings for staffing.
Staffing data comprises one of the three criteria the Centers for Medicare and Medicaid Services (CMS) uses to assign Five-Star Ratings to long-term care and post-acute care facilities. Ratings carry significant financial implications. The government bases per-patient Medicare reimbursements on the facility's Five-Star Rating and distributes greater reimbursements to facilities with the highest ratings. Meanwhile, consumers, physicians, and financial institutions use the Five-Star Rating system to make informed decisions.
However, many facilities receive low Five-Star Ratings because they fail to meet CMS requirements for nursing care. The nursing shortage, high employee turnover, and sudden scheduling changes make meeting staffing requirements an ongoing challenge. Even before COVID-19, the senior care industry experienced 33% employee turnover each year, according to Argentum's 2020 Workforce Trends Report. Skilled nursing facilities report even greater shortages.
A July 2019 study by Harvard and Stanford University revealed many facilities struggle to meet CMS staffing demands that require keeping a registered nurse (RN) onsite at least eight hours a day, including weekends. "One troubling aspect of our findings is that 75% of nursing homes were almost never in compliance with what CMS expected their RN staffing level to be, based on residents' acuity," wrote Fangli Geng, David Stevenson, and David Grabowski in Daily Nursing Home Staffing Levels Highly Variable, Often Below CMS Expectations for HealthAffairs.
The Growing Focus on Staffing Levels
The COVID-19 crisis has prompted new staffing requirements as well as renewed attention on nursing home staffing levels. For example, New Jersey recently passed a law that defines the certified nursing aides (CNAs) per patient ratio.
To accommodate new staffing regulations, operators need integrated scheduling and attendance software that can be easily adjusted. SmartLinx workforce management suite helps operators to effectively address these staffing challenges by creating schedules that support evolving federal and state requirements, tracking attendance against these levels, and quickly closing open shifts before they jeopardize staffing levels.
Key SmartLinx Five-Star Predictor Benefits
In addition to identifying staffing compliance issues before they manifest, SmartLinx Five-Star Predictor calculates each facility's projected star rating for staffing in real-time. Providers learn what they must do to achieve their desired star rating weeks or months before the CMS reporting deadline. The Five-Star Predictor also delivers warnings when a facility's staffing falls below their desired star rating's requirements.

Better Five-Star Ratings: Predicts Five-Star Ratings for staffing on demand.

User-driven calculations: Enables users to choose their desired star rating and instructs them on the steps they need to take to achieve it.

Support for multiple facilities: Displays the status of multiple facilities on one unified dashboard and enables users to drill down to each facility's data.

Responsive design: Allows users to access the tool in real-time on their mobile device.

Proactive warning messages: Displays warning messages when a facility falls below required staffing levels based on real-time scheduling, attendance, and Payroll-Based Journal data.

"We're proud to release SmartLinx Five-Star Predictor to help skilled nursing providers deliver high quality care and reach their optimum rating," said SmartLinx CEO Marina Aslanyan. "In skilled nursing, being able to predict and remediate staffing shortages and achieve their desired Five-Star Rating is essential to achieving business and quality care goals."
Read more from Marina Aslanyan about the importance of Five-Star Ratings in a piece on McKnight's Long-Term Care, here.
About SmartLinx
Founded in 2000 SmartLinx cares for those who care. Used in thousands of leading organizations, the SmartLinx solutions suite helps skilled nursing and senior care providers manage people and processes by harnessing the power of real-time data. Its solutions suite includes talent acquisition and onboarding, human resources, benefits and payroll, time & attendance, scheduling, compliance, and business analytics. New financing options with preferred third-party commercial lender Ascentium Capital provide several flexible structures and low introductory payment options to help clients utilize the breadth of SmartLinx's capabilities and products. The company is headquartered in Iselin, New Jersey.
For more information, please visit http://www.smartlinxsolutions.com or call 877-501-1310.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Medical sales reps name best places to work in 2021 in MedReps survey. Top companies include Syneos Health, Teleflex, and Acella & Avion Pharmaceuticals.

ALPHARETTA, GA. (PRWEB) DECEMBER 01, 2020
A new survey by MedReps, a career site for medical sales representatives, revealed Syneos Health, Teleflex, and Acella & Avion Pharmaceuticals as the overall best medical sales companies to work for in 2021.
The 10th Annual Best Places to Work in Medical Sales survey polled over 2,000 professionals from the MedReps community to identify which medical sales companies are currently the most sought-after in the industry.
The survey results also identified the qualities and values most important to medical sales reps today, which led to them voting for their favorite company. For 2021, medical sales reps reported that they value work-life balance (80%), a focus on team building and collaboration (56%), and a commitment to diversity and inclusion (26%).
"In a year full of uncertainties, companies really stepped up to make their employees happy," said Karyn Mullins, president at MedReps. "A record 95% of medical sales respondents say they're satisfied with their jobs. It seems for many, the difficulties presented by the pandemic made them even more appreciative of the stability and support offered by their employers."
Syneos Health, who is on the list for the 2nd year in a row, recognizes motivated and engaged employees are the single biggest driver of their success. At the core of everything they do, the executive leadership fosters a culture focused on open communication, transparency, and active engagement of employees at all levels of the organization.
"Leading with honesty and integrity is the most important aspect of leading any successful organization and when done well, the engagement and productivity of the team is multiplied," shared Paul Mignon, leader of the deployment solutions team at Syneos.
Teleflex is a company that thrives on shared values, with people at the center of all they do. They have a leadership team comprised of highly talented and professional people who genuinely care about the employees at Teleflex.
"Our Teleflex leadership has shown their honesty and trustworthiness through constant and transparent communications with employees, instating an environment of positivity within and outside of the workplace," shared Mike Cummings, vice president of human resources, The Americas at Teleflex.
Similarly, Acella & Avion Pharmaceuticals really prioritize a healthy work-life balance for employees. Even amid this year's uncertainty, they focus on employees' healthy minds and bodies. They aim for employees to feel happy and content.
"Our company leaders make you feel like you are not alone during these crazy and scary times," one Acella & Avion employee said. "They gave us all the space, time, and resources we needed to do our jobs the best we could. We never felt at a loss during the height of the pandemic and, while it was challenging, we feel Acella & Avion did everything they conceivably could to allow us to continue working and make the best of a terrible situation."
Notable findings from the survey include:

32% of respondents said the best part about their job is the ability to make a difference/impact.

More than half of respondents' top characteristic for leadership is honesty and trustworthiness.

Only 15% of respondents said they are likely to leave their job in the next year.

When asked, "What is the best part of your job?" 21% of respondents said "opportunity for growth."

"Considering the high job satisfaction numbers, it's not surprising that few respondents said they are likely to leave their job in the next year," Mullins added. "Of course, the ongoing pandemic and economic uncertainty may also contribute to a general hesitancy to make a job change any time soon."
For more information about the study, click here.
###
*About MedReps*
MedReps is owned and operated by Healthcare Staffing Technologies. As the leading job site in its niche, MedReps gives members access to the most sought-after medical sales jobs and pharmaceutical sales jobs on the web. Members have access to over 6,000 jobs and can apply directly to the recruiters and hiring managers who post them. For more information on the No. 1 site for medical sales, marketing, and management careers, please visit MedReps.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Trust Certified trains healthcare practitioners in best practices for running efficient and effective practices, corroborates the outcomes through a robust dataset, and shares the results with those seeking care.

NAPLES, FLA. (PRWEB) DECEMBER 01, 2020
Trust Certified is excited to announce to the entire field of medicine its inception as the first business of its kind creating transparency across the entire healthcare industry.
Trust Certified trains healthcare practitioners in best practices for running efficient and effective practices, corroborates the outcomes through a robust dataset, and shares the results with those seeking care. Their vision is to improve healthcare by identifying and rewarding providers who are focused on the best health outcomes for their patients.
Tracey Lombardi, Founder and CEO of Trust Certified, is a serial healthcare entrepreneur whose passion is to transform medicine by creating transparency and providers whom patients can trust. Tracey states "This is the age of rewarding those who are focused on the best possible patient outcomes with a stamp of approval. We put the decision-making power where it always should have been: in the hands of the customer, the patient, to go to the person whom they trust will take care of them."
A seasoned advisory board transcending different specialties backs Trust Certified with many decades of experience. Dr. Gregory S. Gallick, Board Certified Orthopedic Surgeon; Joseph V. Biancamano, Founding Partner, Biancamano & DiStefano; Michael S. Pierson, AIC Retired Third Party Administrator Executive and owner of MPIERSON CONSULTING, LLC.
Trust Certified is already fully operational, vetting practitioners all across the country who meet the highest standards of care, to then begin their reviews and certify them as practices anyone seeking medical attention can trust and rely on.
About Trust Certified
Trust Certified identifies healthcare practitioners with the best outcomes, and then shares them with you. The data and process driven resource that we use accurately benchmarks providers. Trust Certified utilizes a robust dataset that looks at provider success factors across the variables that matter to you the most – the best patient outcome at the quickest pace, the least cost and potentially the least legal exposure.
Additionally, we review office and physician practices to ensure the right processes are in place. Our multi-step review program looks at data, office process, physician handling of insurance cases and other factors. We provide additional training as necessary before requiring a successful completion of a certification examination.
Backed by an authoritative committee of cross-industry of experts Trust Certified helps you make better informed strategic decisions.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Don't let suppliers derail any success, especially in the pandemic. Here's what one must do now — and going forward — to manage them.

FALLS CHURCH, VA. (PRWEB) DECEMBER 02, 2020
The pandemic has brought chaos to the pharmaceutical supply chain. What's the solution? Focus on supplier management with this webinar.
Take a fresh look at the COVID-affected supply chain — not to mention new and revised ideas about how best to manage the supplier relationship — and one will know how to make suppliers become partners to success.
Attendees will explore the basics of the supplier relationship, with an emphasis on the best practices one must incorporate to manage it over time. Come away knowing how to manage problems by tackling them as they arise, conduct pandemic-era supplier audits (how to think about them, prepare for them and execute them) and craft that all-important quality agreement.
The presenter, Steven Lynn, Executive Vice President of Pharmaceuticals at Regulatory Compliance Associates, Inc., will share how to:

Structure a pharmaceutical supplier agreement that incorporates specific clauses to assist in monitoring suppliers during the pandemic

Take advantage of resources limited by COVID-19 within the global supply chain to maintain and/or increase productivity

Emphasize the basics of the supplier relationship from its beginning, to best practices for managing it over time

Use new technology to develop best practices for monitoring and overseeing supplier partnerships

Conduct world-class supplier audits during the pandemic

Retain quality oversight in your supplier relationships and deals

Manage supplier relationships during the pandemic and beyond. Learn to work with them more easily and ensure all products get to market.
Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
to learn about our special multisite discount.
Webinar Details:
Managing Your Pharmaceutical Suppliers During COVID-19:
Pandemic-Era Best Practices
An FDAnews Webinar
Wednesday, Dec. 16, 2020, 1:30 p.m.-3:00 p.m. EST
https://www.fdanews.com/pharmasuppliers
Tuition:
$287 per site
Easy Ways to Register:
Online: https://www.fdanews.com/pharmasuppliers
By phone: 888.838.5578 or 703.538.7600
About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations



START your own Wordpress site, business or personal website, or online store at www.siteground.com

whiskerDocs, North America's largest pet telehealth and teletriage provider, announced plans for the January, 2021 launch of its proprietary on-demand telemedicine service for pet owners in four U.S. states.

SKOKIE, ILL. (PRWEB) DECEMBER 02, 2020
whiskerDocs, North America's largest pet telehealth and teletriage provider, announced plans for the January, 2021 launch of its proprietary telemedicine service for pet owners in four U.S. states with guidance from leading pet telemedicine lawyer/advocate Mark Cushing, founder of Animal Policy Group and author of Pet Nation, the Love Affair that Changed America.
whiskerDocs' proprietary telemedicine model is supported by multiple patents, both allowed and pending, enabling best practice standards for veterinary triage and clinical protocols. whiskerDocs' proactive, consumer driven virtual care program enables cross-platform medical histories, technology-driven solutions, virtual examinations and integrated, transparent medical records.
"By starting with teletriage, pet parents in eligible states will be able to receive the same on-demand services they've come to rely on from whiskerDocs, as well as access to veterinary telemedicine consults," says Deb Leon, CEO/founder of whiskerDocs and a founding member of the Veterinary Virtual Care Association. She added, "Families have become used to speaking with doctors virtually and they not only deserve, but desperately need, the same access when caring for their pets."
whiskerDocs' mission has always been to empower pet owners with right information and resources to care for their companion animals with confidence. "As few as 40% of pets in the U.S. are estimated to receive annual veterinary care," says Mark Cushing. "Virtual access can dramatically improve this while delivering high quality care to the families who need it most."
Currently, most state veterinary practice acts restrict how a veterinary-client-patient-relationship (VCPR) can be established and maintained, limiting access for tens of millions of pet owners in the United States. The numbers are dramatically different in human health, where 49 states and Washington, D.C provide Medicaid reimbursement for at least some form of medical video consult. To reach the remaining states that currently restrict pet telemedicine, whiskerDocs, Animal Policy Group, and industry allies will actively engage state legislative bodies and veterinary boards to implement the legal reforms necessary to allow broader access to veterinary care.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Gainesville Dental Group is pleased to announce that Dr. Jin Han has become the newest member of the dental team. He is bringing valued experience and his dental expertise to the practice.

GAINESVILLE, GA. (PRWEB) DECEMBER 01, 2020
Gainesville Dental Group is excited to welcome Dr. Jin Han to its team of talented and skilled dentists. This modern family dental practice has offices in Gainesville and Jefferson, GA. Gainesville Dental Group provides exceptional, cutting-edge care for patients of all ages in a comfortable, relaxing environment. This thriving practice offers general dentistry as well as cosmetic and restorative dental care, with a personalized and gentle approach. Dr. Jin Han first joined Gainesville Dental Group in 2020. He received his BS in biochemistry at the University of Illinois in Chicago before completing his dental degree at Midwestern University in Downers Grove, IL. During dental school, he volunteered in Cambodia for global dental relief trips, shared his knowledge at local dental functions and published an article in a well-respected scientific journal. Dr. Han is dedicated to helping each patient achieve excellent oral health with the best in preventive and conservative dental care.
"Dentistry is something that I genuinely enjoy. Not only the procedures and technical aspects of it, but also the interaction with my patients. I hope to be able to provide patients with the best care possible all while making the experience as relaxing as I can," says Dr. Jin Han
More about Gainesville Dental Group:
The extraordinary team at Gainesville Dental Group can handle all of your preventive and routine dental care needs, as well as specialized treatments. The highly-skilled dentists at this practice, provide a wide range of options under one roof. They include dental cleanings, porcelain veneers, teeth whitening and advanced procedures such as implants in a caring and comfortable environment.
For more information about the services offered at Gainesville Dental Group, please call 770-297-0401 or visit http://www.gainesvilledentalgroup.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The Forrester New Wave enables customers to identify a vendor best suited to meet their requirements in Computer Vision (CV). Forrester has evaluated 13 of the top technology vendors in CV and ranked their current offering and strategy.

MARLBOROUGH, MASS. (PRWEB) DECEMBER 01, 2020
Quantiphi today announced that it has been named a leader in The Forrester New Wave: Computer Vision Consultancies, Q4 2020. The report by Forrester evaluates Computer Vision Providers That Matter Most And How they stack up based on three categories: Current offering, Strategy, and Market presence.
The inaugural report from Forrester identifies top vendors that offer computer vision (CV) consulting services in the market and assesses the relative strengths and weaknesses of computer vision consulting services offered by the most significant vendors. Based on the independent analysis, Quantiphi was named a leader in this report with differentiated ratings in the criteria of Data, Model Development, Solutions & Accelerators, Vision, and Market approach.
"Quantiphi has tackled a wider and more difficult range of CV projects than any other vendor in this evaluation, including digital pathology, contract analysis, automated inspection, student proctoring, and social distancing monitoring. And it has more prebuilt CV and AI components and platforms than you can point a camera at" states the Forrester report, authored by Kjell Carllson, PhD. "."Quantiphi is a go-to vendor for any real-world CV problem"
"The ability of machines to perform cognitive tasks through visual inference has opened up entirely new possibilities for enterprises across a variety of industries," said Asif Hasan, Co-Founder, Quantiphi. "Over the last few years, Quantiphi has worked extensively to provide AI-based CV solutions in medical imaging, manufacturing quality assurance, video safety and surveillance, image search and retrieval, visual recommender systems, and a range of other use cases. We believe being recognized a leader in CV Consultancies by Forrester is a testament to Quantiphi's commitment to help clients build smarter products, frictionless customer experiences, and highly automated processes through Custom AI solutions."
According to the Forrester report:

Quantiphi tackles quantifiably more, and more challenging, CV use cases.

Quantiphi is a go-to vendor for any real-world CV problem."

Quantiphi could extend its CV offerings even more with CV-related partnerships, especially when it comes to unconventional hardware and data.

Customers praised Quantiphi for its expertise and transparency, as well as over delivering at competitive prices.

About Quantiphi
Quantiphi is an award-winning applied AI and data science software and services company driven by the desire to solve transformational problems at the heart of business. Quantiphi solves the toughest and complex business problems by combining deep industry experience, disciplined cloud and data engineering practices, and cutting-edge artificial intelligence research to achieve quantifiable business impact at unprecedented speed. We are passionate about our customers and obsessed with problem-solving to make products smarter, customer experiences frictionless, processes autonomous and businesses safer by detecting risks, threats and anomalies.
For more on Quantiphi's capabilities, visit http://www.quantiphi.com

"We believe being recognized a leader in CV Consultancies by Forrester is a testament to Quantiphi's commitment to help clients build smarter products, frictionless customer experiences, and highly automated processes through Custom AI solutions" - Asif Hasan, Co-founder



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Plant-Grow Inc., a leading US provider of microbial products and solutions, is launching a brand new microbial product for cannabis growers called MBX. The company is dedicating its super-concentrated microbial population in MBX to enhancing quad cannabis growth. MBX provides organic cultivation solutions for healthy soil, transplanting protection, and root development while enhances photosynthesis absorption to maximize growth.

CARSON CITY, NEV. (PRWEB) DECEMBER 01, 2020
Plant-Grow Inc., the world's technology leader in microbial biofertilizers, is proud to announce MBX. This microbial additive addresses the root of cannabis grower's quest to increase the highest quality buds' yields. MBX is an ultra-concentrated, proprietary blend of beneficial bacteria proven to increase root mass and quad yield. MBX's billions of microorganisms benefit plants by working symbiotically with them to create bigger, healthier, more expansive roots, leading to bigger plants that thrive. MBX works for soil-growers, but it also works for hydroponic growers.
MBX is patent-pending. Plant-Grow documents its innovations with the TrustyIP invention management solution. Our IP submissions are then perfected and patented by the lawyers at the Patent Law Office, PC.
Mary Kimani, Product Manager in Nairobi, Kenya, states: "I'm proud to be part of a team to launch MBX. We have successfully selected unique microbial profiles that help cannabis root growth and rejuvenate soil depleted of nutrients through in-depth research. Optimizing the microbial communities that live in, on, and around the plants substantially reduce the need for chemical fertilizers, herbicides, and pesticides. MBX is proven to work great and has increased quad yield dramatically for the cannabis growers. Extensive trials have demonstrated that the product results in large quad buds with excellent pungency, sharp flavor, and smooth, clean-smelling burn smoke. "
The Plant-Grower program rewards our users and evangelists who spread the word about the efficacy of MBX. Plant-Growers earn extra money in helping fellow growers gain increased yield/potency and profit and saving the earth at the same time!
For more information on the program, go to http://www.plant-grow.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Acumed's ASCent is a customizable program designed to provide Ambulatory Surgery Centers (ASCs) with numerous options to meet in situ challenges for optimal patient outcomes.

HILLSBORO, ORE. (PRWEB) DECEMBER 01, 2020
Acumed's ASCent is a customizable program designed to provide Ambulatory Surgery Centers (ASCs) with enhanced clinical value and pricing transparency.
Featuring Acumed's comprehensive portfolio of medical devices for simple to complex injuries for the outpatient setting, the program is designed to provide surgeons with numerous options to meet in situ challenges for optimal patient outcomes.
Every ASC's needs are unique. ASCent provides flexible pricing and billing structures to meet case needs and assist ASCs in complying with payor requirements, including fixed-price models.
Customizable, Scalable, Flexible: We understand what matters to our ASC customers.
"ASCs demand flexible business models that accommodate surgeon specialty and preference, as well as procedural requirements," said Jim Devine, Director of Ambulatory Surgery Centers at Acumed.
The ASCent program is designed to provide scalable and customized options addressing the unique needs of independent facilities, regional networks, and national contracts. The program includes fixed-price structures for more than 75 procedure types. Pricing is established prior to surgery, providing numerous benefits that will lower the total cost of care, and is sharable with patients and payors. The program also may aid in procedure collections, since implant costs are often variable, which prevents accurate price estimates.
Sharon Wolfington, Acumed's President and CEO said, "This program features Acumed's comprehensive extremity fixation portfolio of medical devices at fixed procedure prices. Choice is at the heart of this program, giving surgeons clinical options with clear pricing transparency."
Acumed has the most complete selection of upper extremity fixation and specialty plates on the market.* Acumed's portfolio includes our comprehensive surgical trays designed for maximum flexibility covering a broad range of case needs, along with our Essential sets that are cost effective and minimize storage requirements while covering the majority of cases. Our loaner bank maintains numerous sets that can be shipped within 24 hours' notice for operating room (OR) days working at maximum capacity.
Procedure packs are a convenient fixed-price option; however, they generate medical waste due to additional packaging, one-time use instruments, and disposed unused implants. Acumed's flexible surgical trays contribute to each organization's sustainability efforts by eliminating the waste generated by procedure packs.
Our ASC consultants will build a program that matches each ASC's specific needs. We will adapt each program to reduce costs, improve efficiency, and facilitate compliance with payor requirements.
Over the past 30 years, Acumed has worked with more than 3,600 ASCs. We have met the needs of independent ASCs as well as hospital affiliated ambulatory surgery centers. "Acumed has delivered millions in cost savings with our customized program, serving thousands of surgery centers and multiple payors over the last two years," said Aaron Greer, Director of National Accounts at Acumed. The ASCent program will serve patients, surgeons, ASC administrators, and payors with a consistent cost-of-care approach.
For more information or to schedule a presentation with our ASC dedicated team, please email ASCent@Acumed.net, or call Jim Devine (704.604.8123).
About Acumed
Acumed is a global leader in developing innovative orthopaedic and medical solutions to improve patient care. Acumed has more than three decades of experience in the orthopaedic industry, with the mission of aiding the afflicted through the ingenuity of our minds, the labor of our hands, and the compassion of our hearts. Founded in 1988, Acumed is headquartered in Hillsboro, Oregon, with offices and a distribution network around the world. For more information, visit acumed.net.
*Data on file with Acumed




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Goliath Technologies, a leader in proactive end-user monitoring and troubleshooting software for Health IT, announced today that CIOLook, a global business authority for technology executives and entrepreneurs, named Goliath Technologies a Top 10 Innovative Healthcare Company in 2020. Their proven purpose-built technology enables IT to remove end-user experience performance barriers to improve patient care.

PHILADELPHIA (PRWEB) DECEMBER 01, 2020
60% of the largest health systems in the U.S. trust Goliath to improve patient care
Goliath Technologies, a leader in proactive end-user monitoring and troubleshooting software for Health IT, announced today that CIOLook, a global business authority for technology executives and entrepreneurs, named Goliath Technologies a Top 10 Innovative Healthcare Company in 2020. Their proven purpose-built technology enables IT to remove end-user experience performance barriers to improve patient care.
Goliath Technologies has become a standard in Health IT, with its technical and business relationships with all four major Electronic Health Record (EHR) providers (Cerner, Epic, MEDITECH, and Allscripts). Health systems can improve clinician experience by leveraging the performance metrics Goliath correlates into a single view from their EHR application, end-user experience, and their Citrix or VMware Horizon delivery infrastructure. IT Pros can then anticipate, troubleshoot, and document end-user experience issues more effectively to improve system performance for their medical staff.
Goliath Technologies has helped many health systems, including Universal Health Services, CommonSpirit Health, Ascension, NorthBay Healthcare, Inspira Health Network, Harnett Health, and Maimonides Medical Center. More healthcare providers are turning to Goliath to meet their clinician's demand for always available, high-performing digital workspaces, EHR, and telehealth applications.
"We are honored to be named a Top 10 Innovative Healthcare Company in 2020," said Thomas Charlton, CEO and Chairman, Goliath Technologies. "The COVID-19 crisis and corresponding burden it places on Health IT underscores, even more, the importance of technology that is purpose-built to solve the challenges inherent in supporting largely distributed workforces that are attempting to access critical applications using various devices and connection methods. At Goliath, we have developed technology with embedded intelligence and automation to discover, monitor, and troubleshoot clinician issues without the need for a group of expensive end-user experience IT professionals. Our clients report that the presence of our technology reduces the need for headcount and makes current IT staff more productive."
What usually requires costly IT resources with very specific knowledge, Goliath accomplishes with software that has embedded intelligence and automation. This is critical because health IT usually has half the budgets and human resources as their enterprise counterparts to support the same number of users. Health systems can easily discover their entire Citrix or VMware Horizon environment and identify what to monitor, the thresholds to set, and then alert when thresholds are exceeded. The software does this for all potential events, conditions, and failure points regarding end-user performance issues when accessing and using their EHR systems along with other business and clinical applications.
"Selecting Goliath Technologies as a Top 10 Innovative Healthcare Company in 2020 was an easy choice," said Alan Swann, CIOLook. "Goliath has been instrumental in changing the Health IT industry by empowering health systems to shift from reactive to proactive in regards to monitoring and troubleshooting clinician experience, which has made a significant impact on health systems' performance and most importantly patient care."
Learn how Goliath can offer value to your Health IT organization.
About Goliath Technologies
Goliath Technologies offers end-user experience monitoring and troubleshooting software, with embedded intelligence and automation, that enables IT pros to anticipate, troubleshoot, and document performance issues regardless of where workloads, applications, or users are located. By doing so, Goliath helps IT break out of reactive mode, and into proactive mode. Customers include Universal Health Services, Ascension, CommonSpirit, Penn National Insurance, American Airlines, Office Depot, Tech Mahindra, Pacific Life, Xerox, HCL, and others. Learn more about how we empower proactive IT at goliathtechnologies.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

SGF physicians and team members will host a variety of webinars and Instagram Live events this December for information seekers looking to learn the most effective treatments to overcome infertility.

ROCKVILLE, MD. (PRWEB) DECEMBER 01, 2020
As 2020 nears its end, Shady Grove Fertility (SGF) will wrap up the year with free virtual events throughout December for those seeking to learn more about infertility and its most effective treatment options. SGF physicians and team members have assembled a calendar of webinars and Instagram Live events ranging in topics from in vitro fertilization (IVF), egg freezing, and menstrual cycles, to coping with infertility during the holiday season. All online engagements offer participants the opportunity to ask questions directly to physician experts on the spot.
"While December is often a joyous season of celebrating with loved ones, SGF recognizes it can be an emotionally tolling time for those struggling with infertility," explains Ellen Eule, LCSW-C, of SGF's Psychological Support Team who will be hosting an Instagram Live on the topic December 15 at noon. "We understand infertility is a deeply personal challenge, and we're here to support patients every step of the way."
To help those on their path to parenthood take the first step, Anthony Imudia, M.D., of SGF Tampa Bay's Westshore and Wesley Chapel locations will host a Getting Started webinar on December 30 at 3 pm. Dr. Imudia, a committed medical researcher and board certified reproductive endocrinologist, will highlight how advancements in treatments can make conception possible for almost everyone. His informative presentation will cover how to best prepare for initial physician consultations, with tips including:

what to expect during your fertility evaluation,

how SGF follows a stepped approach to treatment,

and understanding SGF's unique financial programs that can support your unique situation.

"The resilience and determination of our patients challenged with infertility never ceases to amaze me," acknowledges Dr. Imudia. "You'll know when you're ready to ask for help from a specialist, and when you are, SGF will be dedicated to helping you from day one."
Over the course of nearly 30 years, SGF has helped bring more than 85,000 babies and counting into the world. While not all of these babies were the result of in vitro fertilization (IVF), IVF is a very popular and effective fertility treatment. On December 1 at 3 pm, Michael Edelstein, M.D., of SGF Richmond's Stony Point and Henrico locations will host an IVF webinar where he will review:

what to expect during the IVF process,

IVF success rates,

and exclusive SGF financial programs.

"The more you understand the IVF process, the less intimidating the treatment option becomes," shares Dr. Edelstein. "While IVF is considered high-tech and not always the first solution for infertility care, it can dramatically enhance success rates for patients diagnosed with endometriosis, severe male factor infertility, tubal disease, and more."
December Virtual Fertility Events at a Glance

December 1 @ 3 pm | In Vitro Fertilization (IVF) webinar | Michael Edelstein, M.D.

December 8 @ 12 pm | Egg Freezing webinar | Anate Brauer, M.D.

December 15 @ 12 pm | Coping with Infertility during the Holidays Instagram Live | Ellen Eule, LCSW-C, Psychological Support Team

December 16 @ 4 pm | What Your Period Says about Your Fertility webinar | Shayne Plosker, M.D.

December 30 @ 3 pm | Getting Started webinar | Anthony Imudia, M.D.

While SGF fertility webinars are complimentary, interested parties must register to attend by visiting the SGF calendar of events. For more information, visit SGF's growing resource library for free, on-demand webinars, E-books, and other education resources on topics such as endometriosis, PCOS, low-tech treatment options, weight and infertility, and much more. Follow SGF on Facebook and Instagram for the latest updates and events.
For people struggling to conceive, it may be time to consult a fertility specialist. Contact the SGF New Patient Center at 1-888-761-1967 or complete a brief online request form to schedule a virtual fertility consult with an SGF physician. A virtual physician consult is the first step toward pursuing a pregnancy with the help of SGF.
About Shady Grove Fertility (SGF)
SGF is a leading fertility and IVF center of excellence with more than 85,000 babies born and 5,000+ 5-star patient reviews. With 37 locations throughout FL, GA, MD, NY, PA, VA, D.C., and Santiago, Chile, we offer patients virtual physician consults, deliver individualized care, accept most insurance plans, and make treatment affordable through innovative financial options, including 100% refund guarantees. More physicians refer their patients to SGF than any other center. Call 1-888-761-1967 or visit ShadyGroveFertility.com.





START your own Wordpress site, business or personal website, or online store at www.siteground.com

Torigen's novel immunotherapeutic shows increased survival time for dogs with advanced hemangiosarcoma when compared with surgical treatment alone

FARMINGTON, CONN. (PRWEB) DECEMBER 01, 2020
Torigen Pharmaceuticals Inc., an animal health biologics company, today announced positive preliminary results supporting the therapeutic potential of the company's experimental Autologous Cancer Vaccine for treating metastatic hemangiosarcoma (HSA) in dogs. HSA is an aggressive and ultimately fatal cancer that most commonly originates in a dog's spleen.
Torigen's experimental Autologous Cancer Vaccine is a form of active immunotherapy consisting of cells harvested from the patient's own tumor making this a cancer-type agnostic treatment. The results have been published in BMC Veterinary Research, a leading veterinary journal.
"This is exciting news for veterinarians and dog owners alike," said Dr. Michael Lucroy, Chief Medical Officer and Board-Certified Veterinary Oncologist. "These findings demonstrate the potential for an individualized immunotherapy approach in the management of advanced cancers, like hemangiosarcoma."
The publication reported that Torigen's Autologous Cancer Vaccine had an effect as an active form of immunotherapy based on in vitro results where it was shown to upregulate two important molecules for generating an immune response on antigen presenting cells: MHC-II and CD80. Retrospective analysis of outcomes was done for dogs with stage III HSA treated with surgery alone, surgery followed by maximum tolerated dose (MTD) chemotherapy, and surgery followed by Torigen's Autologous Cancer Vaccine. The study revealed a greater than 3-fold increase in survival of the dogs treated with their Autologous Cancer Vaccine over those receiving surgery alone. The median survival time of the vaccinated dogs was the same as dogs treated with MTD chemotherapy, without reported adverse events. The 1-year survival rate was 12.5% for the vaccinated dogs compared with 0% for dogs treated with surgery alone or surgery followed by MTD chemotherapy.
Lucroy added, "immunotherapy with the adjuvanted autologous cancer vaccine is capable of up-regulating MHC-II and CD80 in cultured canine monocyte-derived cells, which are important stimulatory molecules in generating an immune response, and the vaccine improves survival time in dogs with metastatic (stage III) HSA when compared to surgical treatment alone."
These findings set the stage for a prospective clinical trial beginning in 2021. Torigen's Autologous Cancer Vaccine is currently available to veterinarians in the United States as an experimental therapeutic and is regulated by the USDA.
About Torigen's Autologous Cancer Vaccine:
Torigen's Autologous Cancer Vaccine is a form of active immunotherapy consisting of cells harvested from the patient's own tumor making this a cancer-type agnostic treatment. This whole cell cancer vaccine is generated by a novel method to preserve tumor associated antigens (TAA), and then mixing the cellular material with immune adjuvants. The goal is to increase presentation of TAA to the immune system, thereby increasing activation of tumor-specific T cells. The result is an enhanced ability of the immune system to destroy cancer cells, stop or slow the growth of cancer cells, or delay metastasis which can improve patient survival.
About Torigen Pharmaceuticals, Inc.:
Torigen is a commercial-stage biopharma company founded as a spin-off from the University of Notre Dame in collaboration with Cook Biologics. The company is headquartered in Farmington, CT and holds multiple patents around the novel vaccine technology. To date, more than 800 dogs across the United States have been treated with their Autologous Cancer Vaccine.
The Torigen team is passionate about innovation and dedicated to developing safe, effective, and affordable treatments for companion animals with cancer, solving unmet needs for veterinarians and pet owners. For more information, please visit Torigen.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Euclid Life Science Specialty Names David Bailey New Vice President of Underwriting

ITASCA, ILL. (PRWEB) DECEMBER 01, 2020
Euclid Life Science Specialty, LLC, an Itasca-based specialty program administrator for life science liability, is pleased to announce the hire of David N. Bailey as vice president of underwriting and executive underwriter. David's focus will be growing the company's presence and core book of life science products-work hazard liability and professional liability on the West Coast and partnering with executive leadership to expand product offerings for the Life Science industry.
David brings more than 20 years of experience in life science and technology related underwriting to the Euclid Life Science Specialty team. Prior to joining Euclid Life Science, Mr. Bailey served as the Commercial Director of Life Science for CNA and held medtech leadership, risk control and underwriting roles with Travelers/St Paul and Fireman's Fund.
Managing principal of Euclid Life Science, Ryann Elliott states "David's driven marketplace presence and rich underwriting expertise builds on our extensive academic focus and experience necessary to service client needs in this highly complex industry sector. His focus on growing the team and the book on the West Coast will aid in balancing our team."
Mr. Bailey holds a Bachelor of Science Business Administration from University of California at Riverside and is based in California, reporting to Elliott. He can be contacted directly by phone at +1.213. 247.2250, or via e-mail at dbailey@euclidlss.com
About Euclid Life Science Specialty, LLC
Euclid Life Science Specialty, LLC is a specialty a product and professional liability insurance underwriting platform, providing tailored casualty coverage solutions to the life sciences industry and underwrite with capacity from a leading US insurer rated A+ by both A.M. Best and Standard & Poor's.
About Euclid Insurance Services, Inc.
Founded in 1952, Euclid Insurance Services, Inc. is a program administrator for specialty property/casualty insurance programs operating under the names Euclid Public Sector, Euclid Specialty Managers, Euclid Transactional, Euclid Enviant, Euclid Design Underwriters and Euclid Financial Institution Underwriters and functions as a general agency distributing employee benefit and life products under the name Euclid Managers.
For information on Euclid Life Science visit http://www.euclidlss.com and for information on the Euclid Insurance Services, Inc., visit http://www.euclidprograms.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

There is no reason you have to pack on pounds during the holiday season," explains Dr. G. "By following a simple set of healthy living guidelines, you can maintain a healthy weight or even meet your weight loss goals." "The problem with most weight loss programs is that they don't change the mindset of the person seeking to lose weight," surmises Dr. G. "You can't lose weight if you don't change the things that cause you to gain and retain weight."

CAPE GIRARDEAU, MO. (PRWEB) DECEMBER 01, 2020
Traditionally in the United States the period between Halloween and New Year's is prime fodder for gaining weight. What with Halloween candy, Thanksgiving turkey, the traditional Christmas feast, and endless New Year's Eve hors d'oeuvre and calorie-heavy alcoholic beverages, it is hard not to put on pounds during the winter months.
Enter Dr. Greg Pursley, a healthy living and weight loss expert. Dr. G, as his patients call him, offers a solution that will not only keep the holiday pounds at bay, but will change your mindset to one where healthy decisions become second nature. As a chiropractor, Dr. G has studied the body's inner workings and reaction to different stimuli.
"There is no reason you have to pack on pounds during the holiday season," explains Dr. G. "By following a simple set of healthy living guidelines, you can maintain a healthy weight or even meet your weight loss goals."
Think and Lose Weight, a new multipronged weight loss program from Dr. G, seeks to change the way we think about what we put into our bodies. It allows the subscriber to choose the programs that are right for their individual weight loss goals. The full system includes a 21 Day Kickstart Program, 60 Day Full Program, 5 Day Crash Course, 5 Do's and Don'ts of Healthy Permanent Weight Loss Program, and a Bonus Vault that includes interviews, educational material, and Dr. G's personal routines and recommendations.
"The problem with most weight loss programs is that they don't change the mindset of the person seeking to lose weight," surmises Dr. G. "You can't lose weight if you don't change the things that cause you to gain and retain weight."
To introduce Think and Lose Weight system, Dr. G is offering the 5 Do's and Don'ts of Healthy Permanent Weight Loss Program for just $17. Normally priced $97, this limited time offer gives the subscriber full access to the complete 5 Do's and Don'ts of Healthy Permanent Weight Loss Program for just a fraction of the cost. This all-inclusive program contains 10 educational videos, many with accompanying instructional PDFs, that will put you on the path to healthy and permanent weight loss.
By following Dr. G's 5 Do's and Don'ts of Healthy Permanent Weight Loss Program you will keep the weight off this holiday season by changing your thought process, so you make better nutrition and healthy body decisions.
No matter if you are looking to lose a few extra pounds or if you are seeking dramatic weight loss, Dr. G's Think and Lose Weight program can be the ideal guidance system you need. Encouraging the consumption of water, organic fruits and vegetables, and lean proteins, Dr. G's program also encourages limiting processed food, sugar, starches, caffeine, and alcohol while increasing activity.
"Maintaining a healthy weight is paramount to a healthy life. You have more energy, you experience less pain, and your overall outlook is more positive," explains Dr G. "By embracing the principles of the Think and Lose Weight system, you can not only make it through the holidays without adding pounds, you can actually permanently lose any excess weight you already are carrying."
To take advantage of the limited time offer to get the 5 Do's and Don'ts of Healthy Permanent Weight Loss Program for just $17 and to learn more about Dr. G's overall Think and Lose Weight system visit http://www.gregpursley.com.
About Dr. Greg Pursley
Dr. Greg Pursley is a weight loss expert who has been featured on ABC, NBC, and FOX News. In addition to his work as an advocate for maintaining a healthy body weight, Dr. G is a licensed chiropractor who seeks to treat the whole body as a means to overall health. Dr. G and his wife Sheree are the proud parents of daughter Evee-Kay and son Izaac.
INTERVIEWS AVAILABLE
Dr. Greg Pursley is available for media interviews on maintaining a healthy weight during the holidays
CONTACT:
Dr. Greg Pursley (Dr. G)
(573) 587-1223
info@gregpursley.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The compassionate, experienced dentists at Creekwood Dental Arts in Waco, TX are celebrating their 10th anniversary, providing a full spectrum of dental care to patients of all ages, including permanent, reliable, same-day dental implants.

WACO, TX (PRWEB) DECEMBER 01, 2020
Creekwood Dental Arts is proud to be celebrating 10 years in practice, providing patients of all ages with compassionate, expert dental care, including one-day dental implants. Their unwavering commitment to helping people maintain good oral health and beautiful smiles is reflected in numerous awards and glowing patient testimonials. For two years in a row, the practice has won the prestigious Locals Love Us Award for the Best Dentist in Waco, TX.
The family practice provides general dentistry including dental fillings for cavities, dental sealants, tooth extractions, root canals, and noninvasive therapies for temporomandibular joint (TMJ) disorder and sleep apnea. Dentists Dr. Donna Miller, Dr. Michelle Hinds, and Dr. Austin Green also offer a full range of cosmetic dentistry services, tooth replacement options including dental implants and dentures, as well as state-of-the-art laser dentistry to treat gum disease.
For those with missing teeth or teeth that are beyond repair, Teeth-in-a-Day enables patients to receive dental implants in just one day versus waiting months to be fitted for restorations. In the last 10 years, countless patients have benefited from this innovative technology, leaving the office the same day they came in—with better functioning teeth and improved confidence. Combining their skills as cosmetic dentists with dental implant training and experience, the Creekwood Dental Arts dentists are able to provide new smiles for their patients in the convenience of one office location.
While patient safety has always been a priority, the practice has taken extra steps in response to the coronavirus pandemic. They follow infection control recommendations from the ADA, CDC, and OSHA, with strict sanitization protocols implemented throughout the office. In addition, patients can wait in their car until a room is ready and temperatures are taken upon entry.
Drs. Miller, Hinds, and Green extend their gratitude to their entire dental team and the many patients who made this milestone possible. They look forward to the next 10 years in practice. To learn more about dental implants or any of the dental services performed by this experienced team of dentists in Waco, TX, visit CreekwoodDentalArts.com or call their office at 254-870-9026.
About Creekwood Dental Arts
Creekwood Dental Arts is a general dental practice offering personalized dental care to patients in Waco, Texas. Drs. Donna G. Miller, Michelle Hinds and Austin Green provide an array of services with state-of-the-art technology. Dr. Miller was voted the Texas Dentist of the Year from the Texas Academy of General Dentistry as well as accomplished The Mastership Award from the Academy of General Dentistry, the highest and most respected award in general dentistry. Creekwood Dental Arts is also an award-winning team, over the last two years they have received The Best Dentist Award by Locals Love Us Waco. To learn more about Drs. Miller, Hinds and Green or the services they offer, please visit their website at CreekwoodDentalArts.com or call 254-870-9026 to schedule an appointment.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

A sample size of over 400 subjects, a p-value of .00001, multiple blinded & controlled studies shows 635nm red lasers are an effective treatment

MELBOURNE, FLA. (PRWEB) DECEMBER 01, 2020
Erchonia Corporation, the World Leader in low level laser technology, became the first and only laser to receive U.S. Food and Drug Administration (FDA) 510(k) clearance for the temporary relief of nociceptive musculoskeletal pain, in June 2019. 510(k) #K190572
The results of the clinical trials submitted to the FDA can now be found in the Orthopedics and Rheumatology Open Access Journal (Peer-reviewed Medical Journal). Article title "Efficacy of 635nm Red Low-Level Laser on Nociceptive Musculoskeletal Pain Compared to NSAIDS, Opioids, and Other Light Sources" Click Here for full article
The article includes data from (5) Level 1, double-blind, placebo-controlled clinical trials and (1) non-inferiority trial, with a total of 419 subjects. The assessed treatment areas include chronic neck and shoulder pain, low back pain and heel pain caused by plantar fasciitis.
Musculoskeletal diseases affect more than one out of every two people in the United States age 18 and over, and nearly three out of four age 65 and over. For those individuals, there is considerable impact on expense and daily life, as the yearly cost per patient with a musculoskeletal disease is $7,800 and nearly 364 million lost workdays, which is an average of 10 days per worker.
The most common treatment for musculoskeletal pain is Nonsteroidal anti-inflammatory drugs (NSAIDS). However due to side effects which attribute to as many as 107,000 hospitalizations and 16,500 deaths annually in the United States, the FDA states the use of NSAIDs should be used at the lowest effective amount for the shortest possible time. While short-term use of NSAIDs is appropriate in acute injuries, it is not an ideal treatment for chronic pain as the analgesic effect generally last no longer than 4-6 hours.
Erchonia provides an FDA cleared alternative, that is proven safe and effective. The substantial evidence which is now publicly available in the Open Access Journal, shows a reduction in pain of 45% directly following the Erchonia laser treatment(s). The results compare favorably to an article published in The Journal of the American Medical Association which showed NSAIDS and Opioids reduced chronic pain by 25% and 21% respectively. Remarkably, the pain relief provide by the Erchonia did not rapidly diminish, in fact following 2-4 months post treatment the pain reduction continued to improve to 61% and 73% at 12 months post.
Equally important as the reduction in pain, the published article documented changes in disability indexes; including the Oswestry Disability Index (ODI), which is considered the 'gold standard' for measuring disability and quality of life (QoL) impairment for adults with low back pain. In each condition treated there was a significant improvement in the patient's disability, which can play a direct role in normal daily activities and returning to work.
The article also details the laser fundamentals (wavelength, power, coherence) that must be met to achieve an effective treatment. While other light/laser manufactures may erroneously claim the effectiveness for treating musculoskeletal pain, Erchonia is the only laser to provide blinded & controlled trials and receive FDA marketing clearance.
About Erchonia Corporation
Based in Melbourne, Florida, family-owned Erchonia is the global leader in the manufacturing and development of low-level laser therapy technology ("3LT"). From humble beginnings in a garage in 1996, Erchonia today develops and sells the most advanced, non-invasive 3LT medical equipment on the market in over 50 countries. In fact, Erchonia first low-level laser market clearance in 2002 prompted the FDA to create a new device category: NHN Biostimulation lasers. With 17 different market clearances from the FDA, Erchonia remains passionately committed to effective, research-based 3LT solutions for a wide variety of conditions — from managing chronic pain to promoting fat loss. For more information, please visit http://www.erchonia.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The pandemic accelerates shifts in healthcare IT as health systems adapt to new challenges.

ATLANTA (PRWEB) DECEMBER 01, 2020
Azalea Health, a leading provider of cloud-based patient management and health IT solutions, today announced their predictions for healthcare IT in 2021. Although some trends were already underway, the pandemic has been a catalyst for change as healthcare providers adapt to the new reality.
"The pandemic has put unprecedented pressure on the healthcare system, leading many providers to reevaluate their IT infrastructure," said Baha Zeidan, CEO of Azalea Health. "We saw it first with the rapid adoption of telehealth, then with the urgent need for better data sharing to help providers coordinate their Covid-19 response. However, these trends will not end with the pandemic. We're seeing an enduring transformation of healthcare's relationship with IT."
Zeidan predicts five key IT trends will drive change in healthcare in 2021:
Politics accelerate value-based care, and providers turn to data to improve outcomes.
Even if the Supreme Court overrules the ACA's value-based care incentives, the trajectory towards value-based care is unlikely to change, the only question is how fast it will take over as the dominant reimbursement model. A Joe Biden administration will likely push for more capitation at the agency level, with the pace depending on who controls the Senate following runoff races in Georgia. To succeed under value-based care, providers will look for nimble EHR solutions that enable them to harness the intelligence of their patient data to improve outcomes.
On-premises Health IT infrastructure shifts to the cloud.
The shift to cloud-based EHR platforms will be driven by several factors. First, the financial pressures of the pandemic has led many providers to reevaluate the overhead costs of managing their IT infrastructure on-premises. Additionally, the cloud enables back-room functions to be done remotely, reducing the risk of Covid-19 exposure for staff and patients. Also, with the rise of ransomware, data breaches and other cyberattacks, providers will look to cloud-based EHR platforms to take the burden of security and compliance off their hands. Finally, cloud-based systems will enable providers to access patient data anywhere, enabling telehealth and better care coordination.
Interoperability becomes an essential capability for EHR platforms.
Although the ONC is close to finalizing and implementing its new interoperability standards for EHR vendors, the pandemic has brought into sharp relief the need for greater data sharing to track outbreaks, manage resources and coordinate care between health systems. Providers will look to adopt interoperable EHR systems before the new rules set in to connect to health information exchanges and ensure continuity of care. Another benefit of interoperability is that patients will have greater access to their health data. This will help healthcare to go touch free, replacing clipboards with mobile apps that speed up appointment times, reduce paperwork, and drive efficiency.
Telehealth becomes a permanent staple of healthcare.
The pandemic rapidly lowered the barriers to telehealth out of necessity. But now that everybody has tried it and seen its potential, it's clear that telehealth will outlast the pandemic. Telehealth reimbursements will likely be expanded through 2021, as a hybrid model combining telehealth check-ins and in-person visits becomes the norm. This will save both providers and patients time on their appointments and open up more communication and engagement with patients. There will also be greater recognition of the needs of underserved communities, particularly those with limited access to transportation for whom telehealth will be a new lifeline of care, and those in rural areas where broadband access limits telehealth usage.
EHR adoption grows for behavioral health.
The pandemic has fueled a national mental health crisis, with 40.9% of Americans showing signs of adverse behavioral health conditions. Depression will manifest in higher rates of diabetes, obesity and heart problems as people reduce their physical activity. The connection between behavioral health and physical health will become more clear, and more providers and payers will recognize the importance of addressing behavioral health. EHR adoption, which has long lagged for behavioral health providers, will gain momentum as providers look to coordinate their behavioral health workflows with their physical health workflows.
About Azalea Health:
Azalea Health (Azalea) is changing the way health IT platforms connect community-based healthcare providers and patients across the care continuum. Offering a 100% cloud-based, interoperable solution, Azalea delivers electronic health records, revenue cycle management, and a fully integrated telehealth solution designed for rural, community and urban practices and hospitals, especially those focused on underserved populations. Quick to deploy and intuitive to use, Azalea solutions ensure better care coordination and communication, and the "one patient, one record" approach provides care teams the agility to achieve better outcomes. The Azalea platform also delivers tools and resources to help providers meet Meaningful Use requirements, and informs their strategies to navigate accountable care and alternative payment models.
Azalea Health PR Contact:
Lexi Herosian
lexi@scratchmm.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Approximately 5.8 million Americans age 65 and older are living with Alzheimer's and dementia. Restrictions imposed due to the pandemic have made it even more challenging to help them feel connected, happy and stimulated. Reductions in weekly social support during lockdown contributed to a worsened quality of life and anxiety in those affected by dementia and older adults, as well as reduced well being for their caregivers. Relish discusses ways to combat this and support those living with dementia.

LONDON (PRWEB) DECEMBER 01, 2020
UK-based Relish, a social impact company that aims to bring joy and engagement to people with dementia through creating activities and games focussed on wellbeing, recently conducted a study that brought to light what the potential long-term impact of isolation, social distancing and quarantine is having on people living with Alzheimer's and dementia.
The research followed a study by the University of Liverpool*, which found that reductions in weekly social support in the first lockdown contributed to worse quality of life and anxiety in those affected by dementia and older adults, as well as reduced wellbeing for their caregivers. The Alzheimer Europe Board** also highlighted how physical distancing rules are affecting people with dementia - who 'may find their normal routines disrupted, lack cognitive stimulation, feel lonely and anxious and risk depression.'
"The restrictions put in place as a result of Covid19 can have many negative impacts for people living with dementia and their families, including isolation, disrupted routines and a lack of cognitive stimulation," says Dr Simon Evans, Principal Research Fellow for the Association for Dementia Studies at the University of Worcester. "This makes it more important than ever to take a person-centred approach to wellbeing, focusing on individual abilities and preferences and incorporating meaningful activities in their daily lives."
Approximately 5.8 million Americans age 65 and older are living with Alzheimer's and dementia and around 850,000 people are living with dementia in the UK. Restrictions imposed due to the pandemic have made it even more challenging to help them feel connected, happy and stimulated. The research found that 43% of friends and family of those living with dementia say their loved one is unhappier now than they were at the start of the year.
"The coronavirus lockdown has been a very challenging time for us, and I don't think anyone could have anticipated just how difficult it's been. Looking ahead to Christmas, it is sad to think we may not get to spend time with our friends and family. I am lucky to have my wife, but sadly so many people are alone," explains Keith Oliver, celebrated author and campaigner who was diagnosed with Alzheimer's at the age of 55. Now 64, he had been self-isolating with his wife Rosemary during the early part of the pandemic.
"We try and do a lot of enjoyable activities together that keep my brain and body engaged. But more than half my care plan is based around doing more activities to help me keep well, some of which disappeared with the Covid-19 restrictions."
"Although there have been many challenging days over the past months there have been many positive ones as well - it really has been a Corona-coaster of a year. When social contact with loved ones is so limited, an individual approach to cognitive stimulation for people living with dementia is vital for the months ahead."
A Socially-Distant Holiday Season
With four weeks to go until Christmas, lockdowns and prolonged isolation have left many friends and family of those living with dementia (86%) worried they won't be celebrating the festive season with their loved one. Alongside growing anxiety about the long-term impact of social distancing on their mental wellbeing (90%), almost half (49%) of those concerned about Christmas fear this will be their loved one's last.
Relish, revealed that a third (36%) of those concerned about a loved one with dementia over Christmas are worried about them being on their own, and 29% say this will be their first Christmas apart in recent years. Of those surveyed, just 24% indicated that their loved one was being cared for in a care home, the rest are living at home including 19% who are living by themselves.
Relish founder and CEO, Ben Atkinson-Willes, says: "With more time spent apart, it is understandable that friends and family caring for loved ones with dementia may feel helpless and anxious – it is a particularly difficult time. And whilst there can never be any substitute for being in the company of your loved one, knowing how you can support their wellbeing and joy, even from afar, can help alleviate some concerns."
Now, Relish is working with campaigners and academics to offer advice for supporting the mental wellbeing of people with Dementia during the winter lockdown, encouraging others to do the same on social media using #DementiaWithJoy. Advice includes:
1 - Find opportunities to engage the mind
Author and campaigner Keith Oliver, who lives with Alzheimer's says: "Find an opportunity to engage the mind. This is really important when isolated, especially during darker days of winter. Whether by yourself or with others, find different activities or games to keep busy."
2 - Connect from a distance
Samantha Leech, Relish employee, has 20 years' experience as a dementia care professional. She says: "Even if you can't see your loved one with dementia face to face, the natural human connection that is so important to happiness is still possible. Give daily moments of joy through phone calls and sending letters and postcards – even better, send photos with little stories and your favourite memories."
3 - Stay socially active
Dr Clarissa Giebel, Research Fellow at Liverpool University and the NIHR ARC NWC says: "For people with dementia, staying physically, cognitively and socially active as much as possible is key to getting through social isolation, especially during winter. Continued engagement is critical, both for people with dementia, and their carers."
4- Understand what wellbeing means to the individual
Ben Atkinson-Willes, founder and CEO of Relish says: "A continued focus on overall wellbeing is so important, but it should be recognised that wellbeing can come from a combination of different levers, unique to the individual. For people with dementia, we aim to develop accessible products and activities that support these levers: independence, learning, identity, joy, relationships, keeping active, security and purpose."
5 - Use music to reminisce and relax
Samantha Leech, Relish employee, says: "Although it's good to start each day with a purpose, make sure to build in time to really relax. Create a playlist - listening to music can be powerful for people living with dementia to reduce anxiety by helping to reminisce and meditate."
Notes to editors
RELISH
Bringing joy and engagement to people with dementia, and their care-givers, is often overlooked, but critical to overall wellbeing. Relish products are designed and developed recognising the varying needs of those with dementia, identifying the different stages of dementia, different interests of individuals and different needs – whether that is to bring joy, stimulate the mind, spark memories, install calm, comfort or reassure. Importantly, they keep people with dementia physically, mentally and socially active, all supporting the overall wellbeing of people with dementia.
Relish products are available on http://www.relish-life.com. For more information on the Relish 8 levers for wellbeing, see: https://relish-life.com/dementia-wellbeing/
Ben Atkinson-Willes, founder and CEO of Relish is available to speak to media.
Relish is donating 10% of all sales of the Musical Bingo from now until the 23rd December to the Alzheimer's Society.
Keith is available to speak to media. Find out more about Keith's journey here: https://www.alzheimers.org.uk/blog/coronavirus-social-isolation-dementia-diary-keith-oliver
Research sources
*University of Liverpool: https://livrepository.liverpool.ac.uk/3101439/ or https://onlinelibrary.wiley.com/doi/10.1002/gps.5434
**Alzheimer Europe Board: https://alzheimereurope.newsweaver.com/ConferenceAnnouncement/1rv25ncpo3p3o02st3x388?email=true&lang=en&a=11&p=56822026
Relish research
Survey of 1002 UK adults with a friend or family member living with dementia. Research conducted Oct/ Nov 2020 by Sapio Research.
Relation to loved one with dementia:
Close friend    29%
Grandparent    26%
Parent    23%
Parent in-law    12%
Other    10%
Spouse    6%
Sibling    5%



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The Kelly Law Team in Phoenix, Arizona has announced that it will award a $1,000 educational scholarship for the benefit of those who have been diagnosed with Autism Spectrum Disorder.

PHOENIX (PRWEB) DECEMBER 01, 2020
The Kelly Law Team (KLT), a personal injury law firm in Phoenix, Arizona founded by attorney John Kelly has announced that the firm will award an educational scholarship as part of its scholarship program. The KLT scholarship program has awarded multiple scholarships over the years, and for the fourth time since 2015, the scholarship will be open to individuals with ASD (Autism Spectrum Disorder or autism). The scholarship will be applied to offset a portion of the tuition at an institution of higher learning or continuing education chosen by the successful applicant. That could be a college, junior college, vocational school, or a trade school.
ASD is condition that presents many challenges. While those challenges are varied, they can affect a person's desire to pursue his or her education. This scholarship is intended by Mr. Kelly and his firm to provide impetus for those with autism to continue with their education and as an incentive to strive to achieve their educational goals.
U.S. citizens who have been diagnosed with autism/ASD are encouraged to apply. It is not required than an applicant be enrolled or attending classes at the time the application is submitted. The successful applicant must, however, use the tuition reimbursement scholarship funds within a year after the announcement of the award.
Anyone who is interested in learning more about the scholarship, eligibility, the application process or the KLT scholarship program will find additional information on the firm's website. The website contains the complete application form and all requirements, as well as the firm's privacy policy. To be considered for the current scholarship, applications must be submitted to us on or before December 10, 2021.
Those with questions about the scholarship application, the application process, or the scholarship program should contact the firm, preferably via email. The contact information is as follows:
Kelly Law Team
1 E. Washington St., Suite 1520
Phoenix, AZ 85004
602-283-4122
email: mike@jkphoenixpersonalinjuryattorney.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Dr. Katherine Lorenzo Sirage joins Haute Beauty Network as a smile expert representing the Miami/Fort Lauderdale market.

MIAMI (PRWEB) DECEMBER 01, 2020
Dr. Katherine Lorenzo Sirage is a general and cosmetic dentist and owner of Mirage Dental Arts in Miami, Florida. She is fluent in both English and Spanish. Her state of the art dental office uses the most advanced digital technology to provide the highest quality care. Dr. Lorenzo & her team put each patient first and work together to create a comfortable, stress-free dental experience.
Advanced Training & Certifications
Dr. Lorenzo has advanced training in cosmetic veneers, as well as certifications in Botox, Dermal Fillers, and Invisalign.
Her Mission
To be committed to excellence by performing the highest quality dental care in a friendly, modern, and healthy environment and to remove barriers that get in the way of a patient's ability to have the dentistry they need, desire, and deserve.
Her Vision
To provide an unbelievable dental experience for our patients and build lifelong relationships in our community.
Learn more about Dr. Katherine Lorenzo Sirage by visiting: https://hauteliving.com/hautebeauty/member/dr-katherine-lorenzo-sirage/
ABOUT HAUTE BEAUTY NETWORK:
Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.
For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

Dr. Lorenzo has advanced training in cosmetic veneers, as well as certifications in Botox, Dermal Fillers, and Invisalign.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Experienced industry leader will direct company's global regulatory strategy

SOUTH RIDING, VA. (PRWEB) DECEMBER 01, 2020
Slone Partners, a nationwide executive search firm for life science, biotechnology, and diagnostics companies, has announced the placement of Kevin B. Johnson, Ph.D., MBA, as Senior Vice President of Regulatory Affairs at Inozyme Pharma. In his new role, Johnson is responsible for leading Inozyme's global regulatory strategy.
Johnson brings to Inozyme more than 25 years of experience in developing and implementing global regulatory and clinical development strategies for rare diseases across entire product development lifecycles from preclinical through clinical development and ultimately to product approval for a variety of drugs, biologics, combination products and cell/gene therapies. Most recently, he served as Senior Vice President, Head of Regulatory and Quality, at Magenta Therapeutics, where he led the company's global strategy for a portfolio of biologics. He has also served in senior management positions at Imara, Vtesse (later acquired by Sucampo, which was later acquired by Mallinckrodt Pharmaceuticals), and GlaxoSmithKline.
"Dr. Johnson is an experienced industry leader with extensive knowledge of the current regulatory landscape, in the United States and around the world." said Slone Partners CEO Leslie Loveless. "He will be a tremendously valuable addition to the Inozyme executive team at a time when the company is moving aggressively to develop and bring to market the most advanced set of therapeutic breakthroughs for patients living with rare diseases."
"We are thrilled to have Kevin join the Inozyme leadership team during this period of steady execution and as we prepare to enter clinical development," said Axel Bolte, MSc, MBA, Co-founder, President and Chief Executive Officer of Inozyme Pharma. "Kevin is a talented regulatory affairs executive with deep experience in rare diseases and I look forward to Kevin's contributions in helping Inozyme meet the needs of underserved patient communities."
Johnson holds a Ph.D. in Neurobiology from the University of North Carolina School of Medicine, an MBA from the Kenan-Flagler School of Business at the University of North Carolina, and a B.S. in Chemistry from the University of South Florida. He also holds a Regulatory Affairs Certification (RAC) credential from the Regulatory Affairs Professional Society.
ABOUT SLONE PARTNERS
Slone Partners delivers the leaders who build amazing and diverse life sciences organizations – People Are Our Science. Founded in 2000, Slone Partners specializes in delivering world-class C-suite leadership, executive, and upper management talent to the most promising and established biotech, diagnostics, research tools, healthcare, precision medicine, CRO, and laboratory services companies. With coast-to-coast presence in the most active healthcare industry hubs of Boston, San Francisco, New York, Los Angeles, San Diego, Austin, Research Triangle Park NC, and Washington DC, Slone Partners uniquely and precisely provides an array of executive search and advisory services, including diversity, equity, and inclusion strategy, to innovative life sciences companies. To learn more about Slone Partners' value proposition and processes, visit http://www.slonepartners.com or call 888.784.3422.
ABOUT INOZYME PHARMA
Inozyme Pharma is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. Through our in-depth understanding of the biological pathways involved in mineralization, we are pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. It is well established that two genes, ENPP1 and ABCC6, play key roles in a critical mineralization pathway and that defects in these genes lead to abnormal mineralization. We are initially focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. For more information, please visit http://www.inozyme.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Dr. Adrienne Lara joins exclusive Haute Beauty Network as a Women's Sexual Medicine expert representing the Los Angeles market.

OXNARD, CALIF. (PRWEB) DECEMBER 01, 2020
At Celebrating Women Center in Oxnard, California, Dr. Adrienne Lara, MD, wants her patients to know that she went to medical school for you. She believes good patient care is collaborative and involves both the patient and doctor working together as a team to get to the same goal — patient wellness. Dr. Lara takes the time to listen to her patients to better understand who they are, so she's not treating symptoms, but the whole patient, including their mind, body, and spirit.
Voted favorite MedSpa by the Ventura County Reporter and Best Med Spa Readers' Choice County Star 2018, Celebrating Women Center offers a number of health and wellness treatments focused on regenerative medicine that allows patients' natural beauty to shine through, including micro-needling, platelet-rich plasma (PRP), and vaginal rejuvenation with advanced medical treatments such as laser therapy and surgical procedures.
After beginning her career in health care as a nurse, Dr. Lara then went to medical school at Boston University School of Medicine and completed her internship and residency program in obstetrics and gynecology at Beth Israel Deaconess Medical Center, which is part of Harvard Medical School.
Dr. Lara takes great pride in her community and believes as a doctor it's her role to teach and share her knowledge so that her patients understand that they have options. Her integrity and authenticity when it comes to health care are why she's so loved by all who see her.
Dr. Lara is fluent in English and Spanish to serve patients from a variety of backgrounds.
Learn more about Dr. Adrienne Lara by visiting: https://hauteliving.com/hautebeauty/member/dr-adrienne-lara/
ABOUT HAUTE BEAUTY NETWORK:
Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.
For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

Voted favorite MedSpa by the Ventura County Reporter and Best Med Spa Readers' Choice County Star 2018, Celebrating Women Center offers a number of health and wellness treatments focused on regenerative medicine.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Improving Care Coordination for Over 400 Million Home Medical Equipment & Supplies Orders Placed for Patients Every Year

CARMEL, IND. (PRWEB) DECEMBER 01, 2020
Stratice Healthcare, the nation's leading provider for ePrescribing of medical supplies, equipment and other patient care services, is expanding connectivity and interoperability with every provider in healthcare by partnering with the nation's interoperability leader, Kno2. Stratice's eOrdersPlus, connected by Kno2's Interoperability as a Service (IAAS), will enable every healthcare professional to seamlessly create and receive complete, compliant medical orders for e-signature and more rapid, reliable provider fulfillment, accompanied by filing of medical orders back into patient charts – all through interoperability with every certified or Kno2 Connected EHR.
Stratice's rapidly expanding eOrdersPlus solution set provides direct electronic ePrescribing, eOrdering and ePurchasing connectivity supporting its open, national two-sided network of healthcare professionals, and local, regional and national providers, distributors and manufacturers of patients' post-acute care needs. The eOrdersPlus patient care coordination hub empowers healthcare professionals at the point of patient discharge, and across all post-acute care settings, to ensure faster, seamless transitions and continuity of patient care, followed by reliable claim reimbursement. By partnering with Kno2, Stratice is removing any barriers to the flow of patient information between a care provider's EHR and existing clinical workflows with eOrdersPlus. In addition, through Kno2's aggregated network, Stratice securely gains real-time access to millions of patient records, allowing for a complete and accurate medical order every time, eliminating the back and forth manual phone and fax workflows that plague the HME/DME order, fulfillment and claim reimbursement processes today.
Stratice's latest first-to-market solution enables its networked HME/DME providers to more efficiently transmit patients' expiring "resupply" or "renewal" orders directly to healthcare professionals for faster, more reliable completion and continued fulfillment of such critical items as oxygen, CPAP, incontinence, urological, ostomy, diabetic and wound care supplies. This new eOrdersPlus application is an industry game-changer, achieving resupply order completion rates across all HME supplies categories exceeding 95%, and typically within 24 hours to a week. Being Kno2 Connected via eOrdersPlus, allows providers to securely access current patient clinical information and communicate with the treating prescriber directly within their EHR, removing costly administrative communication burden between provider and prescriber, and dramatically impacting the patient experience and overall patient care.    
"By leveraging Kno2's leadership position within the national interoperability initiative, as well as its respected relationships and solutions connecting EHRs, health systems, physician offices, and all other post-acute care settings, Stratice will continue to deliver next level, enhanced electronic connectivity for its open, two-sided network. Our partnership with Kno2 greatly accelerates Stratice's mission to serve as the industry's sole open, completely neutral care coordination hub filling the gap between "eReferral" platforms and the transmission of complete, compliant orders for a wide array of patient care needs based on true patient and prescriber choice," shared Jason Farmer, CEO of Stratice.
"We are extremely pleased to add Stratice Healthcare to our Kno2 Connected partner community. Enabling Stratice's two-sided network with effective interoperability, allowing its members to create an order, support the order with required clinical documentation, and interact seamlessly within EHRs is a significant step forward for a daily activity that today is horribly inefficient," stated Jon Elwell, CEO of Kno2. "Stratice's partnership continues to exhibit the power Kno2's IaaS platform delivers with our ability to impact all corners of healthcare for those seeking the movement of patient information between disparate systems."
For more information contact:
Stratice: Jason Farmer, CEO, at jfarmer@stratice.com, or visit http://www.stratice.com
Kno2: Jon Elwell, CEO, at jelwell@kno2.com, or visit http://www.kno2.com
About Stratice
Stratice Healthcare developed and operates eOrdersPlus -- a first-to-market suite of ePrescribing, eOrdering and ePurchasing solutions connecting a two-sided, open network of healthcare professionals (and their patients) with local, regional and national providers, distributors and manufacturers of medical equipment, supplies and other patient care services. Our cloud-based, scalable eOrdersPlus solution set provides direct electronic connectivity through interoperable EHR, practice management, and revenue cycle management system integrations supporting critical connectivity within an open, national fulfillment network delivering rapid, reliable fulfillment of patients' medical orders, while providing true patient and prescriber choice. For more information about Stratice Healthcare, visit http://www.straticehealthcare.com.
About Kno2
Kno2 is leading health care's path to interoperability across every patient care setting with the capability to send, receive, find and use patient information with everyone. Through Kno2's Interoperability as a Service, common exchange methods including cloud fax, Direct secure messaging using the DirectTrust framework, patient information query with providers live on Carequality, including those connected through CommonWell Health Alliance, IHE profiles, HL7 messaging, Fast Healthcare Interoperability Resources (FHIR), patient care networks (Referrals, ACOs, HIEs) and other forms of exchange are standardized into simple send and receive workflows, from virtually any source. The innovative technology is smart enough to determine the most interoperable form of exchange to ensure that content flows freely between systems and providers. All this functionality is available to providers and technology vendors through a simple set of REST-based APIs or through a Kno2 portal. For more information about Kno2, visit kno2.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Linked Senior, the leader of the #ActivitiesStrong initiative, and Bridge the Gap Podcast, partner to promote, engage and empower activity, life enrichment directors and senior living executives to continue the conversation surrounding health and wellness in aging adults. The combined efforts of the companies will provide resources and an outlet for conversation to further the mission of combating isolation and encouraging safe, social opportunities for teams and residents.

WASHINGTON (PRWEB) DECEMBER 02, 2020
Due to COVID-19, social isolation has become the single biggest reason for the rapid decline of the cognitive and physical health of residents in senior living communities. Since March 2020, 80% of residents have not had a visit from the outside. Strained activity departments now need to hire an additional 1.2 FTE to deliver the same quality of engagement due to social distancing and isolation measures, with no additional hiring in sight due to slimming of margins most providers have experienced. The activity and life enrichment department is in charge of ensuring every resident can have access to their basic human right of finding purpose every day. Often underfunded and with little communication to executive leadership in their communities, this department has often been left aside and not respected.
The #ActivitiesStrong Initiative led by Linked Senior, is excited to partner with the Bridge The Gap podcast as a media partner to enable a constructive dialog with senior living leaders to fight social isolation and collaborate with activity and life enrichment professionals. This will enable the industry to deliver resident engagement that staff want and residents deserve.
Charles de Vilmorin, CEO and Co-founder of Linked Senior, shared that, "The #ActivitiesStrong initiative was born out of the need to acknowledge, educate and empower activity and life enrichment directors. It is now critical to invite senior living executives and thought leadership to the conversation and I couldn't think of a better partner than Bridge The Gap Podcast: their platform is professional, far reaching and they share common values and a deep desire to disrupt our industry towards the goal of advancing quality of life for older adults."
The partnership will include thought leadership, such as executive focused webinars and roundtables, conversations on the future of resident engagement and innovative approaches to furthering resident quality of life. The educational programming will kick off on Tuesday, December 15th, 2020 at 1pm EST with a webinar featuring Sara Kyle, PhD, Founder and Principal LE3 Solutions and Kelly Stranburg, M.Ed, Principal, LE3 Solutions. Attendees will learn how providers can ensure that their engagement programs are aligned with resident needs and desires.
Bridge The Gap Podcast founders and co-hosts Josh Crisp and Lucas McCurdy are honored to be a media partner of #ActivitiesStrong and will use the podcast network platform to inform, educate and influence the senior living industry on this specific need to empower activity and life enrichment directors.
"We close nearly every episode by reminding healthcare workers that they are important, loved and appreciated," McCurdy said. "Teaming up with #ActivitiesStrong is one tangible way we can show that to the great people in our industry."
"The team members in the communities are who brings life to residents day in and day out," Crisp said. "We are honored to support and partner with #ActivitiesStrong to help shed light on the resources and engagement needed for the vital activities and life enrichment directors."
Linked Senior is an evidence-based resident engagement platform for senior living. The platform optimizes the person-centered experience for residents by empowering staff with digital tools to assess, plan, implement and evaluate engagement for the entire resident population.
The mission of Bridge The Gap podcast is to inform, educate and influence the senior housing industry by providing thought leadership and discussion surrounding the most pressing issues in senior care.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The Visikol research team has developed a novel tissue multiplexing approach which leverages a proprietary antibody stripping reagent combined with traditional fluorescent antibodies and panel co-registration software to allow 10+ plex multiplexing from a single slide. This approach is now being offered as a service to Visikol's clients and provides them with the ability to use conventional antibodies that have already been validated for use in their tissues with an inexpensive and easy-to-use approach.

HAMPTON, N.J. (PRWEB) DECEMBER 02, 2020
The goal of immuno-oncology is threefold: to understand how key cells in the immune system interact with the tumor microenvironment, to understand how these interactions contribute to the outcome of the patient, and to modulate the immune response in a way that reduces tumor growth, ideally toward the elimination of tumor cells. The field of immuno-oncology has necessitated a rapid development of multiplex imaging technologies which allow for all of these markers to be identified from a single slide.
Over the last few years, several technological approaches have been developed to provide researchers with the ability to survey the immune system landscape on slides and to address these complex research questions. However, many of these technologies require expensive imaging or tissue processing equipment and the use of proprietary labeling techniques. The need to spend significant resources to adopt these technologies has limited their widespread use and the inability to use traditionally validated antibodies increases the overall barrier to adoption.
It is because of these short-comings and the need for an easy-to-use multiplexing tool that Visikol has developed a novel multiplex approach for use in its services. The approach leverages traditionally validated antibodies along with standard fluorescent imaging equipment such that it can be easily applied to any therapeutic area of interest. To accomplish multiple rounds of labeling, the technique relies upon the use of a proprietary antibody stripping reagent which removes the primary and secondary antibodies without damaging the tissue or epitopes. After multiple rounds of labeling and imaging are conducted, the data sets are aligned using an elastic co-registration approach that Visikol has developed such that the whole data set can be used to address a researcher's question. For example, assessing the variety and distribution of immune cells within and around tumor tissue.
This multiplex approach is an addition to Visikol's advanced imaging services suite and pairs with its pipeline of 2D and 3D digital pathology software that allows the Visikol team to transform terabytes of data into actionable insights for a Client. The company also provides its Clients with access to Imaging Mass Cytometry services if they want to achieve 30+ plex multiplex slide imaging in tandem or in lieu of the Visikol approach and other endpoints.
"As a leading imaging and digital pathology CRO, we always want to provide our Clients with a diverse set of tools such that they can choose the specific tool that best meets their research needs as well as their cost and throughput requirements. For example, one researcher might require whole slide imaging but only six labels at a time and would use the Visikol approach where another researcher might have a block of tissue micro arrays and want to image each for 35 labels and use imaging mass cytometry instead," described Visikol CEO Michael Johnson, PhD.
There are three steps to starting a multiplexing project with Visikol. First, the researcher discusses with Visikol their specific project needs and the Visikol team conducts a small initial validation study with control samples to demonstrate the labeling panels are effective. After the panels have been validated, they are applied to the researcher's tissues of interest to generate imaging data and lastly the imaging data is analyzed using Visikol's 3Screen image analysis software to create a quantitative report addressing the researcher's key questions.
About Visikol
Visikol is a contract research organization (CRO) focused on advanced drug discovery that is leading the fields of bioimaging, bioinformatics and image analysis. We conduct end-to-end drug discovery services that include both 2D and 3D in vitro models and assays, 3D whole mount tissue imaging, digital pathology and custom drug discovery projects. Visikol offers a portfolio of drug discovery services ranging from 2D and 3D cell culture model and assay development to in vitro screening, animal tissue histology and automated image processing. The focus of these services is to transform tissues into images and ultimately into quantitative datasets that can be mined for actionable insights that help our Clients make more informed decisions during the drug discovery process. Additionally, Visikol manufactures and sells a suite of tissue clearing reagents and 3D immuno-labeling kits. These products allow researchers to easily and rapidly image whole tissues and 3D cell culture models in 3D instead of traditional 2D sectioning. For more information about Visikol or its services, please visit our website at visikol.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Each year, MD Preferred Services, a medical consulting firm, helps physicians and other healthcare professionals find community based, "doctor friendly" financial advisors. Robert Cannon of Cannon Wealth Solutions has been recognized by MD Preferred for his service to physicians.

HARRISON, N.Y. (PRWEB) DECEMBER 02, 2020
Every MD Preferred affiliated professional is recognized for their commitment to serving the healthcare industry. They often work in close concert with other community based professionals helping area medical providers attract and retain talented physicians and medical staff. Financial Advisors who display the MD Preferred Services logo are uniquely qualified to act as recruiting partners to area practice managers and hospital administrators. These knowledgeable professionals can tell the community story while the medical recruiter focuses on the clinical opportunity. Their understanding of the special needs of physicians and their families saves everyone time and resources.
According to the Bureau of Labor Statistics, there are approximately 700,000 physicians in the United States who work in excess of 60 hours per week. A blizzard of government regulations and a host of clinical and economic issues leave little time for a doctor to manage their professional and personal lives. When it comes to finding a provider that is committed to working with physicians, they appreciate a resource that has done the research for them and has pulled a team together to make their lives easier.
Robert Cannon, AIFA has more than three decades of experience working with affluent investors, businesses, and hedge funds across the United States. He places a key focus on creating lifetime income plans for retirement, and in doing so, Robert guides his clients through a very distinctive wealth management and investment process that is specifically designed for financially successful individuals, couples, and families.
"We are proud of the recognition we have received. In an environment of critical physician shortage, we understand that most physicians considering a career in our community will make their decision based partly on life style issues. The last thing we want to have happen is for that prospective physician to go elsewhere because the local support services he or she needed were not available, were unreliable or did not meet the expectations of the physician." – Robert Cannon
Cannon Wealth Solutions
Robert Cannon
600 Mamaroneck Ave, Suite 400
Harrison NY
(917) 991-2945
robert@cannonwealthsolutions.com
http://www.cannonwealthsolutions.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Digital health tracking for patient reported outcomes will improve symptom reporting and patient care across the entire network

SEATTLE (PRWEB) DECEMBER 02, 2020
Navigating Cancer, the developer of the most broadly deployed patient relationship management (PRM) platform in oncology, today announced that Arizona Oncology will deploy the Navigating Cancer platform to streamline triage and standardize care across all practices regardless of the EMR and practice location.
Arizona Oncology is one of the largest cancer centers in Arizona, with more than 65 practicing physicians and 40 advanced practice providers devoted exclusively to the most comprehensive, compassionate and quality cancer care specialized in breast surgical oncology, medical, gynecologic, and radiation oncology, hematology, stem cell transplant, research, genetic risk assessment and patient ancillary programs. Arizona Oncology is also part of the US Oncology Network, one of the nation's largest healthcare services networks dedicated exclusively to cancer treatment and research.
"We wanted to partner with Navigating Cancer because we share a common vision in the value of engaging patients throughout their cancer journey," said Dr. Donald Brooks, MD. "The advanced digital health tools available in the Navigating Cancer platform will help us stay in better communication with our patients remotely across their full course of care and follow-up, and also better target and support high-risk populations across our entire network," Brooks added.
The Navigating Cancer solution includes the Health Tracker program for collecting and managing electronic Patient-Reported Outcomes (ePRO). Health Tracker enables providers to monitor patients remotely and deliver proactive care when needed, helping patients avoid unnecessary hospital visits and further protecting vulnerable patients undergoing cancer treatment. Health Tracker is an integrated part of Navigating Cancer's Patient Monitoring solution, which also enables care teams to collect patient assessments and surveys using validated instruments.
"Our goal is to work closely with cancer providers throughout the country to bring together better, more coordinated care in the fastest way possible in a way that delivers a high level of patient satisfaction" said Bill Bunker, CEO of Navigating Cancer. "We are enthusiastic about our partnership with the entire US Oncology Network, including large community-based practices like Arizona Oncology, to help support more coordinated care across multiple geographies while reducing costs," Bunker added.
The mission of Arizona Oncology is to increase access to high-quality cancer care while delivering the best possible outcomes for patients, delivering care for the whole person and not just the disease. In partnership with Navigating Cancer, Arizona Oncology will be able to connect with patients on mobile devices, tablets at home or in the office, or on the web across 28 locations throughout Arizona.
About Navigating Cancer
Navigating Cancer is a digital health company focused on improving the lives of cancer patients and those who care for them. Our comprehensive Navigating Care platform helps providers boost their financial performance, enables more effective remote care management, and delivers a better patient experience while providing valuable insights for oncology innovation. With over 2,000 providers using the Navigating Care platform to care for over 1 million patients, it is the most broadly deployed oncology patient management solution in the US. For more information, please visit http://www.navigatingcancer.com or follow Navigating Cancer on Twitter @navcancer.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Blockit Inc., a leading provider of digital care coordination solutions, announced today that it will release a no cost version of their award-winning, HIPAA compliant, online patient scheduling solution to any licensed healthcare provider performing COVID-19 vaccinations

MCKINNEY, TEXAS (PRWEB) DECEMBER 02, 2020
Blockit Inc., a leading provider of digital care coordination solutions, announced today that it will release a no cost version of their award-winning, HIPAA compliant, online patient scheduling solution to any licensed healthcare provider performing covid-19 vaccinations. The solution is intended to ease the monumental effort by providing an easy to use online schedule system that is already proven in a multitude of complex healthcare scheduling use cases.
This represents a significant effort to help increase the efficiency of covid-19 vaccination coordination and minimize the stress on both providers and patients during this difficult time. The company is working continuously to increase relevant features and support the needs of healthcare workers, patients, government officials, clients and other organizations focused on helping American's through this Pandemic.
"Since announcing our free covid-19 test scheduling offering in March of this year, Blockit has facilitated the scheduling of just over 50,000 appointments. Our goal is to use innovative technology to simplify patient access while improving patient outcomes and reducing excess work for healthcare professionals," said Blockit CCO Dave Gregorio. "With the continued spread of covid-19 and the upcoming vaccination effort, we are honored to support the front line vaccine delivery organizations with free access to our leading scheduling platform."
For healthcare organizations interested in utilizing this service to easily publish and seamlessly manage covid-19 vaccination scheduling , please visit https://www.blockitnow.com/covidtesting and follow the quick and simple five minute enrollment.
About Blockit:
Blockit's focus on simplifying healthcare processes for everyone has led to being the leading platform that improve patient access that leads to better patient outcomes. By combining advanced technology with expert service and support, Blockit removes the barriers that stand in the way of patient access, seamless closed loop referrals and optimal care coordination.
http://www.blockitnow.com

"Since announcing our free covid-19 test scheduling offering in March of this year, Blockit has facilitated the scheduling of just over 50,000 appointments. Our goal is to use innovative technology to simplify patient access"



START your own Wordpress site, business or personal website, or online store at www.siteground.com

As the weather turns cold and the calendar moves from Thanksgiving, the Holiday season is just around the corner. While this year's festivities will be smaller than usual, we will soon start to retrieve the decorations from the attic and to plan for the big cookie bake.

ASHEVILLE, N.C. (PRWEB) DECEMBER 03, 2020
As the weather turns cold and the calendar moves from Thanksgiving, the Holiday season is just around the corner. While this year's festivities will be smaller than usual, we will soon start to retrieve the decorations from the attic and to plan for the big cookie bake. While certainly my favorite time of the year, the Holidays and present challenges for allergy sufferers.
1. Foods: Cakes, cookies, candies and sweets are just part of holiday fun. For those with food allergies, hidden ingredients like nuts or dairy. Perhaps more than any time of the year, its important for those with food allergies to always ask about ingredients before taking a bite. If the host is not sure, it's best to politely decline!
2. Christmas trees: Allergic to Christmas trees?!? Trees may have mold spores that can trigger allergies and asthma, while artificial trees can carry dust after prolonged storage. It may be a good idea to air out the tree in a dry place like the garage before bringing it inside.
3. All those ornaments: Boxes and boxes of decorations are in my attic and, try as we might, the things get dusty. When moving boxes, wear a mask and clean off dusty items outside or in a well-ventilated area.
4. Candles: Almost as important as the sights of the season are the smells. For some people, however, strong scents and perfumes can trigger sneezing, runny nose and even asthma symptoms.
5. Pets: When visiting friends and relatives, it's a good idea to find out who has pets and who is pet allergic. It's always a good idea to take extra precautions such as keeping pets outside, taking an antihistamine before arriving, and being sure to have your rescue inhaler.
Most importantly, don't let the Allergy Grinch steal your Holiday fun. Taking some time to spot potential problems upfront and being prepared can help make the Holidays happy for everyone.
Allergy Partners, PLLC is the nation's largest single specialty practice with multiple locations across the United States. Our allergists provide evaluation and treatment of following conditions:
Allergic Rhinitis | Asthma | Food Allergies | Eczema Hives | Sinus Problems | Stinging Insect Allergies | Immune Deficiencies | Chronic Cough | Drug Allergies Recurrent Infections | Eosinophilic Esophagitis | Allergist | Pediatric Allergist



START your own Wordpress site, business or personal website, or online store at www.siteground.com

COVID-19 Safety Solution cited by Religious Product News for Protecting and Informing Congregations

CLARENCE, N.Y. (PRWEB) DECEMBER 02, 2020
inLighten (http://www.inlighten.net), for more than 30 years a leader in the field of digital signage, interactive, and audio solutions today announced that, Religious Product News, a publication that reaches 40,000 church leaders, has named inLighten's iVIEW Clean Hand Sanitizer + Digital Signage Stations one of its ' Hot Products' for 2020. Designed to display attention-getting video messaging and ensure compliance with best safety practices, wall-mounted and free-standing iVIEW Clean units can be located anywhere.
In response to the award, inLighten CEO Dan Snyder said, "inLighten is honored by this recognition and is gratified that so many congregations have found iVIEW Clean to be a convenient and reliable way to protect members, visitors and staff while keeping them informed."
iVIEW Clean is outfitted with a 21.5-inch vertical display and integrated digital signage player. The enclosure, mounting bracket, stand and base are all made of steel for durability, and the system enclosure locks for security. The wall mounted-unit is 42 inches tall, 14 wide and 8.5 inches deep and the floor-mounted unit stands 77.5 inches tall. The built-in dispenser for hand sanitizer has a 33 oz. capacity, and liquid, gel or foam sanitizer types can be used.
Jeff Taylor, Vice President of Product Development described how the iVIEW Clean solution came into being. "inLighten has been creating kiosk solutions for over 20 years, and at the onset of the coronavirus pandemic we realized that access to personal hygiene and relevant information was going to be crucial in combatting it. We focused on designing a sturdy, compact unit requiring minimal floor or wall space with a self-contained hand-sanitizer dispenser and good-sized, high-definition video display. We included a digital signage player with the full complement of control and creation capabilities as our enterprise-level digital signage solutions, allowing our clients to add it to their pre-existing digital signage networks and manage it from the same platform. And, finally, we started working on enhancements such as temperature scanning and touchscreen capabilities that will soon be offered as optional add-ons."
Snyder concluded by adding, "For all kinds of organizations, iVIEW Clean is a win-win-win solution. iVIEW Clean gives them the ability to locate announcements and sanitizing where it's most needed and most effective. High-definition video content calls attention to the hand sanitizer dispenser, which encourages a best safety practice. And while people are sanitizing their hands, they're watching on-screen messages to become more aware, alert and better informed."
inLighten is a recognized leader in networked digital media solutions including digital signage products, self-service kiosks, on-hold and environment audio services, check-in and queueing systems and speech privacy solutions that empower clients to effectively and securely communicate with their intended audience to deliver an enhanced consumer experience. inLighten serves clients in financial services, higher education, healthcare, manufacturing, utility, governmental and not-for-profit sectors. inLighten headquarters and operations are located in Clarence, New York.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Rare Cannabinoid Company, the first brand to offer THCV tinctures, is launching its latest uniquely high-dose hemp product: an extra high strength 3000mg CBD Booster. It can be used to enhance the brand's THCV, CBN, CBG, CBC and full spectrum Rare Hawaiian CBD oils.

HONOLULU (PRWEB) DECEMBER 02, 2020
Rare Cannabinoid Company has launched its latest uniquely high-dose hemp product: an extra high strength 3000mg CBD Booster.
The pioneering company leads the "rare" or "minor" cannabinoid industry as the first to offer tinctures of THCV for sale as well as single extracts of CBN oil, CBG, CBC, a full spectrum Rare Hawaiian CBD and one-to-one blends.
Each cannabinoid offers unique mental and physical benefits. With this in mind, Rare Cannabinoid Company's Apothecary line was designed so that people could mix and match cannabinoids to customize their perfect blend for energy, sleep, appetite control or health and wellness needs. Now, those who wish to scale up their dose of CBD can do so easily.
The extra strength CBD Booster contains 3000mg CBD in organic MCT coconut oil. It comes with a measured glass dropper for precision dosing. This is because even a small amount of the oil contains a large amount of CBD. Each drop has 2.5mg CBD and each dropper-full has 100mg.
At just $99, it is priced extremely competitively. Better yet, the brand offers free shipping on all orders to anywhere in the United States and 15% off subscriptions.
Rare Cannabinoid Company also just launched a 1000mg full spectrum CBD extracted from rich Hawaiian hemp. It sells for $79. Meanwhile, their 500mg full spectrum Rare Hawaiian CBD and their 500mg CBG sell for $49 each.
"We want our products to be accessible to everyone who can benefit from them," said Rare Cannabinoid Company founder and CEO Jared Dalgamouni.
"Cannabinoids work best when taken together. We want our customers to have a lot of options so they can fully customize their wellness routines."
While CBD has taken the world by storm over the last few years, many people are just learning about the hemp and cannabis plants' other cannabinoids now.
"Our biggest seller is THCV, followed by CBN," said Dalgamouni.
THCV (tetrahydrocannabivarin) has an almost mythical standing in the cannabis world for its alleged uplifting, stimulating, appetite suppressing properties.
Leafly, the world's largest cannabis information website, just published an article headlined: "Can THCV really curb the munchies?" According to the many scientific studies presented in the article, the answer appears to be a resounding "yes." It functions in a similar fashion to a pharmaceutical anti-obesity drug without the drug's negative side effects. By curbing the munchies, THCV may help people lose weight and be beneficial for those with type 2 diabetes. The article features Rare Cannabinoid Company as the gold-standard for where to buy THCV. Leafly also features the brand's products in their article: "Looking for THCV, CBN, CBG, or CBC? Rare Cannabinoid Company has you covered"
While THCV is an ideal, energizing daytime cannabinoid, CBN (cannabinol) is believed to help people relax and fall asleep faster and stay asleep longer. In this blog on CBN for sleep, it was cited by Steep Hill laborites as being akin to pharmaceutical sleep aid Diazepam. It is also believed helpful for pain, inflammation and other ailments.
CBG (cannabigerol) is real health and wellness cannabinoid, with scientific studies saying it appears to work well for inflammation, fight bacteria, act as a neuroprotectant (aiding those with Parkinson's, Alzheimer's and other dementias as well as MS), and is being researched in the fight against cancer. You can find links to studies in this blog: What is CBG and what benefits does CBG offer?
CBC (cannabichromene) is known as a mood regulator and may also promote healthy skin by controlling acne. It is also known as an anti-inflammatory and is being researched for cancer use.
Rare Cannabinoid Company offers two lines: Apothecary and Ready Blends.
Apothecary products contain 500mg rare cannabinoid and are intended for mixing and matching or combining one's own full or broad spectrum oil or the brand's Rare Hawaiian CBD. Taking a spectrum of cannabinoids increases their effectiveness and offers the entourage effect.
Ready blends are whole hemp supplements that offer the entourage effect as they contain 250mg rare cannabinoid and 250mg full spectrum CBD.
The new extra high strength 3000mg CBD booster can be used to amplify the amount of CBD in any of these products.
For example, one could boost their morning THCV dose with it, add it to a CBG blend for relief after exercising or use it to enhance their CBN before bed.
All Rare Cannabinoid Company products contain large, quantifiable amounts of cannabinoids. This can be verified by looking at the independent lab test results posted on their website.
It is very important to check lab reports before purchasing hemp or cannabis products. Many sites that say "Buy THCV" or "CBN for sale" are actually selling full spectrum CBD products that are naturally slightly higher in THCV or CBN but nowhere near the amounts listed above. A popular tablingual brand sells THCV tablets that only contain 1mg THCV each. Even popular high-THCV cannabis flowers such as Doug's Varin, Durban Poison, Tangie and Jack the Ripper often only contain 1 or 2% THCV. Dangerously, one brand that claimed to be selling THCV posted a lab report showing that it was actually THC! (THC is psychoactive and causes the munchies rather than taking them away).
Rare Cannabinoid Company strives to be completely transparent as it forges ahead into a new world of cannabinoid wellness. The company takes pride in listing its ingredients and lab reports clearly as well as offering links to all of the latest research into the potential health and wellness benefits of each cannabinoid.
"This is a very exciting time. We hope to see more and more cannabinoids being extracted, researched and offering people great benefits." said founder Dalgamouni.
For more information, you can see the brand's blog: "What are Rare Cannabinoids?" and learn about the world's first pure tincture of THCV for sale online here.
Stores interested in stocking Rare Cannabinoid Company products can register for a wholesale account here.
Rare Cannabinoid Company is the sister brand of Hawaiian Choice, Hawaii's most popular CBD brand. All Hawaiian Choice products contain broad spectrum Hawaiian CBD and are infused with organic or wild gathered tropical fruits, essential oils or honey. The luxury CBD products can be found in more than 150 locations from New York to Japan.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The problem that hims.ai solves at the highest level is making sure that MGH is adequately staffed and that the resources are allocated appropriately

WASHINGTON (PRWEB) DECEMBER 02, 2020
hims.ai today announced that Michael Garron Hospital, a large community hospital in Toronto, Canada, has successfully leveraged its ARMADA (automated resource matching & deployment application) healthcare administration automation solution to help with staffing, resource management and deployment during the COVID-19 pandemic. MGH uses ARMADA to manage redeployment of staff from departments with a surplus, to critical departments experiencing a surge during COVID-19.
hims.ai is a no-code data management and workflow automation software platform for automating healthcare administration. In addition to ARMADA, hims.ai offers hospitals and medical facilities a wide range of pre-built applications to automate processes typically handled through spreadsheets, PDFs and other manual mechanisms -- employee onboarding/off-boarding; PTO/LOA requests; IT security access requests; licensing/credentialing renewals. hims.ai empowers hospital administrators and HR managers to easily fine tune the applications to their own requirements without any technical expertise and be up and running in just a few days without needing IT resources.
"The true problem we were looking to solve was staffing the hospital in the middle of a pandemic," said Taylor Martin, Manager, Clinical Resource Team and New Nursing Initiatives at Michael Garron Hospital. "If you're going to be able to provide that critical care to patients who are sick, you need to have the right staff available and assigned where they're needed. The problem that ARMADA solves at the highest level is making sure that we are adequately staffed and that the resources are allocated appropriately," Taylor said.
Since many non-essential procedures across the Ontario health care system were halted to focus on COVID-19, MGH recognized the importance of optimizing its human resources, for example, some departments had a surplus of staff, while other departments providing critical care for COVID-19 were in high demand. ARMADA offers MGH a simple, intuitive interface where managers from respective departments can enter their daily staff surpluses and requirements. The staffing group makes the match with a single click, automatically notifying all stakeholders - the redeployed staff, managers, etc. Historical information on all redeployments are captured in one place, and is readily available for reporting, optimization and payroll purposes.
"My group had the critical role of staff allocation. We were faced with a continuous flood of data and information across telephone calls, person to person interactions, emails, and Excel spreadsheets from surplus staff eager to help on the one hand, and scores of urgent requests for staff on the other. Add to this further communication for every allocation," said Taylor.
ARMADA enables MGH to take disparate data inputs and bring them all together in a standardized format and an accessible and accurate single source of information. Staff have access to this information through a secure platform at a click of a button. This results in reduced data errors and avoids miscommunication, duplication of data and effort, and needing to communicate things over and over again to people.
"ARMADA allows us to view and analyze our data in new ways by taking data from literally a piece of paper into a database that we can filter, sort and analyze," said Taylor. "It also improves internal communications, reduces phone calls, emails, and meetings because people can view their own data and get the reports when and where they need them. Instead of redundant, transactional conversations, we now have more value-added interactions," Taylor added.
With its powerful automation and workflow management capabilities, ARMADA is much more than just a database. It can not only collect and manage data, but it also can move this data across workflows and business processes. In addition, it provides real-time data transparency and visibility across the organization.
"When MGH came to us, we were grateful to be given an opportunity to help during this crisis," said Max Ladjevardi, SVP, HyperOffice. "hims.ai was purpose-built for exactly this type of challenge, to help healthcare administrators transform manual spreadsheet and paper processes into automated online workflows which all stakeholders can access centrally from anywhere, anytime. Our technology handles the redundant grunt work, allowing staff to focus on critical decision-making, driving business processes and yielding better patient care." Max added. "We are eager to help hospitals and healthcare administrators make a difference in patient care by modernizing their business processes through innovative cloud and no-code applications," he concluded.
"It's been a great, great experience. From the first conversation they were so eager and enthusiastic to try to help in this time of global need - it was really refreshing," said Taylor. "I think it's a great platform with good technology that has so many applications for hospitals and for just about any organization looking to do more with what they have. The ability of the platform to do much of the work for us transforms our workflows and business processes. We now get to spend our time on critical decision making instead of transactional data entry and manual work, because ARMADA does that extensive data collection work for us," Taylor concluded.
More about hims.ai can be seen at https://www.hims.ai



START your own Wordpress site, business or personal website, or online store at www.siteground.com

DiabetesSisters will continue to hold all peer support and other meetings via remote methods until June 30, 2021

CHICAGO (PRWEB) DECEMBER 02, 2020
Under the guidance of its Board of Directors, DiabetesSisters has extended the suspension of all in-person meetings until June 30, 2021. DiabetesSisters volunteer peer support leaders and the community they serve will continue to have the opportunity to hold regular PODS Meetups using online or conference call platforms. Programs, including Minority Initiative outreach, will follow a virtual format.
As a national nonprofit with a large number of volunteer leaders in communities throughout the United States, striving to improve the health and quality of life for women with diabetes, DiabetesSisters continues its commitment to ensure safety for its staff, faculty, volunteer leaders, and members of peer support groups taking part in DiabetesSisters programs and activities.
"Women living with diabetes need peer support as much as ever. We provide that support safely through online methods, especially with the uncertainty the COVID-19 pandemic poses throughout the US and around the globe," said Anna Norton, MS, CEO of DiabetesSisters. "Our Board of Directors agrees this is a safe course of action, and we continue to monitor the situation and update our policies as necessary."
People living with any type of diabetes have been identified as a group that may face higher risks of complications when dealing with COVID-19. For the health and safety of its volunteer leaders, group members, faculty, and staff, DiabetesSisters is following recommendations from the US Centers for Disease Control and Prevention (CDC).
About the PODS Meetup Program:
Since 2010, the PODS (Part of DiabetesSisters) Meetup Program has offered monthly support to women living with any type of diabetes or prediabetes, providing a safe and non-judgmental place to discuss the successes and challenges of living with diabetes. Led by women living with diabetes, the groups offer true peer support focused on women and diabetes. The PODS Meetup Program reaches more than 2,000 women annually in person and online. Women age 18 and over, living with any type of diabetes or prediabetes, are invited to attend PODS Meetups.
About DiabetesSisters:
A 501(c)3 nonprofit, DiabetesSisters is the only organization nationwide focusing exclusively on women living with diabetes. Our mission is to improve the health and quality of life of women living with and at risk of developing diabetes and to advocate on their behalf. DiabetesSisters has a nearly 50,000-member peer network that united women with diabetes for the purpose of support, education, and advocacy. Signature programs include monthly peer support meetings (PODS Meetups); the Minority Initiative Program; Annual Leadership Institute for volunteer leaders; online expert articles, blog posts, forums; and conferences. For more information, visit https://diabetessisters.org.

"Women living with diabetes need peer support as much as ever. We provide that support safely through online methods, especially with the uncertainty the COVID-19 pandemic poses throughout the US and around the globe," said Anna Norton, MS, CEO of DiabetesSisters.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

New healthcare information security certification demonstrates commitment to the highest standards of data protection across the company's operations, systems, and products

TEL AVIV, ISRAEL (PRWEB) DECEMBER 02, 2020
MaxQ AI, the industry-leading healthcare technology company that delivers comprehensive clinical workflow solutions assisting with improved patient triage and diagnosis, announced today that after undergoing stringent reviews by the British Standards Institution (BSI), it has achieved ISO 27799 certification and ISO 27001 recertification. Both certifications are widely recognized international standards for information security management systems. These standards separate MaxQ in its commitment to deploying the Accipio Clinical Platform as a comprehensive, seamless, and secure solution for the healthcare industry.
MaxQ's ISO 27001 and 27799 certifications attest to its commitment to securing development lifecycle management, data integrity, and privacy. "Although ISO 27001 certification is not required by any regulatory body at this time, MaxQ AI chose to pursue these ISO standards because of the importance of providing secure healthcare solutions while adhering to the highest industry security standards. Our mission is patient safety, and we see security as part of that mission," said Robert Mehler, Co-Founder, Chief Operating Officer, and Chief Information Security Officer for MaxQ AI. "Cybersecurity is a threat that goes far beyond lost revenue and expenses. An attack can have dire, potentially irreparable consequences for patient care, and to the healthcare organization's reputation."
The Accipio Clinical Platform generates multiple insights into a patient's medical imaging study that may help provide a faster and clinically accurate diagnosis of Intracranial Hemorrhage (ICH) in acute care settings across the globe. There is a stroke patient every 40 seconds in the USA and ICH accounts for approximately 20% of all strokes and presents in up to 30% of all head injuries*. The platform is comprised of Accipio Ix (Intracranial Hemorrhage (ICH) triage and notification, Accipio Ax (Slice-Level Annotation), and Accipio Dxg (Triage for ICH Presence or Absence)**.
MaxQ is the only AI platform company offering advanced AI applications and AI platform solutions, such as MaxQ Xpress, as a seamless, integrated offering, secured through ISO 27001 and ISO 27799 cybersecurity standards.
Willy Fabritius, Global Head Information Security and Business Continuity at BSI comments: "Protecting data has become increasingly challenging for organizations, this is why it's a huge achievement for MaxQ to have been certified against these Management System standards as it shows the organization's proactive approach to managing information security and building resilience for the future."
Accipio devices are globally available with multiple regulatory approvals** and seamlessly deployed through MaxQ's trusted channel partner base, including GE, Philips, Nuance, FujiFilm, Blackford, IBM Watson Health, and TeraRecon. Radiology Departments, Emergency Room, and Neuroradiology teams utilize Accipio to make treatment path decisions while lessening burden and burn-out. MaxQ's Accipio platform can be viewed at the 106th RSNA virtual exhibit through its unique AI experience within each of the MaxQ channel partners.
About MaxQ AI, Ltd.
MaxQ AI is transforming healthcare by empowering physicians to provide 'smarter care' with enhanced clinical workflow solutions assisting with improved patient triage and artificial intelligence (AI) clinical insights. Based in Tel Aviv, Israel and Andover, MA our team of deep learning and machine vision experts develop innovative software that uses AI to interpret medical images and surrounding patient data. Working with world-class clinical and industry partners, our software enables physicians to make faster, more accurate decisions when diagnosing intracranial hemorrhage, stroke, brain trauma, and other serious conditions. To learn more, visit http://www.maxq.ai or follow us on LinkedIn.
*References Available Upon Request
**MaxQ Device Regulatory Status Available at http://www.maxq.ai



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this free webinar, the featured speakers will discuss how risk analysis is becoming increasingly incorporated in clinical monitoring (e.g. traditional clinical monitoring vs. a risk-based monitoring approach). The pros and cons of different approaches to integrate risk assessment into clinical monitoring — with risk-based monitoring being one of the most advanced approaches — will be presented. The importance of electronic data collection and real-time analytics in informing risk-based monitoring will also be discussed. Real-world examples to show how risk-based monitoring coupled with analytics empowers clinical study stakeholders will be presented.

TORONTO (PRWEB) DECEMBER 02, 2020
Since being officially condoned by the FDA in 2013, risk-based monitoring (RBM) has progressed to become a viable clinical monitoring technique, leveraging the latest technology to proactively identify challenges to trial safety, data analysis and compliance. With clinical trial resources prioritized by risk, RBM has brought study sponsors, CROs and other stakeholders greater oversight into how trials are conducted.
Could there be a better pathway for RBM – a more strategic approach that can optimize monitoring in real time?
In their upcoming webinar, Biorasi will be discussing a more sophisticated methodology for addressing RBM throughout the clinical trial. By introducing real-time analytics, RBM can empower trial stakeholders to make better decisions related to speed, cost and quality.
As part of this discussion on innovating RBM, Biorasi will be joined by data, analytics and technology partner IBM Watson Health, who will explore the importance of successful electronic data capture (EDC) to inform data management and analysis at all stages of the clinical trial. Biorasi encourages everyone to engage with the future of RBM by joining this webinar.
Join Roberto Silberwasser, VP, Data Sciences & Biometrics, and Geetesh Shrivastava, Director, Clinical Monitoring from Biorasi; along with Rob DiCicco, Deputy Chief Health Officer, and Sebastien Bohn, Offering Manager Lead - IBM Clinical Development, from IBM Watson Health, in the live webinar on Thursday, December 17, 2020 at 11am EST (4pm GMT/UK).
For more information, or to register for this event, visit Revolutionizing Risk-Based Monitoring Through On-Study Analytics.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The agreement will accelerate commercialization of its AI mental health platform, PREDICTIX, in Australia, New Zealand and the USA, pending regulatory approval.

TEL AVIV, ISRAEL (PRWEB) DECEMBER 02, 2020
Taliaz, a mental health startup harnessing artificial intelligence (AI) to revolutionize mental health treatment and management, today announced that it has entered into a three-year partnership agreement with molecular diagnostics leader, Genetic Technologies Ltd (ASX: GTG; NASDAQ: GENE, the 'Company') (GTG) for the distribution of its PREDICTIX products in Australia, New Zealand and the USA, pending regulatory approval.
Starting in the field of depression, the new agreement will accelerate global commercialization of Taliaz's pioneering decision-support and management platform, while supporting GTG to expand its product offering and the establishment of a mental health vertical. This announcement follows Taliaz's recent $2.7 Million EU Horizon funding awarded earlier this month.
Under the terms of the binding agreement, Taliaz will grant GTG exclusive distribution to its PREDICTIX products within Australia and New Zealand for a period of three years and non-exclusive distribution rights within the United States.
With 1 in 10 Americans [1] and 1 in 8 Australians [2] prescribed antidepressants per year, PREDICTIX empowers psychiatrists and general practitioners to provide a more accurate and rapid treatment plan for patients. This helps reduce treatment costs and the growing burden on society from depression.
The PREDICTIX technology uses AI to analyse multiple streams of patients' data, including genetic, metabolic, demographic and clinical information. Doctors receive a personalized patient report that ranks the statistical efficacy and potential side effects of various antidepressant medications based on each patient's genetic makeup and health record. PREDICTIX can improve today's antidepressant prescribing accuracy by 47% [3].
PREDICTIX is CE-registered and commercially available in the UK, France and Israel, with the process underway for Therapeutic Goods Administration (TGA) approval in Australia.
Dekel Taliaz, CEO and Co-founder of Taliaz said, "We are excited to partner with Genetic Technologies, world-leaders in the genetic risk assessment space. This new partnership will support rapid commercialization of PREDICTIX to help more depression sufferers in Australia, New Zealand and the USA, while adding a complementary and advanced mental health solution to GTG's growing suite of DNA tests."
George Muchnicki, GTG's Interim CEO stated: 'We are incredibly pleased to have partnered with Taliaz to bring their predictive and personalized mental health product to Australia and New Zealand. GTG are at the forefront of providing personalized and predictive products to empower patients to make informed decisions about their health. This distribution agreement is our first external product partnership and our first product within the mental health vertical. Mental health has remained at the forefront of media discussions and government initiatives within Australia, New Zealand and globally due to the ongoing social and economic impact and given the impact from the current global pandemic. We look forward to working closely with the Taliaz team to deliver their product into these markets at this critical time."
Taliaz is currently in the process of raising an additional round of investment to further accelerate and expand commercial efforts with healthcare systems, payors, providers, DNA laboratories and telemedicine providers globally.
Marketing Manager
Viki Gronau
Taliaz
M: +972-54-258-7278
E: viki@taliazhealth.com
Investor Relations (AUS)            
Stephanie Ottens                    
Market Eye                        
M: +61 434 405 400                    
E: stephanie.ottens@marketeye.com.au        
About Genetic Technologies
Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE) is a diversified molecular diagnostics company. GTG offers cancer predictive testing and assessment tools to help physicians proactively manage patient health. The Company's lead products GeneType for Breast Cancer for non-hereditary breast cancer and GeneType for Colorectal Cancer are clinically validated risk assessment tests and are first in class. Genetic Technologies is developing a pipeline of risk assessment products.
For more information, please visit http://www.gtglabs.com
About Taliaz
Taliaz is revolutionizing the treatment and management of mental health disorders with PREDICTIX. PREDICTIX is a CE-registered product that provides an advanced decision support software for psychiatrists and general practitioners. Harnessing artificial intelligence, PREDICTIX can enable easy, effective and rapid patient assessment, improved prescribing precision and management for a wide range of mental health conditions. Starting in the field of depression, the PREDICTIX Genetics and PREDICTIX Digital products can improve today's prescribing accuracy by up to 47%4.
For more information, please visit predictix.ai.
1. Source: https://www.health.harvard.edu/blog/astounding-increase-in-antidepressant-use-by-americans-201110203624
2. Source: https://www.psychwatchaustralia.com/post/1-in-8-over-3-million-australians-are-on-antidepressants-why-is-the-lucky-country-so-miserable#:~:text=In%20the%202018%20financial%20year,SSRIs%20for%20depression%20or%20anxiety.&text=As%20shown%20in%20Table%201,antidepressant%2C%20in%202017%2D18.
3. Based on a retrospective analysis of STAR*D study medications versus current clinician treatment selection prescribing accuracy (Chekroud et al., 2016). STAR*D is one of the world's largest prospective studies for optimal antidepressant administration.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Two leading disability advocacy organizations, United Cerebral Palsy (UCP) Detroit and UCP Michigan are joining forces to help close the disability divide

DETROIT (PRWEB) DECEMBER 02, 2020
Two leading disability advocacy organizations, United Cerebral Palsy of Detroit (UCP/Detroit) and United Cerebral Palsy of Michigan (UCP/Michigan) have merged to expand the scope of service and reach provided to the disabled community. The new entity is MI-UCP (pronounced My-UCP), and will continue to operate from offices in Detroit and Lansing. The merger became official on July 1, 2020, but the announcement was delayed due to the COVID Pandemic. MI-UCP President and CEO Leslynn Angel made the announcement.
"This is positive news in times where we are seeing people with disabilities become increasingly disenfranchised," said Angel. "With approximately 1.4 million people with disabilities in Michigan, there's a definite need for the services we provide. Our goal is to close the disability divide that has marginalized so many of our clients. They deserve every advantage that we all have."
The two merging organizations were founded in 1949, the same year that the national organization, United Cerebral Palsy, was founded. They have joined together to work for one mission "To enable all Michiganders with disabilities to live to the best of their abilities and ambitions." The new MI-UCP will be here to serve every person in Michigan with a disability. This includes those affected by cerebral palsy, autism, spinal cord injuries, intellectual disabilities, visual impairments and many other disabling conditions. And, because COVID is disproportionately affecting people with disabilities, they are here to help reduce that disparity.
As an advocacy organization, MI-UCP closes the disability divide by providing services connecting its clients to organizations that can best address a particular need.
Examples of services include: a Representative Payee program to assist with financial matters; Benefits Counseling that helps individuals navigate complicated systems like Social Security and Medicaid; and Assistive Technology can be provided via grants to address needs in the areas of mobility, communication, learning, transportation, independent living and more. MI-UCP also provides Quick Ramps for Kids who are in need of an inexpensive, portable option for wheelchair accessibility.
Angel said that the staff would remain the same, and that there were several changes to the board. New to the board as Treasurer is David Brown, and moving from the Treasurer position to board member is Charlie Hawes.
About MI-UCP
MI-UCP was founded in 1949 as United Cerebral Palsy Association of Metropolitan Detroit (UCP/Detroit). This included Wayne, Oakland and Macomb counties. That same year, United Cerebral Palsy Association of Michigan (UCP/Michigan) was formed to serve the needs of constituents throughout the remainder of the state of Michigan.
In 2020, these two organizations merged into MI-UCP (Michigan United Cerebral Palsy). The goal is to expand our scope of service reach. In reality, more than 65 percent of the people we serve have a disability other than cerebral palsy. These include autism, spinal cord injuries, intellectual disabilities, visual impairments and many other disabling conditions.
By unifying as MI-UCP, we are able to operate more efficiently and effectively as one of the state's leading sources of information, referral and strategic partnerships with like-minded organizations. And by having offices in Detroit and Lansing, we can continue to be a leading advocate for all 1.4MM of Michiganders with disabilities. For more information or to contact MI-UCP, please visit the web site at mi-ucp.org
###



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In most practices, the standard procedure is to outsource your dental lab needs. These typically include dentures, dental crowns, porcelain veneers, implant restorations and more. While convenient and often less expensive for dentists, quality and precision are often compromised. With Saxon Dentistry, this is now kept on-site, ensuring greater quality control, accuracy of fit and most importantly, higher patient satisfaction.

OKLAHOMA CITY (PRWEB) DECEMBER 02, 2020
Providing the highest quality, longest lasting and most honest dentistry available has been a commitment of OKC dentist Dr. Chris Saxon's since he began practicing dentistry. He is keeping this commitment by providing his patients with an on-site dental lab. This allows Dr. Saxon and his team at Saxon Dentistry to work hand in hand with the lab specialists to ensure an outstanding level of quality and service.
The Saxon Dentistry Difference
In most practices, the standard procedure is to outsource your dental lab needs. These typically include dentures, dental crowns, porcelain veneers, implant restorations and more. While convenient and often less expensive for dentists, quality and precision are often compromised. With Saxon Dentistry, this is kept on-site, ensuring greater quality control, accuracy of fit and most importantly, higher patient satisfaction.
When patients embark on full smile makeovers, dental implants, porcelain veneers and even a single crown, they are putting a lot of trust in their dentist. This trust is not taken lightly at Saxon Dentistry. The on-site lab utilizes top tier dental materials, advanced technology and employs skilled, meticulous technicians. Combining this with Dr. Saxon's expertise allows for predictable, high quality outcomes.
When teaming up with the on-site dental lab specialist, Dr. Saxon can bring them directly into the room with the patient and together listen to the patient's concerns. Without an on-site lab, dentists have to relay information to their labs via phone call or email. Details get lost in translation, and details matter greatly when customizing a smile for patients. Sometimes the most minor adjustment can have the biggest impact.
Smile Makeovers OKC
Dr. Saxon has a particular passion for making dentistry beautiful and natural. His keen eye for detail can make any dental restoration, from a single cracked tooth repair to dental veneers to full mouth dental implants, blend seamlessly into a smile. This has made him a highly sought after OKC cosmetic dentist and implant dentist.
"When dentistry is done to the highest level, no one should be able to detect that you've had dental work completed."
He believes in meeting patients exactly where they are in life, understanding their goals and setting forth the appropriate treatment from there. There is no one size fits all dentistry in his office. Personalized care is not only necessary; it's what every patient deserves that walks through a dentist's door.
Get to Know Oklahoma City Native, Dr. Chris Saxon
Dr. Saxon is a native of Oklahoma City and a graduate of Putnam City North high school. He received his doctorate from the University of Oklahoma College Of Dentistry. He takes between 100-150 hours of continuing education every year, far exceeding the Oklahoma Board of Dentistry's requirements.
Dr. Saxon is committed to giving back to the local community. One way he does this is by being an Oklahoma Mission of Mercy participant. Dr. Saxon is an avid golfer, cyclist and kite boarder, but his greatest joy comes from spending time with his family.
Visit our Oklahoma City dental office at 3621 NW 63rd. Suite E, Oklahoma City, OK 73116.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

A new partnership helps students build skills and connect to peer-to-peer support when and where they need it

NEW YORK (PRWEB) DECEMBER 02, 2020
Kognito, a leading health simulation company offering skill-building simulations that promote safe and healthy campuses, has partnered with Togetherall, a 24/7 online peer-to-peer mental health community.
Through this new partnership, Togetherall and Kognito will help campuses expand their mental health services to students—particularly remote options, which have become increasingly important during the pandemic. Combining Kognito's practice-based learning experiences with Togetherall's online community will help colleges build a stronger peer-to-peer support system in their efforts to enhance the safety and wellbeing of their campus community.
Togetherall is an online peer-to-peer mental health community where students can anonymously seek and provide support 24/7. It is moderated by registered practitioners who keep members safe and facilitate the process. Togetherall provides service to more than 200 post-secondary institutions serving 1.6 million students worldwide, with thousands of new members joining each month.
Kognito offers a suite of evidence-based virtual human simulations for both students and faculty, used by over 700 campuses to address critical issues including mental health, suicide prevention, and sexual misconduct prevention. A key component of its student-focused online simulations is allowing students to practice conversations with peers. Students learn how to identify and talk to friends in distress in an experiential private practice environment with virtual humans, building the skills and confidence to have these conversations in real life.
This partnership comes at a time when colleges around the country are responding to the growing mental health needs of students—almost 75% of college students say their mental health has worsened during the pandemic. Engaging students to support each other is one important strategy to foster a more positive campus climate. Kognito's solutions go beyond awareness to help grow student skills, while Togetherall provides students with a place to use those skills and support one another.
"Partnering with Togetherall will allow Kognito to expand how we support the hundreds of schools that already utilize our comprehensive mental health and resilience skill-building simulation products," says Ron Goldman, Co-Founder and Chief Simulation Strategist at Kognito. "As more schools adopt a stepped care model, they can continue to look to Kognito as part of a comprehensive solution to improve student mental health and wellness."
Offering a spectrum of mental health support resources aligned with a stepped care model is becoming more common for campuses. But with the shift to remote learning, the need to think outside the "one-on-one counseling" box has grown even more. As campuses seek solutions to address their students' mental health needs, Togetherall and Kognito work in concert to help fulfill a need at a critical time.
"Students need mental health support perhaps now more than ever, which can be a challenge during this pandemic when campus services are often limited due to safety concerns," says Matthew McEvoy, Senior Vice President and General Manager of Togetherall in North America. "We're excited to partner with Kognito to provide a more comprehensive solution to higher education institutions and help them give more support avenues to their student community."
About Togetherall:
Established in 2007 as Big White Wall, Togetherall is a leading online mental health service that provides millions of people throughout the UK, New Zealand, Canada and the US access to community and professional support, 24 hours a day, 365 days a year. The service is registered with the Care Quality Commission (CQC) and is clinically proven to help those who are struggling with stress, isolation, anxiety, depression and other common mental health issues. Togetherall has supported over 220,000 members with their mental health since launch in partnership with clients in the corporate, education, health and charity sectors, and all serving military personnel and veterans in the UK. Learn more at http://www.togetherall.com.
About Kognito
Founded in 2003, Kognito is a leader in designing immersive practice experiences that develop and assess users' competencies in transforming challenging health conversations into opportunities to drive meaningful and sustainable changes in attitudes, self-efficacy, and behavior. Kognito's award-winning online and mobile experiences use emotionally responsive virtual humans to simulate real-life conversations within a risk-free and adaptive environment that provides personalized feedback and in-depth analytics. Kognito uses a science-driven, research-proven approach and currently has more than 450 clients in education, government, and healthcare settings. Learn more and access demos at http://www.kognito.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The Dreaded Wedding-Day Pimple: What You Can Do?

STATEN ISLAND, N.Y. (PRWEB) DECEMBER 02, 2020
It's not just bad luck that a nasty pimple pops up just before an important day. Stress, excitement, lack of sleep – all practically guaranteed to be present – can all contribute to a breakout. There's nothing that will guarantee flawless skin for your wedding, prom, or performance but there are things you can do that will minimize your risk and put you in control.
"The key is to start thinking about your skin well in advance," says Rebecca Sklar of Advanced Dermatology. "As with so much about a wedding or other important event, planning is essential. Your plan should consist of three steps: You want to do everything you can to prevent a breakout, treat it if it occurs, and conceal it if necessary."
Prevent
Enlist a dermatologist months in advance as part of your team. Discuss whether your regular skincare regimen needs modification. If you're considering a change, now is the time to try new products or procedures so you have time to deal with any adverse reaction. Ask whether a microdermabrasion treatment a week or so before your day might be helpful to exfoliate and clear away dead skin cells that can clog pores. Also, talk to the doctor about options for an emergency treatment, if needed, a day or so before the big day.
Exercise good skin hygiene: Never go to sleep without washing off makeup. Wash your face in the morning and at night to remove the bacteria, oils, and grime that can clog pores and lead to a breakout. Use a gentle cleanser or scrub appropriate for your skin type. As you approach your big day, avoid or go easy on makeup to refresh your skin and avoid anything that could be irritating like exfoliants. Keep your hands clean and keep them away from your face as much as possible. Never, ever, pop a pimple or pick at a scab.
Follow a healthy lifestyle. Eat a diet that includes lean protein and lots of fruits and vegetables. Avoid greasy foods. Drink eight glasses of water a day to rid the body of toxins that can cause a breakout and to keep skin hydrated and moisturized. Exercise every day. Change your pillowcase and towels regularly. Don't smoke!
Treat
Don't panic if a blemish appears a day or two before the event. If you have twenty-four hours, call your dermatologist. If the problem is a big, red bump, a cortisone shot might stop it from further growth and reddening and the puffiness will subside by the next day. The dermatologist may also be able to extract pus or whatever is causing the inflammation without leaving any trace.
Over-the-counter remedies include a variety of fast-acting spot treatments in the form of gels, oils, lotions and "acne dots" that have a combination of active ingredients. You may want to have more than one product on hand. Salicylic acid, which removes excess oil, and benzoyl peroxide, which unclogs pores, are tried and true ingredients in acne treatments although they're seldom found in the same product. Other helpful ingredients include witch hazel to shrink pores, colloidal sulfur to extract impurities and excess oil, aloe vera and vitamins that soothe the skin and reduce redness, and glycerin to combat dryness. Tiny, waterproof hydrocolloid patches that are applied directly to the pimple after cleansing help tame inflammation, exfoliate the skin, and shrink pores. Some products go on clear and can be left in place under makeup.
Conceal
Blemishes can be trickier than other skin imperfections to cover without making them more noticeable. Use concealer that matches your skin tone rather than one that is lighter. Use a thin, firm brush to apply a tiny speck to the blemish starting at the center and working outward to where the redness ends. Then apply translucent powder. To counteract stubborn redness, apply a dab of green concealer first then skin-toned concealer. Don't forget that the photographer will be able to fix anything that isn't fully concealed.
"One of the most important bits of advice we can offer brides-to-be and others preparing for an important event is to find ways to reduce their stress," says Ms. Sklar. "Take time for a relaxing bath, practice yoga, meditation, or other relaxation techniques. Your skin will benefit as will the rest of you! The more relaxed you are, the better you'll be able to enjoy your big day!"
Bio: Rebecca Sklar, RPA-C is a certified physician assistant through the National Commission of Certification of Physician Assistants.
Advanced Dermatology P.C. and the Center for Laser and Cosmetic Surgery (New York & New Jersey) is one of the leading dermatology centers in the nation, offering highly experienced physicians in the fields of cosmetic and laser dermatology as well as plastic surgery and state-of-the-art medical technologies. http://www.advanceddermatologypc.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The British Dental Journal finds that poor oral hygiene may be connected to serious post COVID-19 complications due to high levels of harmful oral bacteria

TAMPA, FLA. (PRWEB) DECEMBER 02, 2020
After enjoying holiday celebrations, dentists have a special message for everyone: brush your teeth. Why is that so important this year? According to a new study published in the British Dental Journal, poor oral hygiene may be connected to serious COVID-19 complications due to high levels of harmful oral bacteria. The mouth is the gateway to the body, and the study suggests that good oral health practices could help reduce post COVID-19 complications, such as respiratory infections.
COVID-19 affects people in different ways, with patients exhibiting a range of symptoms and severity. So why do some people suffer more severely? It's become clear that bacterial superinfections are common in patients suffering from a severe case of COVID-19. The British Dental Journal states, "More than 80% of COVID-19 patients in ICUs exhibited an exceptionally high bacterial load, with more than 50% of deaths exhibiting bacterial superinfections."
While COVID-19 has a viral origin, it's suspected that in severe cases, complications such as pneumonia and acute respiratory distress (ARDS) may be caused by bacterial superinfections.
And those bacteria may originate in the mouth.
According to the study, "We recommend that oral hygiene be maintained, if not improved, during a SARS-CoV-2 infection in order to reduce the bacterial load in the mouth and the potential risk of a bacterial superinfection."
In addition to traditional oral care practices, such as flossing, brushing and using mouthwash, oral-care probiotics can also offer protection. This specialized type of probiotic is formulated to re-populate the oral cavity bacteria which crowds out harmful bacteria which can lead to cavities, gingivitis and periodontal disease. ProBiora Health the only oral-care probiotic designed specifically to help support gum and teeth health.
Dr. Eric Goulder, a cardiologist and founder of the Heart and Stroke Prevention Center in Central Ohio, believes that better heart health stems from improved oral-care health and has integrated a team of dentists and hygienists into his cardiology practice. His team regularly uses Probiora products to help keep patient's oral health in check. "We think everyone should be extra careful during the pandemic, and oral-care probiotics are a great way to help keep the oral cavity in balance 24-7."
Reference link:
https://www.nature.com/articles/s41415-020-1747-8



START your own Wordpress site, business or personal website, or online store at www.siteground.com

First global patient-powered data collection, analysis, and sharing platform will accelerate rare disease research and collaboration.

ALISO VIEJO, CALIF. (PRWEB) DECEMBER 02, 2020
RARE-X, a collaborative platform for patient-controlled and structured data collection, global data sharing and analysis that will accelerate treatments for rare diseases, announces the launch of its 2021 priorities and pilots made possible by critical early-stage funding from Alexion – a leading global biopharmaceutical company focused on the development of medicines for rare diseases and devastating conditions.
The RARE-X technology platform is specifically designed to:

Spur the development and sharing of data sets that aren't currently being generated, connected, properly structured and curated, or made accessible to enable meaningful research;

Level the playing field for patient communities that might not otherwise have the opportunity to participate effectively in pivotal research on their behalf;

Expand the usability, visibility, and reach of data from existing research programs, registries, and other aggregation efforts, thereby eliminating silos that may keep a brilliant researcher from a game-changing discovery or an innovative company from seeing the possibilities in a disease area needing a therapy;    

Support patients in responsible data ownership and sharing

"This data collection initiative significantly changes the outlook for patient communities needing treatments, and for researchers and drug developers working to find and develop those therapies," said Nicole Boice, RARE-X Co-Founder/Executive Director. "RARE-X positions patients everywhere to become central drivers in the efforts to progress research in their disease. RARE-X will also be supporting cross-disease research for rare conditions, as well as creating greater efficiencies that will result in a more effective and collaborative research ecosystem. A core RARE-X guiding principle is that patients own their own data, and in doing so, hold a central position in enabling research and drug discovery, to advance care and the next generation of therapies for the disease they care about."
The RARE-X platform for data contribution, aggregation, analytics, and research is powered by Broad Institute technology and expertise, which has successfully been implemented in other large-scale public data-sharing efforts. Designed to support data collection at scale, the RARE-X Data Collection Platform will have the capability to interconnect, structure, and securely accommodate a wide range of data, from genomic and clinical to patient-reported outcomes and even wearable or digital exhaust data. The types of data contributed and accessed via RARE-X will be entirely at the discretion of participating patients/patient communities and other data owners. The goal is to help enable a vibrant ecosystem of discovery needed to support the development of future cures. The core governance principles are patient-centered and intended to meet the most stringent global standards, and have been similarly tested via other major public sector data initiatives.
"For more than 25 years, Alexion has been focused on serving patients with rare diseases and devastating conditions by developing transformative medicines, and in this time, we have made significant advances and delivered life-changing medicines to thousands of patients globally," said Wendy Erler, Vice President, Patient Experience at Alexion. "However, we recognize there is a lot more work to be done to help those living with undiagnosed rare diseases and those who still do not have a therapy today. We are proud to support the work of RARE-X, the rare disease communities, and the goal of accelerating the development of new medicines for rare diseases by empowering patients to share their data."
As RARE-X initiates its 24-month pilot period, to demonstrate how this new approach to patient-owned data collection and federated data sharing for biomedical research will accelerate disease understanding and therapy development, RARE-X will showcase the platform scalability that will efficiently support thousands of global data collection portals and patients. Key priorities include:

Structured Data by domain – launching in Neurology, followed by four additional domain areas through the end of 2021

Twenty (20) neurology-focused data collection portals – disease areas to be announced in early 2021

Five (5) collaborative demonstration projects will leverage the entire technology platform supporting 21st-century data collection and federated data sharing globally—partners to be announced in early 2021.

Scoping the first international patient owned data collection effort, with the release of a landscape report in collaboration with RARE-X founding partner, IndoUSrare.

Early RARE-X collaborators have embraced this innovative approach to transform the rare disease research landscape, including an extraordinary Board of Directors and Advisors. Other organizational collaborators include: The Alliance for AI in Healthcare, The ARM Foundation for Cell and Gene Medicine, The Broad Institute Data Sciences Division, Global Genes, Sanford Health, and additional partners being announced over the next several months.
For partnership inquiries and to support this growing effort please contact the RARE-X team at collaborators@rare-x.org.
ABOUT RARE-XTM
RARE-X is a 501(c)(3) patient advocacy organization focused on supporting the acceleration and development of life-altering treatments and future cures for patients impacted by rare disease. Enabled by best-in-class technology, patients, researchers, and other technology vendors, RARE-X will gather structured, fit-for-purpose data to share broadly, benefitting from 21st-century governance, consent, and federated data sharing technology. RARE-X is building the largest collaborative patient-driven, open-data access project for rare diseases globally. For more information, visit tomh@rare-x.org http://www.rare-x.org.
Media Contact:
Tom Hume, Marketing Communications – RARE-X
tomh@rare-x.org



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Midwest leader in urgent care selected Noble to better manage inbound and outbound contacts and appointment setting for its growing network of clinic locations.

ATLANTA (PRWEB) DECEMBER 02, 2020
Noble Systems Corporation, a global leader in omnichannel contact center technology solutions, is pleased to announce that Physicians Immediate Care has chosen the Noble Contact Center Suite to help provide remarkable care to its patients.
Physicians Immediate Care, also known as Physicians Urgent Care, is a Midwest leader in urgent care and occupational health services with over 40 locations in Illinois, Indiana, and Wisconsin. No appointments are required, and most clinics are open seven days a week, up to 12 hours a day, to treat non-life threatening illnesses and injuries. The clinics are committed to building healthy communities through quality, caring service.
The healthcare provider selected a blended system in Noble Contact Center to manage inbound and outbound contacts and appointment setting for its growing network of clinic locations. Advanced management and reporting tools will give them more effective control of programs and better use of resources. The Noble Composer Agent Desktop helps automate processes and tasks so that agents can handle calls and requests more efficiently. Noble IVR with self-service and automated callbacks lets patients get answers more quickly and reduces hold times. Omnichannel services give the clinics the ability to expand their use of non-voice channels, such as email, SMS and web chat, to meet consumers' changing needs.
Todd Vang, President and COO at Physicians Immediate Care, said, "Our core values guide us every day to provide remarkable care to our patients, when and where they need it. As we grow, we needed a more robust system to manage our appointments and referrals. That need was made even greater with the Covid-19 crisis, as our call volumes spiked. With the Noble contact center technology and the support of their team's knowledge, we'll have the tools to take back control and manage our operations more effectively and provide better service for our communities."
Chris Hodges, SVP sales and marketing of Noble Systems, said, "Today's consumers demand responsive service and are more likely than ever before to change providers after just one bad experience. Therefore, it's critical that companies have the right tools in place to deliver a great experience each and every time. Noble Systems is excited to work with Physicians Immediate Care and to provide not only our advanced customer contact technologies, but also our know-how from over three decades of experience, to help them meet their business goals."
About Noble Systems
Noble Systems Corporation is a global leader in the customer communications industry, providing innovative solutions for Contact Center, Workforce Engagement, Analytics, and Gamification technologies. Tens of thousands of agents at client installations worldwide use Noble platforms to manage millions of customer contacts each day. Noble offers a unified suite of inbound, outbound, and omnichannel contact processing, strategy planning, resource management, and compliance tools for companies of all sizes. Our premise, cloud, and innovative premise/cloud hybrid platforms include ACD, predictive dialing, blended processing, recording and monitoring, IVR, messaging, interaction analytics, robotic process automation and decisioning, workforce management, and gamification. With a portfolio of more than 210 patents and growing, Noble leads the way in pioneering solutions for the contact center market. For more information, contact Lee Allum at 1.888.8NOBLE8 or visit noblesystems.com.
About Physicians Immediate Care
Physicians Immediate Care, also known as Physicians Urgent Care, is the Midwest leader in urgent care and occupational health services with over 40 locations in Illinois, Indiana, and Wisconsin. For more than 30 years, the company has provided affordable, convenient medical care to millions of patients. Physicians Immediate Care is dedicated to building healthy communities and reducing emergency room utilization by providing remarkable care you can count on, when and where you need it. Through its network of urgent care clinics (over half of which are partnered with health systems), the company is fully equipped to provide x-rays, lab testing, medical exams, minor procedures, and treatments for non-life-threatening illnesses and injuries. Its clinics offer convenient hours and accept patients who walk-in or self-schedule same-day appointments through its Urgent Care Pass application. For locations and services, go to visitphysicians.com.
CONTACT: Physicians Immediate Care: Todd Vang, 847.232.6718, tvang@visitphysicians.com




START your own Wordpress site, business or personal website, or online store at www.siteground.com

DSignage and Medrics released a personalized healthcare app in the U.S. that gives patients improved access to medical services and helps hospitals control spending.

MIAMI (PRWEB) DECEMBER 02, 2020
DSignage (DSignage.net), a South Florida company that uses smart technology to enhance business communications, joins Medrics (Medrics.us), a developer of interactive healthcare applications, on the release of a mobile app designed to improve patient experience and access to medical services.
The Medrics app's location and workflow technology uniquely benefit healthcare providers by reducing patient no-shows, increasing referrals and shortening outpatient wait times.
"Our partnership with Medrics offers patients better control over their care. At the same time, it gives hospitals a better handle on reducing costs because of improved efficiency and communication," said Jose Diaz, CEO and founder of DSignage.
The app is already available at VA hospitals in Las Vegas and Orlando and at healthcare facilities in the United States, Romania, Turkey, Saudi Arabia and United Arab Emirates. It currently serves more than 350,000 users and has placed more than 15,000 appointments. The app features 47 customizable functions, including:

Smart appointment management;

Virtual doctor appointments;

Patient referral management;

Health-related videos and entertainment;

Access to medical records and results;

Manual and location-based messaging;

Wayfinding/location services;

Integration with provider EMR and CRM systems;

Zero-contact patient registration;

Smart patient surveys.

Medrics and DSignage leverage location intelligence technology to send users essential details, such as the fastest route to get to their appointments. It also lets the hospital know when patients are running late.
The app will link to DSignage digital displays in healthcare centers, allowing for personalized messages as patients walk by screens. Digital signs will dynamically refresh to display information relevant to the user. The app will even help patients navigate confusing healthcare facilities.
"We'll be able to trigger content on large screens and on their phones based on a user's location," Diaz said. "We can send them text messages, videos and emails to keep them informed with information essential to their health."
More than 40 healthcare facilities in Europe, Asia and the Middle East use Medrics' interactive patient-care app, adding their brand and customizing user and multilanguage options to meet patients' needs. Hospitals, physicians and healthcare staff credit the app with streamlining services, eliminating long patient waits and vastly reducing missed appointments, which cost the industry billions every year.
Hospital patient apps are at the forefront of the digital transformation of healthcare worldwide. COVID-19 accelerated the industry's need for change, prompting healthcare companies to invest millions in new technology to improve efficiency and ensure sustainability.
"The industry now understands that innovation and technology — long used to treat and cure illnesses — delivers benefits that improve services at every level," said Medrics Co-founder and CEO Altug Ozdamar. "The app enhances a provider's value-based care, and everyone benefits – from the administrators to the patients."
The partnership with Medrics marks a significant milestone for DSignage, which uses digital tools like touchscreens and video displays to enhance communications with customers in the healthcare, corporation and retail industries. Using smartphones was a logical next step since it's the digital screen we all carry around.
"Like it or not, everyone has a smartphone in their hands. It's become an essential part of our lives," Diaz said. "Now they give patients an edge when it comes to their health; it delivers tools that hospitals can bank on."
###
About Medrics
The San Francisco-based Medrics develops integrated patient experience solutions to digitize the outpatient journey. Company uses location intelligence and mobile technologies to increase hospital KPI's resulting in increasing revenue and lowering cost of hospital operations. All solutions are white-labeled and customized, depending on priorities of clients.
Visit http://www.medrics.us.
About DSignage
Founded in 2005, DSignage is a South Florida-based tech company that develops smart technologies for businesses worldwide. The company uses technology to optimize the experience in large facilities such as hospitals, manufacturers and retailers. DSignage solutions range from mobile apps to touchscreens to video walls to better communicate with customers, patients and employees. Visit http://www.dsignage.net.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

As Pandemic Rages, CMS Rule Puts America's Seniors at Risk

ROCKVILLE, MD. (PRWEB) DECEMBER 02, 2020
In a move that will restrict Medicare beneficiaries' access to a host of medically necessary services, the Centers for Medicare & Medicaid Services (CMS) yesterday formalized significant payment reductions to more than three dozen health care provider groups for 2021. Audiologists will suffer a 6% cut and speech-language pathologists a 9% cut to Medicare reimbursement for their services. These reductions stand to put patients in jeopardy and risk the economic viability of health care practices, according to the American Speech-Language-Hearing Association (ASHA).
ASHA, the American Occupational Therapy Association (AOTA), and the American Physical Therapy Association (APTA) are calling on Congress to take immediate action to offset the cuts in CMS's 2021 Medicare Physician Fee Schedule. In a joint statement issued last night, the associations note: "The clock is ticking—these cuts will be implemented in 30 days. AOTA, APTA, and ASHA urge Congress to include H.R. 8702, the Holding Providers Harmless from Medicare Cuts During COVID-19 Act of 2020, in any moving legislative vehicle before the end of the year. H.R. 8702 is bipartisan legislation that will address these cuts by providing relief payments in an amount that will ensure parity with current payment for impacted services."
The groups explain: "Our members serve a critical role in the health and vitality of this nation, frequently evaluating and treating older adults with physical, cognitive, communication, psychosocial, hearing, and balance disorders. Our services help ensure that these beneficiaries have the functional stability required to remain safe and independent within their communities. The care we provide is all the more important to patients recovering from COVID-19."
ASHA also joined a larger coalition of physician and nonphysician provider groups who are decrying CMS's final rule. In a separate statement, these groups assert: "Thousands of comments submitted by providers, patients, and Members of Congress highlighted the importance of mitigating payment cuts associated with budget neutrality requirements triggered by higher payment and modified reporting requirements for evaluation and management (E/M) services. Due to CMS's unresponsiveness to address these concerns, organizations representing more than 1 million physicians and nonphysician health care providers across the United States urge Congress to include legislation in any year-end package to prevent these arbitrary Medicare cuts in order to protect patient access to medically necessary services."
According to ASHA, the timing of the cuts is especially bad, given that the pandemic is disproportionately impacting older Americans and that many health care practices have already reduced their staffs or shuttered due to economic strains of COVID-19. Cuts to reimbursement will compound this situation, making it even more difficult for patients to receive needed care. Those in rural and underserved areas would be the hardest hit.
For more information, visit ASHA's website.
About the American Speech-Language-Hearing Association (ASHA)
ASHA is the national professional, scientific, and credentialing association for 211,000 members and affiliates who are audiologists; speech-language pathologists; speech, language, and hearing scientists; audiology and speech-language pathology support personnel; and students. Audiologists specialize in preventing and assessing hearing and balance disorders as well as providing audiologic treatment, including hearing aids. Speech-language pathologists identify, assess, and treat speech and language problems, including swallowing disorders. http://www.asha.org
###

The clock is ticking—these cuts will be implemented in 30 days. AOTA, APTA, and ASHA urge Congress to include H.R. 8702, the Holding Providers Harmless from Medicare Cuts During COVID-19 Act of 2020, in any moving legislative vehicle before the end of the year.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Women-owned skincare brand to offer counsel and resources, in addition to an annual contribution, to support the program

LYONS, COLO. (PRWEB) DECEMBER 02, 2020
All-natural body care brand Green Goo, under parent company Sierra Sage Herbs, recently established a partnership with PARSA (Physiotherapy and Rehabilitation Support for Afghanistan) to develop a sustainable herb garden program to foster vocational training and economic opportunities for members of PARSA's Healthy Afghan Women's Support Groups as part of its Trade Afghan Business Network.
In tandem with PARSA's professional staff, Green Goo will provide counsel, resources, and training to support group members, who will then grow a selection of herbs that may be used to produce clean, natural body care products. The products, which will be formulated by Green Goo Co-Founder and Director of Product Development Jen Scott to fit the Afghan context, will be simple to produce and will only require locally-available resources. Suggested starter products include healing first aid, dry skin, and pain relief salves. The PARSA support-group members will be trained in growing, dry processing, and storing the herbs, in addition to learning to produce and package the respective products. They will then be taught basic entrepreneurship, wherein the women will be able to sell the products locally, reinvest their earnings to grow their small businesses, and earn income for their families. PARSA intends to start the program as a pilot with a support group based at their head offices in Marastoon, Kabul.
"The idea of introducing a sustainable herb garden model to communities, especially women, in developing nations has been a concept we have evolved for the better part of the last decade," said Green Goo Co-Founder and CEO Jodi Scott. "We feel so incredibly fortunate to have found a partner in PARSA who can help us make this dream a reality. We've seen the extraordinary healing qualities of herbs in our own products firsthand, and to be able to share that insight and ingenuity with PARSA beneficiaries, and to empower them to take these ideas to create economic opportunity for their families, is especially momentous."
As part of the Green Goo partnership with PARSA, Jodi Scott has been named to the philanthropic organization's international Board of Directors, where she will also serve as an adviser to their Trade Afghan Business Network, a mentorship program established in 2013 in response to women in Afghan communities who requested help developing and finding markets for their products.
"The Green Goo Partnership creates a program where Afghan women can support themselves and their children through a cottage industry and products that can be made at home," noted PARSA Executive Director Marnie Gustavson. "This is especially important in the current historical context in Afghanistan where women's rights to economic access is becoming more and more uncertain because of the re-incursion of the Taliban in Afghan communities, and the subsequent increase in violence against women. This project will provide a safe network for women entrepreneurs to earn a living, to survive the instability of the current political conflicts, and to continue to have a voice in their future."
Green Goo plans to make an annual financial contribution to PARSA in support of the herb garden initiative and various other programs. For the month of December 2020, Green Goo will also donate a percentage of their hand sanitizer sales to the organization.
###
Media Contact:
Shea Martin, Vice President of Public Relations
shea@greengoohelps.com
T: 917-903-2795
http://www.greengoo.com
Facebook/Instagram/Twitter -- @greengoohelps
#PlantsWithPurpose #SpreadGoodness
About Green Goo
Formed in 2008, Green Goo is a women-owned, family-operated, B-Corp. Our products are cruelty free and made in the USA with 100% natural ingredients. We started small, making products for friends, family, and the local farmer's market, and we have now grown into a thriving, value-driven company. As we evolve, we remain committed to our roots: a time-honored infusion process, high-quality ingredients, and simple, effective products that are safe for you, your family, and the environment. Visit Green Goo to learn more.
About PARSA
PARSA, an international 501(c)(3) nonprofit organization, trains and develops professional Afghan leaders who care for the women, youth, impoverished families, and the disabled citizens of Afghanistan by offering innovative programs that provide the greatest impact to these communities. They believe strongly in empowering visionaries who want to make a positive change and their organic approach has allowed them to be highly creative in program development. PARSA has been working at the most grassroots level in Afghan communities since 1996, consistently evolving over the years to meet the changing needs of the people they support. Visit PARSA to learn more.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Reporting an adverse event for a device marketed in the U.S. and EU isn't simple but this webinar has the framework one needs. Register today.

FALLS CHURCH, VA. (PRWEB) DECEMBER 03, 2020
Adverse Event Reporting:
A Tale of Two Systems
An FDAnews Webinar
Thursday, Dec. 17, 2020, 1:30 p.m.-3:00 p.m. EST
https://www.fdanews.com/aereporting
Reporting an adverse event in the U.S.? If a device is being marketed in the EU, one must report it there as well. And there are different requirements in the two regions making the task even more complicated.
During this Adverse Event Reporting: A Tale of Two Systems webinar on Dec. 17, attendees will find ways to make the process more straightforward. Through Ombu Enterprise's regulatory reporting paradigm, one will learn the similarities and differences between the two systems when it comes to triggers, timing, content, transmission, retention, custodian and access. Get practical insights into the process and discover what methods a team should use to ensure compliance.
Dan O'Leary, President of Ombu Enterprises, will demonstrate these procedures with a hypothetical event that would be reportable in the U.S. and the EU. One will move through both forms with a side-by-side analysis of the obligations and steps, gaining the insights needed to complete a successful reporting document.
During this webinar, attendees will cover:

Key requirements in adverse event reporting to regulators in the U.S. and the EU

Important differences between reporting systems in both regions

Recent changes in the adverse event reporting forms in the U.S. and the EU

Comparisons of the content expectations in the forms for both systems

The details of a report, including what triggers it, how much time a manufacturer has to report, what is included on the forms, how to share this information with a regulator, how long the report should be kept, who is responsible for reporting and who has access to the report

Adverse event reporting is never a simple process but having to do it in two places makes it twice as complicated. Join this webinar and get the knowledge you need to more smoothly and appropriately report an event in both the U.S. and the EU.
Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
to learn about our special multisite discount.
Webinar Details:
Adverse Event Reporting:
A Tale of Two Systems
An FDAnews Webinar
Thursday, Dec. 17, 2020, 1:30 p.m.-3:00 p.m. EST
https://www.fdanews.com/aereporting
Tuition:
$287 per site
Easy Ways to Register:
Online: https://www.fdanews.com/aereporting
By phone: 888.838.5578 or 703.538.7600
About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In collaboration with Nationwide, Prudential Financial, and Securian Financial, The Institutes RiskStream Collaborative has announced proof-of-concept completion of the Mortality Monitor application, which will help carriers close out and process death benefits and claims more efficiently.

MALVERN, PA. (PRWEB) DECEMBER 02, 2020
In collaboration with Nationwide, Prudential Financial, and Securian Financial,The Institutes RiskStream Collaborative, the risk management and insurance industry's largest enterprise-level blockchain consortium, has announced proof-of-concept completion of the Mortality Monitor application, which will help carriers close out and process death benefits and claims more efficiently.
Providing a single source for decedent information and allowing the secure and permission-based exchange of this data among RiskStream Collaborative member companies, Mortality Monitor sets the stage for a large-scale decentralized death registry. The RiskStream Collaborative partnered with Kaleido to leverage their blockchain services and develop the application, which serves as RiskStream's first life and annuity-based distributed ledger proof-of-concept.
"We are living through unprecedented times with the outbreak of COVID-19. Timely closure of life insurance and annuity claims has never been more important and remains an ongoing challenge, as verification and validation of death claims requires carriers to have comprehensive decedent information, but no one source has emerged to fill this need," said Christopher McDaniel, president of the RiskStream Collaborative. "The Mortality Monitor solution makes inefficient manual processes obsolete by sharing decedent information securely, in real-time, and with transparency and traceability."
The proof-of-concept efforts emphasized Mortality Monitor's ability to securely share death data amongst the network of participants. It represents the first project to advance through RiskStream Labs, a framework established by the RiskStream Collaborative that's focused on accelerating completion of blockchain-centered innovations through participation from both member and nonmember organizations. The application gained initial support from Nationwide, Prudential, and Securian Financial—member organizations of the RiskStream Collaborative that participated in the proof-of-concept endeavor.
"The Mortality Monitor proof-of-concept shortens the response time from date of death to notification of beneficiary, thus improving the beneficiary's experience while reducing time, cost, and risk to the insurer," said Eric Henderson, President of Nationwide Annuity and chair of the Life & Annuity Advisory Board. "Nationwide is committed to driving digital innovation and is pleased to be part of this important work to help shape the future of claims processing for the life and annuity industries."
"This proof of concept is a prime example of how we are leading through technology innovation, and for Prudential, it is all about protecting the safety, security, and privacy for our customers during what can be a particularly challenging time. We are a socially responsible organization and believe it's important to protect our customers. We are excited that our participation in the consortium allows us to invest in solutions that solve real-life challenges in our industry," said Bob Bastian, CIO Global Technology, Individual Solutions Group at Prudential and Vice Chair of the Life & Annuity Advisory Board. "The Mortality Monitor use case illustrates how blockchain can be applied to enhance customer-centricity and drive innovation."
"This progress is exciting to see and only a starting point for the innovation this consortium will bring to the industry. We see a great opportunity to build a "single source of truth" in the industry using blockchain technology to better serve our customers and their loved ones while protecting their personal data. Prudential is proud to be a founding member of the consortium and to partner together with innovative leaders to provide new solutions that are secure and lead to better outcomes for our customers," said Anindya Sengupta, Vice President, Business Development, Emerging Technology Solutions at Prudential.
"Customers entrust life insurers to care for their loved ones if something happens," said Brian Oberman, Innovation Lab Director at Securian Financial. "Often times, a death benefit claim is the first experience loved ones have with a life insurer. The Mortality Monitor application helps us support our commitment to provide an excellent customer experience at a time of grief. We're proud to be a member of the RiskStream Collaborative."
The RiskStream Collaborative operates in property casualty, reinsurance and life & annuities. Its life & annuities (L&A) sector was born in collaboration with LIMRA, a research and professional development trade association for the financial services industry, which continues to serve in an advisory capacity to the L&A consortium. RiskStream aims to expand its network of members and connect insurance-oriented organizations to create greater efficiencies and achieve growth opportunities through blockchain innovations. The focus for Q4 2020 is to conduct a viability study to analyze and quantify the overlap of claims across carriers for the Life, Annuity, and Retirement sectors.
"The Mortality Monitor application demonstrates industry-leading innovative technology that optimizes the claims process. This allows carriers to proactively service beneficiaries and ensure a seamless, and stress-free experience," said Patrick Schmid, vice president of the RiskStream Collaborative. "Carriers that wish to gain access to the Mortality Monitor application, expand their technical knowledge, and collaborate with leading carriers can still join the Mortality Monitor Working Group in RiskStream Labs through the end of the year."
###
About The Institutes RiskStream Collaborative
The Institutes RiskStream Collaborative is the risk management and insurance industry's first enterprise-level blockchain consortium that brings together experts and developers to advance insurance-specific use cases via Canopy, a custom blockchain architecture. The RiskStream Collaborative is committed to equipping organizations to work together to inspire product innovation, enable efficiencies, and open new technological frontiers.
The Institutes, the leading provider of risk management and insurance knowledge education and solutions, offer professional designations, including the CPCU program. In addition, The Institutes provide introductory, foundational, and leadership courses and programs; online and continuing education courses; custom solutions; events and conferences; online and print news platforms; assessment tools; and research reports.
CPCU is a registered trademark of The Institutes. All rights reserved.
About Kaleido
Kaleido is a digital transformation platform that offers blockchain-as-a-service, digital assets services, smart contract management, network governance, insights and monitoring, collaboration services, apps and integration, along with a marketplace with third-party integrations, developer tools, and connectors.
Kaleido has been running thousands of networks globally with built-in high availability, disaster recovery, and 99.99% uptime achieved over the last three years. Kaleido provides multi-party consortia with one native network across the major public clouds, across all global regions and on-premise deployments. It offers the industry's highest levels of security, compliance, performance, and scalability, along with enterprise SLAs and 24/7 support. It is the first blockchain SaaS to have achieved ISO 27K certification.
The leading global enterprise blockchain consortia in production today across trade finance, supply chain, payments, insurance, banking, healthcare, media and entertainment, and retail rely on Kaleido for continued innovation across the open-source and blockchain communities.
To learn more, visit us at kaleido.io

"With the outbreak of Covid-19, the timely closure of life and annuity claims has never been more important and remains a challenge. Mortality Monitor will make inefficient manual processes obsolete by sharing decedent information securely, in real-time, and with transparency and traceability."



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Recently updated healthcare industry research affirms the eroding financial performance of healthcare providers as a result of the COVID-19 crisis. But innovation inspired or accelerated by the crisis has set the stage for a more patient-centered reimagining of healthcare in America, especially as it applies to consumer choice and payment.

LAFAYETTE, CALIF. (PRWEB) DECEMBER 02, 2020
Healthcare consulting firm KaufmanHall just published its November flash report with updated financial analyses of hospitals and health systems. For the period Jan. 1 through Oct. 30, 2020 median changes across the U.S. reflect "a challenging month for hospitals and health systems nationwide amid ongoing instability spurred by the COVID-19 pandemic." Not surprisingly, operating performance remained below 2019, managing only 2.4% on the Kaufman Hall Operating Margin Index with CARES Act funding and negative 1.6% without CARES.
Throughout this challenging year, healthcare has been hit with higher expenses (up 14% per Adjusted Discharge YTD) and reduced volumes (down 11%). Pointing out that "Expenses continued to rise as hospitals replenished staffing levels in light of rising COVID cases and incurred the cost of drugs, personal protective equipment and other supplies needed to ensure safe care," the report goes on to predict that, "such increases will put hospitals in a tenuous situation if volumes plummet," something that now appears increasingly likely as COVID cases and hospitalizations continue to spike and states impose ever stricter stay-at-home policies.
It's tempting to view healthcare's disappointing financial performance so far in 2020 as an anomaly - something that will quickly self-correct when the crisis is over and market conditions get back to normal. Based on our clients' experiences, however, we're convinced that patients won't be satisfied returning to healthcare's old normal. If health systems and hospitals hope to benefit financially from the surge in demand that will follow the pandemic, they'll need to recognize and adapt to some important consumer dynamics that predated the pandemic but have been amplified because of it.
Better Patient Care. Lower Costs. Higher Margins – Realizing the Benefits of Holistic Virtual Care
The COVID-19 crisis has taught Americans that it is not necessary to go to a medical facility to get care from a qualified health professional. Before the pandemic, virtual care was a minor sideline for most healthcare providers with little or no long-term value as a strategic asset. But with support from the Center for Medicare and Medicaid Services (CMS) during the national emergency, virtual care delivery quickly became one of the most impactful silver linings during the crisis.
The success of the channel for safer, more cost-effective care delivery caused CMS administrator Seema Verma to announce as recently as October that, "CMS is taking action to increase telehealth adoption across the country." She went on to state that, "This revolutionary method of improving access to care is transforming healthcare delivery in America. (We) will not let the genie go back in the bottle."
At the same time patient acceptance of – and demand for - telehealth has exploded, hospitals and other healthcare providers have discovered compelling financial benefits to the improved productivity, reach and scalability of digitally delivered care. But the benefit potential for providers is limited by the fact that telehealth as it is currently imagined has a number of inherent long-term deficiencies.
As stunningly successful as telehealth has proven to be during the pandemic, it's important to note that virtual care as it is currently delivered is effectively incomplete. And even though Medicare reimbursements for expanded telehealth services continue to encourage Americans to access their healthcare electronically, the patient benefits of telehealth are exclusively clinical. In other words, they impact the patient's medical experience only. That would be fine if patient care experiences were composed entirely of medical needs and events, but we all know that the actual care journey is much longer and more complex. And nowhere is that journey more fraught with obstacles than with patients' financial experiences.
Even before the pandemic, millions of Americans were delaying or avoiding care because of concerns about their ability to afford the personal out-of-pocket costs for deductibles and copays. Since the pandemic began, according to research published by Kaiser Health News, "48% of Americans said they or a family member has skipped or delayed medical care because of the pandemic, and 11% of them said the person's condition worsened as a result..." The same report found that, "about 3 in 10 adults have had trouble paying for food and 11% paying medical bills. Nearly 1 in 4 adults said they or a family member in the next year will likely turn to Medicaid."
We have written extensively on this topic in recent months. In "Patients Love Virtual Health. Digital Financial Engagement Makes It Better," we shared the results of consumer research published this fall. Noting that, "patients are very happy with their COVID-19-inspired virtual care experiences," but that, "To achieve a truly patient centric experience, Hospitals and Health Systems must expand their vision for virtual care to include every patient experience in every setting." As noted above, this is particularly true when it comes to the patient's financial experience.
In the same article, we explored the convergence of digital patient enablement and consumerism. Citing a report published by IBM titled "Patient-centric healthcare: It's time for a new operating model," we expanded on the report's observation that, "Success comes when a company learns to deliver experiences or content in a personalized, participatory way, designed with the consumer's preferences in mind," with our own experiences working with some of the country's largest healthcare providers.
Concluding that "COVID-19-inspired innovation and patient enthusiasm for digital engagement have created the ideal environment for the rapid development of holistic, patient-centered operating models," we shared our clients' determination to, "reframe their vision of care to include every dimension of the patient experience." Pointing out that, "Consumers are demanding it. The competition is stepping up to deliver it, and the technology exists to realize it," we concluded that, "healthcare providers who expect to thrive in the post-COVID-19 healthcare marketplace must embrace it."
Ramping Up for Healthcare's Post COVID-19 Recovery
Like it or not, the pandemic has forced a historic reset on the American healthcare industry. It's impossible to predict with certainty what the industry will look like in the next few years, but it is possible to imagine the opportunities. In analysis published by PwC titled, "COVID-19 recovery for the healthcare ecosystem, gearing up for the next normal," the consulting firm offers a planning framework to, "rethink the enterprise and accelerate transformation to seed future growth." We agree completely, especially as the potential transformation affects consumers' financial experiences, our area of expertise for thirty years.
To truly realize the considerable promise of virtual health over the long-term, health systems and hospitals must employ digital tools to reduce or remove the financial barriers to patient care and payment. Even before the pandemic, patient payments were an increasingly important revenue source for providers everywhere. By delivering financial transparency, affordability options, and clear & concise personal communications, we're seeing every day how patients' financial experiences can be elevated to the level of their clinical experiences.
As providers look for new, more cost-effective operating models to meet the high standards of what PwC calls the New Health Economy, our clients' experiences are proving that holistic virtual care can be leveraged to reduce costs, improve patient engagement and drive growth all at the same time. As the industry looks for certainties in the uncharted territory after the pandemic, better patient financial experiences look like a sure bet. That's a race we're happy to be running in.
Kevin Fleming is the CEO of Loyale Healthcare
About Loyale
Loyale Patient Financial Manager is a comprehensive patient financial engagement technology platform leveraging a suite of configurable solution components including predictive analytics, intelligent workflows, multiple patient financing vehicles, communications, payments, digital front doors and other key capabilities.
Loyale Healthcare is committed to a mission of turning patient responsibility into lasting loyalty for its healthcare provider customers. Based in Lafayette, California, Loyale and its leadership team bring 27 years of expertise delivering leading financial engagement solutions for complex business environments. Loyale currently serves approximately 12,000 healthcare providers across 48 states. Loyale is proud to have an enterprise-level strategic partnership with Parallon which includes the deployment of Loyale's industry leading technology at all HCA hospitals and Physician Groups.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The HonorHealth FastMed Urgent Care clinics to provide high-quality, convenient and affordable healthcare options in the Phoenix and Tucson areas

PHOENIX (PRWEB) DECEMBER 02, 2020
HonorHealth and FastMed Urgent Care announce that their joint venture transaction to manage 30 existing Arizona urgent care clinics is complete, and the clinics will now be operating under the co-branded name HonorHealth FastMed Urgent Care. In September, the two healthcare organizations announced their intention to form a joint venture to improve access in the Phoenix and Tucson markets.
"HonorHealth and FastMed share a common goal to deliver high-quality, convenient and affordable care," said Todd LaPorte, CEO, HonorHealth. "Through this partnership, our patients will have increased access to urgent care and occupational health services that are closer to where they live and work."
"Combining FastMed's strengths in providing easy access to high-quality, affordable urgent and occupational healthcare with HonorHealth's many strengths in delivering exceptional primary, specialty and tertiary care will create significant value for the patients and communities we serve," said Web Golinkin, CEO of FastMed.
HonorHealth and FastMed are both committed to delivering the highest standards of care to patients in a safe environment. In October, FastMed was reaccredited by The Joint Commission for the second time, earning its coveted Gold Seal of Approval for Ambulatory Care. FastMed is the only independent urgent care in Arizona to hold this accreditation, which signifies that it has met the industry's highest quality and safety standards.
Additionally, in September, FastMed became the first independent urgent care operator to launch Epic, a leading electronic health record (EHR) system that is used by many of the nation's largest health systems, including HonorHealth. This allows for better care coordination between the two organizations.
HonorHealth FastMed Urgent Care provides urgent care and occupational health services, in person and via telemedicine, and will closely coordinate patient care with HonorHealth's six acute-care hospitals, physician practices, outpatient surgery centers and other network services, as needed. HonorHealth and FastMed share ownership in the new venture, with FastMed managing its day-to-day operations. HonorHealth continues to operate six wholly owned HonorHealth Urgent Care locations.
# # #
About HonorHealth
HonorHealth is a non-profit, local community healthcare system serving an area of 1.6 million people in the greater Phoenix area. The network encompasses six acute-care hospitals, an extensive medical group, outpatient surgery centers, a cancer care network, clinical research, medical education, a foundation and community services. HonorHealth has approximately 12,300 employees, 3,700 affiliated physicians and 3,100 volunteers.
HonorHealth was formed by a merger between Scottsdale Healthcare and John C. Lincoln Health Network. HonorHealth's mission is to improve the health and well-being of those we serve. Learn more at http://www.honorhealth.com
About FastMed Urgent Care
FastMed Urgent Care owns and operates more than 100 clinics in North Carolina, Arizona and Texas that provide a broad range of acute/episodic and preventive healthcare services seven days a week. FastMed also provides workers' compensation and other occupational health services at all its clinics, and family and sports medicine services at select locations. FastMed has successfully treated more than 6 million patients and is the only independent urgent care operator in North Carolina, Arizona and Texas to be awarded The Joint Commission's Gold Seal of Approval for quality, safety and infection control in ambulatory healthcare. For more information about locations, services, hours of operation, insurance and prices, visit http://www.fastmed.com.

HonorHealth and FastMed share a common goal to deliver high-quality, convenient and affordable care.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Roya.com provides results-driven websites and marketing strategies to thousands of veterinary practices nationwide

GREELEY, COLO. (PRWEB) DECEMBER 02, 2020
Patterson Veterinary today announced an exclusive partnership with Roya.com to offer corporate consolidators and multi-location customers the ability to digitally brand their practices through the latest website technology and marketing tools.
Roya.com is a leading provider of digital marketing and CMS platforms, specializing in custom web design and digital marketing services. Through this agreement, Patterson Veterinary customers will now be able to utilize Roya.com's CANVAS platform and Marketing Packages at special partnership pricing.
"Now more than ever, it is so important that we help customers not only serve their patients, but also generate leads to continue growing their businesses," said Dan Holland, Director of Technology, Patterson Veterinary. "Partnering with Roya.com will especially help our larger, multi-location practices by offering tailored services designed to help them brand their practices and effectively track all efforts."
Additionally, Roya.com says the decision to partner with Patterson was an easy one, based on the two companies' shared commitment to their customers.
"Roya.com focuses on understanding the individual needs of our customers, while keeping a close eye on industry trends and best practices," said Mo Ranji, Founder and CEO of Roya.com. "We're excited to help Patterson customers create an online experience that is unique to their individual practices and provide an effective conversion funnel driven by real-time data and the ever changing user behavior."
For Patterson, this partnership supports Patterson Veterinary's key objective of providing the best, most relevant and most innovative technology solutions to veterinarian practices.
"Finding the right partners that bring value to our customers is a top priority for our organization," adds Holland. "Patterson Veterinary is dedicated to providing the most innovative technology solutions to veterinarian's practices, and this partnership with Roya.com allows us to continue supporting that goal."
To learn more, contact your Patterson Veterinary sales representative for a demo.
About Patterson Veterinary
Patterson Veterinary, combined with sister company Animal Health International, forms one of the largest animal health companies in North America, distributing products, equipment, technologies and practice-management solutions to companion animal veterinary clinics, livestock operations and dealer/farm stores. For more information, visit pattersonvet.com and http://www.animalhealthinternational.com.
About the Canvas CMS Platform
Roya.com's Canvas CMS is a best in class technology with a range of built-in features to market small to midsize businesses online. The proprietary platform is powered by cutting edge cloud based technologies and is designed to elevate online marketing initiatives and ultimately convert online visitors to customers. As an early adaptor to Google's AMP project, Roya.com continues to differentiate its offerings, marketing services and CMS products as best in class.
About Roya.com
Roya.com is a SaaS provider of Canvas CMS Platform digital marketing & CMS platforms for thousands of Veterinary Practices across the United States and Canada. Roya.com is one of the fastest growing companies in San Diego, California. For more information visit Roya.com's Blog or call 858-345-5500.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Clinical trials for treatment for one of the most common inherited neurological disorders set to begin in 2021

WOODBRIDGE, CONN. (PRWEB) DECEMBER 02, 2020
AlloMek Therapeutics, a privately held orphan disease-focused company, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation for its macrocyclic MEK kinase inhibitor, CIP-137401, for the treatment of Neurofibromatosis type 1 (NF1).
The FDA awards "orphan" status for treatments of diseases affecting fewer than 200,000 people in the U.S., for drugs to be used for the safe and effective treatment of rare diseases or for drugs that are not expected to recoup the costs of development and marketing. This designation qualifies AlloMek for incentives including certain tax credits and a new drug application fee waiver. It also entitles AlloMek to a period of market exclusivity after approval.
According to the Children's Tumor Foundation, Neurofibromatosis-1 is one of the most common inherited neurological disorders, affecting about 1-in-3,000 people throughout the world.
AlloMek's lead drug, CIP-137401, is a macrocyclic MEK kinase inhibitor with excellent pharmacokinetics and a profile optimized for potency and safety. The drug has been tested in an established preclinical model of NF1 and been found to dramatically reduce both absolute tumor numbers and the size of plexiform neurofibromas. The potential to administer this drug on a once-daily basis makes it an excellent candidate to combine with therapeutics with complementary mechanisms of action.
CIP-137401 has been shown in IND-enabling animal toxicological studies to be well tolerated with limited side effects which could potentially result in an improved therapeutic index (TI) and best-in-class profile. AlloMek is currently focused on developing the compound in rare diseases, including LMNA cardiomyopathy and Noonan Syndrome, along with NF1. The company is also seeking partnerships for trials in oncology, both as a single agent and in combinations.
The company plans to begin human testing in 2021.
About AlloMek:
AlloMek Therapeutics is a Woodbridge, CT based, privately held orphan disease-focused company, developing therapeutics using macrocycles. AlloMek is applying its expertise in macrocyclic chemistry and molecular modeling to design novel drug candidates to build a high-quality pipeline of drug candidates. For more information, please visit https://allomek.com.
Forward-Looking Statements
This press release contains forward-looking statements, including statements regarding potential benefits associated with CIP-137401 and Orphan Drug designation. These statements involve known and unknown risks, uncertainties and other factors which may cause any actual benefits to be materially different from those expressed or implied by the forward-looking statements. These statements reflect our current views and are subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Some of the factors that could affect the forward-looking statements contained herein include: Orphan Drug and Fast Track designations by the FDA may not lead to a faster development, regulatory review, or approval process with the FDA and does not increase the likelihood that CIP-137401 will receive marketing approval; and ongoing and future preclinical and clinical development of CIP-137401 may not have positive results.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Belle Meade Family Dentistry impresses the importance of oral health on its Nashville, TN community. They offer dental implants, gum disease care, tooth extractions, pediatric dentistry, and emergency dental care to help their patients stay in peak health.

NASHVILLE, TENN. (PRWEB) DECEMBER 02, 2020
The dentists at Belle Meade Family Dentistry improve oral health in Nashville, TN to impact the overall health of its community. Drs. James Pace Sr., Temp Sullivan, and James Pace Jr. are passionate about promoting the wellbeing of their patients and community, and as a result, are raising awareness of the impact oral health has on maintaining a healthy body and strong immune system. These highly experienced dentists bring their patients to peak oral health through skilled treatments such as dental implants, gum disease treatment, and emergency dental care in Nashville. TN.
It is commonly known that strong teeth are important for maintaining a balanced diet, which is essential to keeping a healthy immune system. However, a lesser-discussed aspect of oral health is that the bacteria built up within the mouth can spread into the blood steam, affecting a person's entire body. In fact, research has shown a link between the bacteria caused by gum disease and systemic concerns such as heart disease, diabetes, stroke, and Alzheimer's disease.
While visiting the dentist may not be top priority for some during the coronavirus pandemic, Belle Meade Family Dentistry emphasizes that oral health concerns must be resolved in order to maintain a healthy body and strong immune system. Drs. Pace Sr., Sullivan, and Pace Jr. offer general and pediatric dentistry to maintain healthy mouths. They can also provide minimally invasive laser dentistry to rid mouths of decay and treat gum disease. For anyone who has lost teeth due to decay, these dentists offer permanent dental implants. Dental implants are secured into the jawbone, giving patients a smile that looks natural and can allow them to eat a full and balanced diet again.
Belle Meade Family Dentistry has implemented safety measures to help prevent the spread of COVID-19 and maintain the health of their patients and staff. They are limiting the number of patients in the office at a time and following strict sanitization protocols.
Those looking to improve their oral health in Nashville, TN can connect with the experienced dentists at Belle Meade Family Dentistry for a consultation. To schedule an appointment, visit http://www.bellemeadedental.com or call 615-298-2030.
About the Dentists
Belle Meade Family Dentistry serves the Nashville, TN area with full-service family dentistry, for 43 years running. Dr. James Pace Sr. has served as a Chairman of the Nashville Peer Review Committee and as a delegate to the Tennessee Dental Association. He was selected by his peers in 2019 as one of the Top Dentists in Nashville, has consistently received recognition by the Tennessee Dental Association for his hours of continuing education, and has led and participated in multiple dental and medical mission trips to the Dominican Republic. Along with Dr. James Pace Jr. they have been honored each year from 2015-2019 as Patient's Choice Award Winners. Dr. Pace Jr. has also received the 2011 Tennessee Dental Association's Ace Award. Dr. Temp Sullivan earned his fellow in laser dentistry at World Clinical Laser Institute and serves as a delegate for the Tennessee Dental Association and as a member of the Peer Review committee for TennCare. The team at Belle Meade Family Dentistry strives to provide the finest quality dental care for patients in a warm, caring, and clean environment. They execute the most advanced dental care with every service, including dental implants, Invisalign, the Pinhole Surgical Technique and laser dentistry. To learn more about the dentists at Belle Meade Family Dentistry and the services they offer visit http://www.bellemeadedental.com or call 615-298-2030.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The process will allow the company to test for the presence of living microorganisms in just 15 seconds.

ATLANTA (PRWEB) DECEMBER 02, 2020
Germinator Mobile Sanitizing and Disinfecting continues to dominate the sanitization and disinfection industry, announcing the addition of adenosine triphosphate (ATP) monitoring to its service offerings as part of its patent-pending methodology. ATP monitoring allows Germinator to test surfaces for the potential presence of living microorganisms in as little as 15 seconds prior to sanitizing and disinfecting.
ATP is an energy molecule found in all living organisms —including bacteria, mold and other potentially harmful microorganisms. When activated, ATP gives off a bright bioluminescent light, which is measured in relative light units (RLUs). Upon entering a business or residence, Germinator will take samples from surfaces using swabs, which are then inserted into the luminometer. The luminometer gives a rapid and accurate reading of ATP on a surface. The higher the light output, the greater the indication of the need for proper cleaning.
"We are excited to implement the ATP monitoring technology into our sanitizing and disinfecting process," said Jeff Gill, CEO of Germinator. "Our mission is to serve as long-term partners for our customers to help them live protected. We plan to be there every step of the way to ensure that we properly sanitize and disinfect areas of concern and measure the effectiveness of our work after a job is complete."
Germinator will offer ATP monitoring prior to performing its sanitizing and disinfecting process. Once the initial ATP test has been completed, Germinator applies its Genesis surface treatment. Genesis is a one-step cleaner and broad-spectrum sanitizer and disinfectant treatment that harnesses the power of hypochlorous acid (HOCI). Derived from naturally occurring minerals, Genesis not only eliminates odors at their source, but kills a wide range of bacteria including Staphylococcus aureus, MRSA, Salmonella enterica and Pseudomonas aeruginosa, and viruses including norovirus, rotavirus and adenovirus on hard, non-porous, environmental surfaces. It meets the Association of Official Agricultural Chemists (AOAC) germicidal spray standards for Hospital Grade Disinfection and is on the EPA N List of products determined to meet the criteria for use against SARS-CoV-2, the virus that causes COVID-19. As a result, this treatment will eliminate bacteria and viruses that may reside in your environment without the use of harsh chemicals or fumes.
Once Genesis has been applied, Germinator applies its Shield, a water-based quaternary ammonium compound that imparts a durable bacteriostatic finish. It is EPA-registered as effective against mold, mildew, algae and odor-causing bacteria. This application creates an invisible barrier that combats deterioration and discoloration and promotes freshness for up to three months.
The Genesis and Shield products are applied by using an electrostatic sprayer, which is the most efficient and effective means of delivering the products to the intended application sites. After Germinator's surface treatment and protectant services are applied, the company's highly trained field specialists retest ATP levels to ensure the surfaces have achieved the intended results.
Upholding the highest standards of sanitizing and disinfecting, Germinator makes claims that are scientifically supported and within EPA regulations. Germinator's research and process are validated by the Germinator Scientific Advisory Board. The board is made up of key leaders such as Dr. Roscoe M. Moore, Jr. —who was an Assistant to the United States Surgeon General for five administrations; Dr. Harold Smith, who has extensive expertise in cell biology, molecular biology and biochemistry, along with decades of experience leading sponsored research on infectious diseases for the National Institutes of Health (NIH); Dr. David Miller, the Protocol Chair of University of Rochester Center for AIDS Research Community Advisory Board; and Chad S. Johnson, Esq., a Harvard-trained corporate, legislative, and regulatory attorney with significant experience in advising health and biotechnology companies.
Germinator was founded by Jeff Gill in 2015 with the vision of providing an effective method of proper sanitizing and disinfecting for businesses and households. Since February, Germinator has continued to rapidly expand across the country.
With Germinator, society can now have greater peace of mind and the freedom to live or work in a sanitized and disinfected environment. For more information, visit http://www.thegerminator.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

PerioWest raises awareness of the harmful effects of gum disease on the entire body. They offer minimally invasive LANAP laser dentistry in Eden Prairie, MN to help rid gum disease and improve oral health.

EDEN PRAIRIE, MN (PRWEB) DECEMBER 02, 2020
PerioWest is raising awareness of the systemic effects of gum disease in Eden Prairie, MN. At a time when health is at the forefront of everyone's minds, experienced periodontist, Dr. Andres Sanchez, is impressing to his community that oral health plays a significant role on the health of the entire body. This compassionate periodontist is welcoming patients for industry leading periodontal care in Eden Prairie, MN with or without a referral. To help fight gum disease, Dr. Sanchez offers LANAP laser dentistry, periodontal maintenance, and he can restore bone lost due to gum disease with bone grafting and dental implants.
A recent study from the ADA reveals that a majority of dentists are seeing a rise in stress-related oral health conditions since the coronavirus pandemic began. Conditions that are on the rise include gum disease, teeth grinding, and chipped and cracked teeth. Before the pandemic, extensive research showed a link between gum disease and systemic health conditions such as heart disease, respiratory disease, diabetes, and stroke.
Because of the connection between the state of the mouth and the health of the body, Dr. Sanchez is urging his community to seek oral health care at the onset of symptoms in order to keep their immune system strong and their whole body in optimum condition. Symptoms of gum disease include:

Bleeding gums while brushing or flossing

Red, swollen, or tender gums

Bad breath (halitosis)

Shifting teeth

When a patient suffers from gum disease, as a board-certified periodontist Dr. Sanchez can provide non-surgical scaling and root planing, osseous surgery, and periodontal maintenance. An early adopter of modern, minimally invasive, and effective alternatives, Dr. Sanchez also offers LANAP laser dentistry. With LANAP, Dr. Sanchez utilizes precision laser technology to eradicate bacteria from the periodontal pockets and remove unhealthy gum tissue. This procedure also regenerates the healthy gum tissue that remains, an advantage not achieved by traditional techniques.
LANAP is the only FDA-cleared laser gum disease treatment and it allows for a fast recovery and minimal loss of tooth and bone structure. When bone loss has already occurred as a side effect of gum disease, Dr. Sanchez can provide bone grafting to restore the jawbone and dental implants to replace missing teeth.
The entire team and PerioWest is passionate about the health of Eden Prairie, MN. They are working diligently to improve the oral health of their community while simultaneously keeping their office sanitized and safe to help stop the spread of COVID-19. PerioWest stays current with the pandemic guidelines recommended by the CDC, OSHA, and ADA.
Individuals experiencing signs of gum disease in Eden Prairie, MN can connect with Dr. Sanchez for a LANAP laser dentistry consultation. To schedule an appointment, visit http://www.periowestmn.com or call 952-567-7457.
About the Periodontist
PerioWest is a periodontal practice offering personalized dental care for patients in Eden Prairie, MN and the Twin Cities areas. Dr. Andres R. Sanchez received his Certificate & Master's Degree in Periodontics from the prestigious Mayo Clinic in Minnesota. He is a board-certified periodontist and a Diplomate of the American Board of Periodontology. In addition, Dr. Sanchez has been involved as a primary author in more than ten scientific papers published in major periodontal and implant dentistry journals. His associate, Dr. Eleni Voltidi is a prosthodontist who completed her Fellowship in Dental Oncology and Maxillofacial Prosthetics from the prestigious Mayo Clinic in Minnesota. PerioWest provides state-of-the-art dental implant treatment, LANAP laser therapy, and advanced periodontal care to Eden Prairie, MN and the Twin Cities areas. To learn more about Dr. Sanchez and the services provided at PerioWest, please visit the practice website at http://www.periowestmn.com or call 952-567-7457.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Abortion Care Network's new report on independent providers finds the majority of people who have abortions receive care at independent clinics, which are closing at an alarming rate.

MINNEAPOLIS (PRWEB) DECEMBER 02, 2020
As a shifting Supreme Court poses a direct threat to legal abortion care in the United States and anti-abortion extremists continue to target providers, Abortion Care Network's fourth annual Communities Need Clinics report — released today — finds that 3 out of 5 people (58%) who have abortions receive care at an independent clinic. The report also finds that independent providers continue to close at an alarming rate: the number of independent clinics in the U.S. has decreased by over a third since 2012, making it increasingly difficult for patients to get the care they need.
"Our analysis demonstrates just how essential independent abortion providers are to the availability of compassionate abortion care throughout pregnancy, and how critical it is that they are able to stay open," said Nikki Madsen, executive director of Abortion Care Network. "From fighting for their patients and winning at the Supreme Court to defeating political attempts to exploit the pandemic and ban abortion, independent providers continue to show up for their communities in the face of unparalleled challenges."
Key findings in the report include:
In some parts of the country, independent clinics are the only places people can get abortion care.

Independent providers operate the only clinic in three of the five states with one remaining abortion clinic—Mississippi, North Dakota, and West Virginia.

All of the abortion clinics in Louisiana and Wyoming are independent.

Access to abortion as pregnancy progresses heavily relies on independent clinics:

62 percent of U.S. clinics that provide care after the first trimester are independent;

81 percent of U.S. clinics providing care after 22 weeks are independent;

Independent clinics are more likely to provide both medication and in-clinic abortion – 80 percent of independent clinics offer both options, as opposed to 48 percent of Planned Parenthood clinics. Limiting abortion care to medication only means that services are only available for 10–11 weeks of pregnancy.

The total number of independent clinics in the United States has decreased by more than 34 percent since 2012.
COVID-19 Impact on Abortion Care and Independent Providers
As COVID-19 continues to ravage the health care system, economy, and communities across the country, this year's report highlights the pandemic's impact on independent abortion providers, from financial challenges as well as increased attempts by anti-abortion elected officials to exploit the pandemic for their own political gain.
Eleven states, including Texas, attempted to effectively ban abortion via executive order, forcing clinics to cancel or delay appointments and forcing patients to decide between risking their health and safety by traveling across state lines or forgoing care entirely. Other states placed unnecessary restrictions on medication abortion care via telehealth by requiring in-person appointments and therefore forcing patients to put themselves at increased risk of COVID infection to get care.
"Our staff battled the constant changes and updates to policies and procedures, as we took all precautions to keep everyone safe," said Marva N. Sadler, Senior Director of Clinical Services, Whole Woman's Health, LLC, in Texas. "Through it all, what has remained true is the dedication of our clinic staff and providers to protect and provide for the women and families that need our essential services. That is the light that guides us through this unforeseen time and continues to shine bright."
"For years, unnecessary restrictions have forced the doors of many abortion clinics to close. Access to abortion services is already scarce and many patients have to travel long distances and incur increased costs," said Dr. Yashica Robinson, Medical Director, Alabama Women's Center for Reproductive Alternatives in Huntsville, Alabama. "The current pandemic has created more job loss, travel restrictions, and increased health concerns that have made accessing abortion services even more difficult. This is abundantly true for low-income patients and patients in rural areas, and the people who have been most negatively impacted are the same people who have historically been disproportionately affected by systemic healthcare disparities: people of color."
"The pandemic has hit us hard financially. Our huge concern was risk mitigation, so we made efforts to limit the number of people in the clinic and cut our appointments so we could stagger and distance patients," said Mercedes Sanchez, Director of Development, Communications, and Community Education and Outreach, Cedar River Clinics in Washington. "Like many clinics, the majority of our revenue comes from patient services so cutting our schedule affected our financial health greatly. It feels like we are figuring out what the future holds on a month-to-month basis, and this is going to impact us financially for a long time. Our future isn't certain."
The full report is available here.
Abortion Care Network
The Abortion Care Network (ACN) is the only national membership association dedicated to independent, community-based abortion care providers and their allies. ACN works to ensure that all people are able to experience respectful, dignified abortion care.
http://www.facebook.com/abortioncarenetwork or http://www.abortioncarenetwork.org



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The New London, CT and Westerly, RI periodontists at Shoreline Periodontics and Dental Implants recently hosted a virtual Hygiene Study Club for dental hygienists on communicating effectively with multicultural patients and ways to improve ergonomics.

NEW LONDON, CONN. (PRWEB) DECEMBER 02, 2020
Periodontists Dr. Gregory A. Toback and Dr. Marianne Urbanski of Shoreline Periodontics and Dental Implants in New London, CT and Westerly, RI, went virtual when they hosted a recent 2020 Hygiene Study Club seminar. Offered exclusively to local dentists and dental hygienists in Southeastern CT and RI, this session fulfilled cultural competency continuing education (CE) requirements.
"Cultural Competency" featured guest speaker Cathie Collier, RDH BEd, a well-known dental hygiene educator. The seminar covered verbal and nonverbal communication with patients from diverse cultures and how this is integral to understanding the reason behind their healthcare decisions and values. Participants learned strategies for effective communication by using different styles and skills to overcome potential cultural barriers. Drs. Toback and Urbanski believe that good communication is as integral to delivering compassionate care as leveraging state-of-the-art gum disease treatments.
Shoreline Periodontics offers permanent dental implants and periodontal disease (gum disease) treatment, including advanced LANAP laser dentistry. LANAP is a minimally invasive alternative to osseous surgery. Instead of scalpels and sutures, this innovative technology uses laser energy to gently and effectively clear away the bacteria responsible for gum disease. This approach results in less pain, postop sensitivity, and gum loss, as well as greatly decreased downtime after treatment.
In addition to good communication, safety is also a top priority, which is why the Shoreline Periodontics Hygiene Study Club was presented virtually. The practice has also taken extra steps to protect patients during the coronavirus pandemic. In addition to following infection control recommendations from the ADA, CDC, and OSHA, the number of people allowed in the office is limited.
To learn more about Shoreline Periodontics, their compassionate periodontists, and cutting-edge services, visit their website at http://www.shorelineperio.com or call 860-443-2428 for the New London, CT location, or 401-596-0000 for the Westerly, RI office.
About the Periodontists
Shoreline Periodontics is a periodontal practice offering personalized dental care for patients since 1998 and is located in New London, CT and Westerly, RI. Leading board-certified periodontist, Dr. Gregory A. Toback, received his B.A. from St. John's University and his Doctorate of Dental Medicine from the University of Connecticut. He also received advanced training in periodontics and dental implants at the University of Texas Health Science Center in San Antonio. Dr. Marianne Urbanski has been voted one of Connecticut's top dentists for more than seven years by Connecticut Magazine. Dr. Urbanski graduated cum laude from the College of Holy Cross in Worcester, Massachusetts where she earned a Bachelors' degree in Biology. She also received her Doctor of Dental Medicine degree and her Masters' of Dental Science degree from the University of Connecticut Dental School. Dr. Urbanski and Dr. Toback pride themselves on offering caring, professional treatment to each patient. Dr. Toback and Dr. Urbanski focus on minimally invasive surgeries including LANAP laser gum surgery and are certified to offer the Chao Pinhole Surgical Technique for treatment of gum recession. To learn more about Shoreline Periodontics and their dental services visit their website at http://www.shorelineperio.com or call 860-443-2428 for the New London, CT location, or 401-596-0000 for the Westerly, RI office.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Company Launches Beta Program for Radiologists

CHICAGO (PRWEB) DECEMBER 02, 2020
Inference Analytics Inc., a Chicago-based healthcare Artificial Intelligence startup, today announced Beta availability of its Auto-Impression Assistant software on the Nuance AI Marketplace. The Auto-Impression Assistant is the first radiology solution to be launched by Inference Analytics and relies on the Inference Analytics Neural Network platform (IANN). IANN is a next-gen text-based AI platform geared towards improving physician productivity and reducing errors in care delivery. The Nuance AI Marketplace is the first and largest portal with one-stop access to a wide range of AI diagnostic models from within the industry's most widely used radiology reporting platform.
The Inference Analytics Neural Network (IANN) Auto-Impression Assistant is the first non-pixel-based AI solution (i.e., an AI solution that uses AI to process text as opposed to images), available on the Nuance AI Marketplace and offers seamless real-time integration with Nuance's PowerScribe One platform. IANN is based on a text-based AI system that was trained by leveraging several million radiology reports from a premier academic hospital. Initial results were presented at 2019 RSNA.
Through deep learning methodologies designed to understand healthcare text and language, IANN augments and complements the roles played by physicians. The platform generates impressions based on a radiologist's findings and the patient's clinical history.
"We are mimicking how the human brain understands language. IANN's deep learning-based Natural Language Processing (NLP) identifies information from text and narratives using patterns similar to the human brain," said Inference Analytics Founder and CEO Farrukh Khan. "IANN replicates an experienced physician's ability to translate notes and reports into clinically meaningful conclusions and suggestions. The IANN Auto-Impression Assistant serves as a radiologist's assistant. Since radiologists can be expected to read and document more than one hundred cases in a single day, any technology that can help reduce the chances of burnout, fatigue and errors can have an enormous impact. Over the next few months we will have leading radiologists participate in Beta testing the Auto-impression Assistant, preparing the platform for general availability in early 2021."
"One of the core deficiencies in healthcare IT systems is the ability to understand and process unstructured healthcare data such as text, and traditional Natural Language Processing (NLP) rules-based technologies have not shown good results, creating the need for an NLP Platform like Inference Analytics, a system that is using next-generation techniques to understand text and the copious amounts of notes and narratives that physicians are creating. The IANN Auto-Impression Assistant is an example of what is possible with next generation NLP technology and how it can impact a radiologist's workflow." said Dr. Paul Chang, MD, Professor of Radiology, Vice Chair, Radiology Informatics, UChicago Medicine.
Nuance AI Marketplace
The Nuance AI Marketplace functions like an app store dedicated to radiology. It gives AI developers consolidated, at-scale access to users of the Nuance PowerScribe One platform, the radiology reporting system trusted by approximately 80 percent of U.S. radiologists across more than 8,000 connected healthcare facilities. Radiologists can discover, test, and use AI services from within their familiar PowerScribe reporting and workflow orchestration solutions to increase reporting efficiency and quality, and to help care teams improve patient outcomes and reduce healthcare costs.
A built-in feedback channel lets users share real-world results with developers for algorithm refinement and post-market surveillance. Hospital systems benefit with simplified purchasing and metrics showing AI usage, costs, and performance. The Nuance AI Marketplace has made it easy for partners like Inference Analytics to build and distribute AI services in an integrated and seamless manner. The AI Marketplace creates a win-win for partners like Inference Analytics and Nuance.    
ABOUT INFERENCE ANALYTICS
Inference Analytics is developing a neural network-based AI platform called IANN (Inference Analytics Neural Network) to reduce healthcare inefficiencies and physician burnout while simultaneously improving the overall quality of care. We are piloting IANN at leading academic hospital systems, and we enjoy a strong strategic partnership with Nuance, one of the leading companies providing radiology solutions globally to radiologists. IANN is capable of understanding and applying medical language across multiple clinical specialties and domains. To learn more about IANN and how to become a Beta user, visit the Inference Analytics website.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

As the numbers of COVID-19 cases continue to spike dangerously this fall, pushing healthcare and frontline workers to their breaking point, Shahnaz Broucek, Ashley Nelson, Robin Ross and Sharyn Galindo, were overcome with compassion and decided to do something about it. Together, they launched Care for Givers, a website offering curated meditations, mindfulness and yoga practices specifically designed for frontline workers and caregivers.

ANN ARBOR, MICH. (PRWEB) DECEMBER 02, 2020
An article about the frustration and desperation of healthcare workers as the third surge of COVID-19 drives them to the breaking point, kick-started an idea for Shahnaz Broucek, founder of OptimizeU and University of Michigan Ross School of Business professor. When she read, "no one is listening to us," she felt drawn to take action and let them know "we hear you...and we will help." A few days later, along with her colleagues Ashley Nelson, Founder of Inseus, Robin Ross, OptimizeU Partner and Sharyn Galindo, Founder of True North Yoga and Wellness, they launched a website offering curated meditations, mindfulness and yoga practices specifically designed for frontline workers and caregivers that will be available free of charge through the pandemic with gratitude and appreciation to the frontline workers and caregivers who put their lives on the line every day for our communities.
This group of mindfulness practitioners are all trained teachers of the Search Inside Yourself Leadership Institute, a mindfulness and emotional intelligence program developed at Google, and together have a wealth of training and background in Mindfulness Based Stress Reduction (MBSR), Mindful Self-Compassion, Yoga, health/wellness coaching, and leadership/executive coaching. The goal is to offer resources very tailored to the immediate needs of frontline workers and caregivers, from brief In-the-moment support, to mindfulness and renewal practices to wind down after a stressful shift.
COVID-19 has presented unprecedented emotional and mental health stress on frontline workers. The current circumstances with the pandemic leaves these workers at "high risk for full-blown stress response syndromes, anxiety, depression, post-traumatic stress disorder, chronic illness and burnout", according to the International Council of Nurses. They face a personal struggle to stay optimistic and resilient while dealing with uncertainty and overwhelm. They encounter ongoing demands during this time, leading to burnout, empathic distress, fatigue, anxiety and depression. Despite a strong emotional connection to their purposeful work, they can reach a breaking point as they face moral decisions that cause emotional distress and secondary trauma, with a chronic inability to fully renew and recharge. Beyond their challenges at work, many find themselves unable to keep up on things at home and carry worries from home to work and vice versa.
What can be done about it? Broucek and her team believe that mindfulness is a key part of the solution. Mindfulness is a profound practice that strengthens our physiological, emotional and mental health, heightening resilience, wellbeing, and effectiveness. It specifically targets many of these challenges that nurses and other frontline workers are prone to, and numerous studies have proven the benefits of mindfulness-based interventions for frontline workers. Broucek and her careforgivers.org team also offer training programs to organizations seeking to help their employees deepen these practices. Participants learn to manage stress, build resilience, develop greater self-awareness and emotion regulation, use compassion practices to diffuse empathic distress fatigue and increase self-compassion, and learn ways to deeply connect and communicate effectively. It is their hope that the http://www.careforgivers.org will be one small way to support the community during this unprecedented time of challenge.
More information: https://www.careforgivers.org/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Dental Implants of Ocala raises awareness of the health benefits of a complete set of teeth and encourages individuals with tooth loss to consider permanent dental implants in Ocala, FL to maintain proper oral health amidst the COVID-19 pandemic.

OCALA, FLA. (PRWEB) DECEMBER 02, 2020
Drs. Nickelice Brand and Eric Rustemier, esteemed implant dentists at Dental Implants of Ocala, raise awareness of how oral disease and tooth loss negatively affect oral health and the immune system. They provide dental implants in Ocala, FL to permanently replace missing teeth and improve overall health during the COVID-19 pandemic.
Tooth loss can occur for many reasons, but the most common reasons include gum disease, decay due to neglected oral health, or a tooth abscess that requires extraction. In cases involving infection and disease, whole-body health can also be negatively affected. Bacteria from gum disease, the most common cause of tooth loss, can spread throughout the mouth and body via the bloodstream. Left untreated, gum disease can damage oral structures, lead to loose teeth and tooth loss, and diminish systemic health, including the body's immune system. In most cases, Drs. Brand and Rustemier recommend dental implants to permanently restore oral health and improve overall health and immunity, especially during the COVID-19 pandemic.
Dental implants are permanent tooth replacements that are surgically placed into the jawbone. They can replace one, several, or an entire mouth of missing teeth with a comparable level of durability, aesthetics, and strength. Unlike partials and dentures, dental implants are permanently fixed in the jaw like natural teeth and allow for proper biting and chewing of nutritious, healthy food. When implants replace infected or decayed teeth, dangerous bacteria from the mouth is removed, improving oral health and overall health. For individuals who have multiple failing or missing teeth as a result of gum disease or decay, full mouth dental implants provide a permanent improvement in dental function, natural smile aesthetics, and oral health. Overall, in addition to providing permanent restoration of function and aesthetics, dental implants can help improve oral health, systemic health, and the immune system.
Dental Implants of Ocala offers decades of experience in implant dentistry and solely provides comprehensive dental implant treatment. Drs. Brand and Rustemier place thousands of dental implants each year, with a specialization in full mouth dental implants, and maintain an over 98 percent success rate. Using innovative technologies, including custom surgical guides and bone morphogenetic protein, the implant dentists provide customized and predictable treatment that permanently restores each of their patient's smiles, health, and quality of life. In light of the COVID-19 pandemic, the team continues to practice advanced safety and sanitization measures for the health and safety of their staff and patients.
Individuals with tooth loss who are interested in improving their health, immunity, and quality of life can schedule a consultation for dental implants in Ocala, FL by visiting http://www.dentalimplantsofocala.com or calling 352-653-2500.
About the Practice
Dental Implants of Ocala offers all-inclusive dental implant treatment to patients of Marion County, including Ocala, FL, The Villages, and beyond. Dr. Nickelice Brand, the practice's leading implant dentist, has over 25 years of experience and focuses solely on providing innovative implant solutions for his patients. Placing over 1000 dental implants a year, Dr. Brand has retained a 98 percent implant success rate and an even higher level of patient satisfaction. Dr. Eric Rustemier graduated from the University of Louisville and received the prestigious Dawson Scholar Award, which is awarded to two dental students in the country per year in recognition of commitment and achievement in clinical comprehensive dentistry and temporomandibular disorders. Dr. Rustemier is an avid pursuer of knowledge and completes over 100 hours of continuing dental education each year. The team at Dental Implants of Ocala remains up to date on implant dentistry's most innovative and unique technologies, including bone morphogenetic protein and CeraRoot ceramic dental implants, to ensure the highest standard of care and most predictable treatment outcomes. To learn more about Dental Implants of Ocala and their innovative implant care, visit http://www.dentalimplantsofocala.com or call 352-653-2500.                                                                     



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Election outcomes and the pandemic loom large over trends changing the healthcare industry

ATLANTA (PRWEB) DECEMBER 02, 2020
Jvion, a leader in prescriptive clinical artificial intelligence (AI), today announced their predictions for healthcare in 2021. As the outcome of the 2020 election comes into focus and the pandemic surges to its most severe stage yet, both factors will weigh heavily on the direction of healthcare in the year to come.
"With the election decided, it's clear that health system revenue will continue to shift to value-based care models," said Dr. John Showalter, Jvion's Chief Product Officer. "Once it reaches a tipping point of 50% of total revenue, providers' financial performance will be inextricably linked to their patients' outcomes."
"To survive, providers and payers will need to harness their data to predict and mitigate patient risk, and prescriptive clinical AI will be an essential capability," adds Dr. John Frownfelter, Jvion's Chief Medical Information Officer. "And with a new surge in Covid-19 extending the toll on health systems through at least early 2022, clinical AI will be more essential than ever to prevent negative quality events and keep costs down."
In this context, Dr. Frownfelter and Dr. Showalter predict four key trends will drive change in healthcare in 2021:
Value-based care accelerates, hinging on election and Supreme Court outcomes.

A Joe Biden presidency will likely accelerate the trend towards value-based care, with the pace depending on who ultimately controls the Senate following runoff races in Georgia. Democratic control will likely lead to a stronger legislative push for capitation over fee-for-service models, while divided government may limit action to the executive agency level. The Supreme Court will also impact this trend if the ACA's value-based incentives are upheld or overruled.

Consumerism will drive greater transparency in clinical AI applications.

As patients shoulder an increasing burden of healthcare costs, and new HHS rules require greater price transparency, patients will be more engaged in their care and demand to know why costly procedures and services are necessary. This trend will drive healthcare payers to invest in prescriptive clinical AI platforms that deliver personalized care plans and engagement recommendations for their members. With more transparency around the use of clinical AI, patients will better understand their risk and be empowered to take action to reduce their risk.

Clinical AI adoption will expand for behavioral health use cases.

The pandemic has fueled a national mental health crisis, with 40.9% of Americans showing signs of adverse mental or behavioral health conditions. Combined with the shift to value-based reimbursement models, these trends will drive more behavioral health providers to adopt prescriptive clinical AI solutions to predict which patients are at risk and apply clinically-validated interventions to prevent adverse behavioral health outcomes.

Pandemic economy will intensify impact of social determinants on health outcomes.

8 million Americans have been driven to poverty since the pandemic recession began. This means social determinants of health (SDOH), such as unemployment, housing instability and malnutrition, will have a greater impact on patient outcomes in 2021. To improve outcomes, providers will need to better understand the social and economic needs of individual patients, how they impact their risk, and what resources can be leveraged to address their needs. Prescriptive clinical AI will be a valuable tool for delivering these population health insights.

About Jvion:
Jvion, a leader in clinical artificial intelligence, enables providers, payers and other healthcare entities to identify and prevent avoidable patient harm, utilization and costs. An industry first, the Jvion CORE goes beyond predictive analytics and machine learning to identify patients on a trajectory to becoming high-risk. Jvion then determines the interventions that will more effectively reduce risk and enable clinical and operational action. The CORE accelerates time to value by leveraging established patient-level intelligence to drive engagement across healthcare organizations, populations, and individuals. To date, the Jvion CORE has been deployed across hundreds of clients and resulted in millions saved. For more information, visit https://www.jvion.com.
Jvion PR Contact:
Lexi Herosian
lexi@scratchmm.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The partnership launches RoosterBio's first international platform with off-the-shelf working cell banks and hMSC bioprocess media products in Asia

FREDERICK, MD. (PRWEB) DECEMBER 02, 2020
RoosterBio, Inc, a leading supplier of innovative cellular therapy bioprocess tools and scalable manufacturing solutions for regenerative medicine, today announced it entered into an exclusive agency agreement with Sartorius Korea Biotech, a subsidiary of the Sartorius Group, a leading international partner of the biopharmaceutical and life science research sectors. This strategic partnership combines Sartorius' proven expertise in providing high-caliber bioprocess testing, technical and customer services to the local South Korean market, as well as its global reach, and RoosterBio's advanced platform of RUO and cGMP-grade human mesenchymal stem/stromal cell (hMSC) working cell banks, optimized paired media, and hMSC bioprocess systems. This winning combination sets the stage for accelerating the development of new, effective medical treatments and expands RoosterBio's footprint into Asia, especially in South Korea.
"South Korea is a preeminent innovator in hMSCs, and the South Korean biotech ecosystem has been flourishing according to every measure of growth. One of the first MSC therapies was developed in Korea, clearing an entirely new path to treat previously incurable diseases," said RoosterBio CEO Margot Connor. "We are delighted to be working with Sartorius Korea Biotech in our global effort to industrialize the supply chain for next-gen treatments, and we are committed to accelerating the commercialization of cell- and gene-based therapies. We believe the talented team at Sartorius is uniquely suited to provide our mutual customers with scalable hMSC systems to expedite their cell-based therapeutic programs."
Under the terms of the agreement, Sartorius Korea Biotech will engage with its customers as an exclusive agent for RoosterBio to facilitate sales operations and increase the market potential for RoosterBio products on an exclusive basis in South Korea.
"RoosterBio's commercialized product systems standardize hMSC manufacturing to remove years of time and millions of dollars from the timeline of traditional mesenchymal cell therapeutic product development and clinical translation efforts," said Duck Sang Kim, Managing Director of Sartorius Korea Biotech. "We look forward to introducing this synergistic biotechnology relationship to South Korea."
About RoosterBio, Inc
RoosterBio, Inc. is a privately held cell manufacturing platform technology company focused on accelerating the development of a sustainable Regenerative Medicine industry, one customer at a time. RoosterBio's products are high-volume, affordable, and well-characterized adult human mesenchymal stem/stromal cells (hMSCs) paired with highly engineered media systems. RoosterBio has simplified and standardized how living cells are purchased, expanded, and used in development, leading to marked time and costs savings for customers. RoosterBio's innovative products are ushering in a new era of productivity and standardization into the field. Visit http://www.roosterbio.com.
About Sartorius Korea Biotech, Ltd.
Sartorius Korea Biotech based in Pangyo, South Korea, addresses the evolving needs of the biomanufacturing industry to produce biotech medications and vaccines safely and efficiently. The company is a subsidiary of the Sartorius Group, a leading international partner of life science research and the biopharmaceutical industry, and offers a diversified business portfolio reflecting the products and services of the two Group divisions, Bioprocess Solutions and Lab Products & Services. Sartorius Korea Biotech provides pharmaceutical and laboratory equipment, validation service, training, engineering and consulting, and KOLAS calibration, among other products and services. Visit http://www.sartorius.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Harned brings 15 years of hearing healthcare experience to AuDConnex. He will work alongside members helping them to execute practice strategy and measure results.

RENO, NEV. (PRWEB) DECEMBER 03, 2020
AuDConnex is excited to announce the addition of Mark Harned to their team as account Manager. Harned has nearly 15 years of experience in the hearing healthcare industry and marketing technology. Prior to joining AuDConnex, Harned was the strategic partner manager for a large technology and customer service company. Harned will work closely with current AuDConnex members ensuring resources and communication are executed.
"Mark is incredibly passionate about teaching others how to be more strategic in their practice operations. His wealth of knowledge will be used to educate members to help take their practice to the next level. We are lucky to have him on our team," says Rich Johnson, co-owner and co-founder of AuDConnex.
AuDConnex is a collaborative audiology network/buying group that was founded in 2011 to unite independent practice owners in an effort to help keep them working independently.
"I've been in the industry for a long-time and I love how innovative AuDConnex is. They help members think outside the box and do things differently. What sets a practice apart is how they execute their strategy. Often times practice owners aren't taught to think strategically and measure results. I truly believe you cannot improve anything that is not measured," says Harned.
Harned earned his Bachelor of Arts degree in speech communication from UC Santa Barbara and a Bachelor of Arts degree in computer science from California State University-Northridge.
Harned has been married to his wife, Jen, for 15 years. They have two fur babies, Maximus and Louie. He is a certified personal trainer and enjoys being active. In his spare time you might find him playing tennis, mountain biking and hitting the gym.
For more information about Mark Harned or to schedule an interview, please contact Rich Johnson at (775) 722-6644.
To learn more about AuDConnex, visit http://www.audconnex.com
About AuDConnex
AuDConnex is a collaborative audiology network/buying group with operations in both the United States and Canada. Founded in 2011 by Rich Johnson, Au.D., Michael Illiff, Au.D., FAAA, CCC-A, and Ryan Lewis on the belief that we are stronger as a group than as individuals. The goal of AuDConnex is simple. We are dedicated to helping private practice audiologists simplify their practice strategy, save money, and succeed in an ever changing and competitive marketplace.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Long-time Lafayette resident and dermatologist, Jennifer Waguespack-LaBiche, has joined Hubbell Dermatology and Aesthetics.

LAFAYETTE, LA. (PRWEB) DECEMBER 03, 2020
Long-time Lafayette resident and dermatologist, Jennifer Waguespack-LaBiche, has joined Hubbell Dermatology and Aesthetics. Due to an increasing demand for the practice's medical dermatology services, Dr. Waguespack-LaBiche will be seeing patients starting January 4th, 2021.
Dr. Waguespack-LaBiche has been in private practice for over 17 years and has extensive experience in the diagnosis and treatment of acne, rosacea, psoriasis, and skin cancer. She is licensed by the American Board of Dermatology and by the Louisiana State Board of Medical Examiners. She recently practiced at Sanova Dermatology in Lafayette and for over 6 years at The Dermatology Center in Broussard, LA. "She brings tremendous experience and expertise to our medical dermatology patients", says Dr. Chris Hubbell, MD, Medical Director and Founder of Hubbell Dermatology and Aesthetics.
Dr. Waguespack-LaBiche's expertise allows her to treat each patient uniquely to enhance their individual skin health and wellness. "I am pleased to join Dr. Hubbell and staff at their new state of the art facility in River Ranch," says Dr. Waguespack-LaBiche. She received her medical doctorate from LSU Health Sciences Center in New Orleans and completed her dermatology residency training at the University of Texas. Dr. Waguespack-LaBiche has published extensively and has participated in key clinical trials in medical dermatology. She is a member of the American Academy of Dermatology, Women's Dermatology Society, American Society of Contact Dermatitis, and the Louisiana Dermatology Society. She lives with her family in River Ranch.
To make an appointment with Dr. Waguespack-LaBiche or to transfer your medical records, please call 337-982-6065 or email contactus@skinexpert.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Naturex, part of Givaudan, will assist Upgraid in expanding its portfolio of offerings through clinically validated ingredients, formulation and scientific expertise

NEW YORK (PRWEB) DECEMBER 03, 2020
Upgraid, the first ever wellness company with a science-based approach, has announced a collaboration with Naturex, part of Givaudan, to expand its product portfolio.
Through the collaboration, Naturex will provide Upgraid with state-of-the-art clinical science that backs the benefits of natural formulations increasingly in demand in the market today. This will allow Upgraid greater focus in delivering better, healthier, organic ingredients to consumers.
"All organics are not created equal," said Helene Rutledge, co-founder of Upgraid. "Naturex is known as a best in class provider of the finest organic, sustainable, ethically sourced raw ingredients available. Their worldwide network of agronomists works closely with local partners to facilitate responsible practices in the supply chain, biodiversity, and local entrepreneurship. Our collaboration will provide better solutions to a society rapidly moving towards proactive, plant-based preventative health and wellness lifestyles."
The collaboration of the two companies began with the launch of Upgraid's first product, Perform: Daily Inflammation (). Perform: Daily Inflammation () is backed by rigorous clinical data and demonstrated to help reduce soreness and recovery time, when taken daily, proactively. It is a standardized, proprietary blend of the following organic ingredients found in nature and formulated by scientists to work better together.
Naturex's TurmiPure Gold, the most bioavailable organic turmeric extract, which has been associated with helping to support healthy joint function Organic ashwagandha, which has been shown to help consumers manage stress by maintaining healthy cortisol levels Organic tart cherry fruit and organic ginger root, which have shown effects in supporting the immune system and reducing muscle soreness.
The two companies will continue using the collaboration as a growth catalyst through future product launches. In exchange for playing a significant role in Upgraid's product expansion, Naturex will gain exclusive access to Upgraid's consumer-facing market innovation, psychographics, and purchasing analytics.
"We are excited about the collaboration and have been impressed by Upgraid's rigorous review of the science behind the ingredients they use," stated Emilie Fromentin, Head of Explore Health, Wellness and Nutrition at Givaudan Taste & Wellbeing. "We look forward to providing our expertise, high quality ingredients and state-of-the-art science and formulation knowledge to help contribute to beneficial outcomes for customers."
With a mission to reduce the amount of daily artificial ingredients that society takes, Upgraid aims to do just that – provide beneficial outcomes for customers by delivering clinically tested and science-backed products with zero chemicals, zero compromise, and zero false promises backed by 100% transparency and organic ingredients.
"We came together to take a rigorous, scientific approach to fully organic products," said Justin Kamine, co-founder of Upgraid. "Reverting society and human health to the way we started, by using diet as a form of preventative healthcare. Being proactive and preventative is much needed. Unfortunately, we have become accustomed to too many quick fixes rather than addressing the underlying problems."
Neither Perform: Daily Inflammation nor TurmiPure Gold are intended to diagnose, treat, mitigate, prevent or cure any disease or medical condition.
###
About Upgraid
Upgraid is an organic wellness company that drives healthy aging by developing and leveraging the latest technology and market innovation. Founded by Helene Rutledge, a chemical engineer and former big pharma C-suite executive, and Justin Kamine, a Forbes 30U30 for food and impact entrepreneur. Upgraid supplements help consumers to get a little better every day.
For further information, visit https://www.upgraid.me/.
About Naturex, part of Givaudan
Naturex sources, manufactures and markets natural specialty ingredients for the food and health industries. Naturex's portfolio includes natural preservation ingredients, specialty fruits and vegetables, phytoactives, and numerous other plant-based natural ingredients, designed to help its customers switch to natural ingredients and create healthy, authentic, and effective products. The success of the company is based on a strong commitment to sustainability, continuous innovation, and the talent of its people. Naturex is part of Givaudan, the global leader in the creation of flavors and fragrances.
Learn more about Naturex at http://www.naturex.com
About Givaudan Taste & Wellbeing
Powered by innovation and creativity, Givaudan Taste & Wellbeing aims to shape the future of food by becoming the co-creation partner of choice to its customers. Built on its global leadership position in flavours and taste, the Company goes beyond to create food experiences that do good and feel good, for body, mind and planet. With an expanded portfolio of products across flavours, taste, functional and nutritional solutions and a deep knowledge of the food ecosystem, Givaudan's passion is to collaborate with customers and partners to develop game-changing innovations in food and beverage. Let's imagine together the future of food.
Learn more at http://www.givaudan.com/taste-wellbeing
MEDIA CONTACTS
Sparkpr for Upgraid
upgraid@sparkpr.com
Stephen Collins, Head of NOAM Communications, Givaudan Taste & Wellbeing
Stephen.collins@givaudan.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Leading pre- and post-settlement solution services provider appoints 35-year insurance industry veteran to lead the company through its next phase of strategic growth

LONGWOOD, FLA. (PRWEB) DECEMBER 03, 2020
NuQuest, the leading provider of Medicare Secondary Payer (MSP) compliance solutions, including Medicare Set-Aside Allocation (MSA), Medical Cost Projection, and Professional Administration services, is pleased to announce the confirmation of Barbara Fairchild as Chief Executive Officer. Under Ms. Fairchild's leadership, we look forward to a vibrant and flourishing future for our organization and for the customers that we serve each year.
Ms. Fairchild brings over 35 years of in-depth experience and outstanding performance in the insurance industry specializing in catastrophic case management, drug and medical utilization review, and critical care nursing. This year she was honored as National Programs and Services Division Office MVP for her outstanding contribution to NuQuest and our customers.
Ms. Fairchild holds a bachelor's degree in nursing from St. Louis University, graduating with honors. Additional professional credentials include Registered Nurse, Certified Life Care Planner, and Medicare Set-Aside Consultant Certified. A sought-after speaker, Ms. Fairchild is nationally recognized as a thought leader and industry expert in Medicare Set-Asides in both worker's compensation and liability cases. She presents leading-edge, mission-critical information to her diverse audiences in easy-to-understand terms.
"Barbara is the right leader for NuQuest," said Julie Turpin, Chief People Officer of Brown & Brown, Inc. "Her extensive expertise in the marketplace will help NuQuest strengthen our partnerships, grow our sales, and take NuQuest to new heights."
About NuQuest
NuQuest is a national provider dedicated solely to Medicare Secondary Payer (MSP) Compliance services, including a complete suite of services for Medicare Set-Aside Allocations (MSA).
With our years of MSP Compliance experience, gained from completing tens of thousands of MSAs and related reports, we work to help our customers realize the maximum cost savings possible in pharmacy utilization and medical treatment.
Our focus on quality, customer service, and technology is key to our success and yours. We employ an experienced and highly credentialed team for the completion of all services; principled customer focus is at the core of our culture. We encourage you to contact us or explore our website to learn more about our team, quality assurance program, and services.
http://www.mynuquest.com
https://www.linkedin.com/company/nuquest-bridge-pointe
866-858-7161
About Brown & Brown, Inc.
Brown & Brown, Inc. (NYSE: BRO) is a leading insurance brokerage firm, providing risk management solutions to individuals and businesses. With more than 80 years of proven success and thousands of teammates, we offer knowledge you can trust and strive to deliver superior customer service. For more information, please visit http://www.bbinsurance.com.

"Barbara's extensive expertise in the marketplace will help NuQuest strengthen our partnerships, grow our sales, and take NuQuest to new heights."



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Allergy Standards Ltd (ASL) is Delighted to Announce that their CEO Dr. John McKeon will present at a highly relevant talk entitled 'The Breathe Clean Air Program: Advanced Training for Building Professionals' at 11am-12pm EST December 3rd 2020.

DUBLIN (PRWEB) DECEMBER 03, 2020
The presentation will be delivered to healthcare facilities managers, who play a key role in the construction industry. It is one of an expanding series of webinars, presented by Dr. McKeon which builds on Allergy Standards participation in the US Greenbuild Conference and Expo, where they shared the stage with Tracy Washington Enger of the Environmental Protection Agency (EPA) and focussed on the growing issue of poor Indoor Air Quality and the impact it has on human health. More specifically, it is now time to highlight the impact building materials and products have on the consumer's surroundings and consequently the effect this environment has on health.
Dr. John McKeon, CEO of Allergy Standards, is recognised for delivering informative, cutting edge talks, lectures and workshops on developing international standards, Indoor Air Quality, third body certification and innovation so is particularly honoured to be presenting this talk hosted by Tarkett.
Tarkett have cemented their reputation as leaders in the healthcare facilities industry by their involvement in the Clean Hospitals network and in The Sustainability and Health Initiative for Netpositive Enterprise (SHINE) at the Harvard T.H. Chan School of Public Health.
Tarkett are internationally renowned for developing sustainable flooring solutions that respect the environment and contribute to health and well-being and their participation in asthma & allergy friendly Certification Program reflects this.
"I am delighted to be presenting this talk to such a vital group of the construction industry. Our expertise at Allergy Standards in the Indoor Air Quality field allows us to fill a knowledge gap made increasingly apparent by the global pandemic It is imperative that construction and design professionals embrace the paradigm shift from an engineering focus to a people centred healthy design approach to meet expanding consumer needs," says Dr. John McKeon.
This talk gives Allergy Standards the opportunity to highlight their online Education Program, 'The Breathe Clean Air Program', designed and delivered by the ASL science & medical team and tailored specifically for construction professionals, retailers and CERTIFIED manufacturers. The e-learning program will enable the delivery of construction and product solutions that are specifically matched to the needs of the air aware customer.
The launch of this Education Program comes at a time when Indoor Air Quality is worsening and the medical consequences of this deterioration are increasingly common and more serious. According to the EPA Indoor Air Quality (IAQ) can be up to 5 times more polluted than outdoor air. Awareness of 'invisible' air quality issues is spiking due to adverse weather related events such as seasonal forest fires, "pollen tsunamis" and the global COVID-19 pandemic.
The upcoming talk hosted by Tarkett will explore how to empathize about air quality concerns, the rising awareness of the impact of poor Indoor Air Quality and issues related to asthma and allergies. The expansive curriculum includes contributions from the EEBA and Construction Instruction. Other areas to be covered are:

The rising demand for clean indoor air with the 'indoor generation'

Understand the science on asthma and allergies, indoor triggers, and the corresponding impact on human health

Indoor air & pathogens such as Coronavirus

Medical impact of poor indoor air quality

How the construction industry is responding

Stakeholder Values + Environmental Sustainability + Wellness Movement

How material science alone is not sufficient in creating better building inhabitant outcomes

Linking conversations regarding clean air with medical impacts and how to create better indoor air

Date: Thursday December 3rd, 2020
Time: 11am-12pm EST
We invite you to register for the talk here
https://us03web.zoom.us/meeting/register/u5wsc-irqD4oHtNvYGzM4LbnYuvUzXTBJ6yt
Enrolment in the Education Program will be available to all those in the professional building and design industries, retailers and those interested in gaining insight into the creation of healthier homes for all. Contact us for more information.
https://www.allergystandards.com/contact-us/
About Allergy Standards Limited (ASL)
Allergy Standards Ltd uses Design Thinking Principles to operate the world's most recognised certification program for the allergy aware consumer. As an international certification and health data analytics company, ASL develops international standards for innovation and testing of a wide range of consumer products and services. ASL works with researchers, manufacturers and retailers throughout the supply chain, using design thinking and innovation to create a healthier indoor environment.

It is imperative that construction and design professionals embrace the paradigm shift from an engineering focus to a people centred healthy design approach to meet expanding consumer needs, says Dr. John McKeon



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Collaboration aims to educate cancer care professionals in radiation therapy and nuclear medicine to provide better access to cancer treatments in low and middle-income countries

WASHINGTON (PRWEB) DECEMBER 03, 2020
Global Access to Cancer Care Foundation (GACCF) http://www.globalaccf.org, the leading global cancer care organization providing oncology education programs in low and middle-income countries (LMICs), announced today that it signed a partnership agreement with the International Atomic Energy Agency (IAEA) to advance oncology training and treatments in LMICs in South America, Africa, South and East Asia.
The alliance will greatly enhance training for cancer care professionals around the world in radiation therapy and nuclear medicine, optimize resource mobilization to enhance comprehensive cancer control in LMICs, and spur collaboration on capacity-building by providing on-location teaching courses for practitioners in health facilities. The partnership will also organize outreach activities and awareness-raising programs through relevant regional/global initiatives and high-level events with key partners and stakeholders.
"Working together with IAEA we will increase the availability of technical resources and training for cancer care providers and help prevent unnecessary cancer deaths in developing countries around the world," said Tonya Steiner, executive director of the Global Access to Cancer Care Foundation. "The scope of the global cancer epidemic is staggering. It is estimated that in 10 years there will be nearly 24 million cases globally and most of these cases will occur in low- and middle-countries that are unable to offer people the most rudimentary of cancer care and treatment."
Founded in 2016, GACCF supports comprehensive clinical training programs in LMICs to create a core base of local cancer care professionals that include: oncology doctors, nurses, medical physicists, dosimetrists, and radiotherapy technicians. By collaborating with local professionals and institutions, GACCF continues to champion local solutions and enhance cancer treatment for the world's most vulnerable patients through the science of radiotherapy.
Widely known as the world's "Atoms for Peace and Development" organization within the United Nations family, the IAEA is the international center for cooperation in the nuclear field. The agency works with its member states and multiple partners worldwide to promote the safe, secure, and peaceful use of nuclear technologies.
To make a donation to GACCF, visit http://www.globalaccf.org.
About Global Access to Cancer Care Foundation:
The Global Access to Cancer Care Foundation (GACCF) offers training, technology, access, and hope; specifically for low and middle-income countries (LMICs) in South America, Africa, South and East Asia. The Foundation's cancer care professionals help to implement and oversee training courses and workshops in collaboration with local partners such as universities, hospitals or governmental institutions that enhance cancer treatment through radiotherapy treatment. These regional programs aim to overcome the lack of trained professionals who treat cancer patients in the near term. By empowering local faculty to deliver training, the GACCF education programs encourage self-reliance and sustainability. To support the success of these programs, the GACCF provides project management, financial support, and professional teams from within and outside the region. For more information visit: http://www.globalaccf.org.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Lakeland introduces the implementation of ActX – a genomic decision support platform geared toward elevating patient care in real time

LAKELAND, FLA. (PRWEB) DECEMBER 03, 2020
Lakeland Regional Health is adding the ActX Genomic Decision Support platform, also known as GenoACTSM, into their electronic health record (EHR). Lakeland strives to deliver the best outcomes and safest care by placing people at the heart of all that they do. Lakeland is passionate about wellness, education, and discovery for their patients, and integrating ActX is their most recent move in creating a healthcare experience that is as personalized as possible.
Last year, leaders from Lakeland took a trip to NorthShore University HealthSystem in Chicago and were inspired by the work NorthShore has accomplished with genetics and their ActX platform integration. With ActX activated in the EHR, physicians will receive real-time alerts as they write prescriptions, and they will be able to check hereditary risks and carrier statuses, all within regular EHR workflow.
Genomics is part of the 2025 strategic vision for Lakeland. Joseph Davis, the Associate Vice President of Physician Recruitment and Ambulatory Operations, has spearheaded the ActX roll out. Davis says, "My plan for Lakeland, in regards to genomics, is to increase utilization, customize patient treatment plans, create a sub-physician group of active platform users, and make Lakeland a leader in precision medicine that providers want to be part of. I'm thrilled to be launching ActX and I can't wait to see where it takes us".
"We are thrilled that Lakeland has joined our effort to make genomic decision support part of regular patient care," says Dr. Andrew Ury, ActX CEO. "Integrating our information with their EHR is crucial for making genomic support a seamless addition to Lakeland's everyday medical care and to help to improve healthcare quality and outcomes."
About ActX
ActX is the industry leader in EHR-integrated precision medicine. Our service helps physicians make better decisions about medical treatment, using a patient's genetic information to guide therapy. The ActX Genomic Service offers proven, tightly integrated, real-time genomic decision support for medication orders and actionable genomic risks, a built in patient Genomic Profile, and the ability to fully customize content.
As medications are ordered, and before the prescription is finalized, medications are checked against the patient's genetics for efficacy, adverse reactions, and dosing. Extensive evidence based and actionable content is provided as default, customizable content, covering hundreds of genes. You can easily suppress any content or interactions, or add or modify content. The ActX Genomic Service is live at numerous U.S. health systems. For more information, visit http://www.actx.com, email info@actx.com or call 888-998-2289.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

SOUL spreads kindness and equality to society through volunteer work with the Autistic community

SEATTLE (PRWEB) DECEMBER 03, 2020
Charity work is an important indicator to show progress in human civilization. Individuals and companies in China are starting to actively play an exemplary role in charity work to create a more equal and friendly atmosphere in society.
Especially during this difficult year in 2020, charities in China have demonstrated strong organizational capabilities and quick response speeds. Currently China's charitable organizations including foundations, social groups and social service organizations, lead the world in education, disease treatment and prevention, and disaster relief.
In September 2020, the Tencent Charity Platform brought together hundreds of charitable organizations and well-known companies to launch the "99 Giving Day," aimed at providing relief for people in China's disaster-stricken areas and impoverished regions.
In October 2020, Soul App and WABC Charity Foundation launched the "I'm Not Lonely Because of Being Different" charity exhibition. This exhibition was open to the public at the Su Shanghai Community Art Museum and helped bring the attention of the Autistic community to more people.
Autism is a developmental disorder characterized by difficulties in communication and social interaction and may also include repetitive and limited interests and behavior. According to the World Health Organization (WHO) report, the global average prevalence rate for autism is 0.62%, which is about 1 in every 160 children. WABC is a charity foundation that focuses on providing free art therapy services for people with intellectual disabilities, including those with autism.
This charity event included an online registration, a call for theme paintings, and offline mentoring and art exhibition set up. Volunteers recruited from Soul App and students with special needs of WABC worked together to create paintings with the theme of "Please Visit My Planet", and SOUL collected paintings with the theme of "I Will Come to Your Planet". A total of 30 paintings were collected for the exhibition to publicly display. With this charity exhibition, SOUL provided a kind space for the autistic children to express themselves through painting and gave the special Autistic community with a platform to gain more social attention. On Soul App, users actively participate in charitable activities, showing love and positive energy. In the future Soul App will continue to work with WABC to establish long-term cooperation for more community service work and to be able to spread equality and kindness to more people in need.
About SOUL
Soul App went online in November of 2160 and is committed to creating a new generation intelligent social platform that promotes equality, kindness, and efficiency. Users can express themselves with kindness and equality on the platform, and hundreds of millions of young people have shared their lives and spread kindness on SOUL



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Sagora Senior Living is proud to announce that they have been honored with certification as a Great Place to Work. The certification process considered associate surveys from Sagora's 44 multi-state communities and Home Office where almost 90% of the company's associates responded.

FORT WORTH, TEXAS (PRWEB) DECEMBER 03, 2020
Sagora Senior Living is proud to announce that they have been honored with certification as a Great Place to Work. The certification process considered associate surveys from Sagora's 44 multi-state communities and Home Office where almost 90% of the company's associates responded.
Great Place to Work, an independent research and consulting firm, evaluated more than 60 elements of Sagora's associates' experience on the job. These included associate pride in Sagora's community impact, belief that their work makes a difference, and feeling their work has special meaning. Rankings are based on associates' experiences, no matter who they are or what they do.
"Sagora has a culture all its own, and we are beyond proud that we are recognized for being a great place to work. Our rich history of diversity, hard work and dedication to our Resident First philosophy help make us who we are," said Sagora Senior Living's Sr. Vice President, Dara Brown.
During COVID-19, Sagora Senior Living provided several resources for their associates including temporary pay increases, a Sagora Associate Pantry to purchase groceries and toiletry items and emotional wellness programs. The company also offers an Employee Assistance Program (EAP) for any associates who need support in regard to counseling or emotional distress.
"We applaud Sagora Senior Living for seeking certification and releasing their associates' feedback," said Dr. Jacquelyn Kung, of Great Place to Work's senior care affiliate Activated Insights. "These ratings measure its capacity to earn their associates' trust and create a great workplace for high performance."



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Winners of the 2020 IMV ServiceTrak Imaging Awards

ARLINGTON, VA. (PRWEB) DECEMBER 03, 2020
IMV, part of Science and Medicine Group, the leading market research and business intelligence provider to the medical imaging industry, announced the category winners of the 2020 IMV ServiceTrak Awards in diagnostic imaging equipment at RSNA 2020.
2020 Imaging Awards
MR

Best Service: Canon Medical Systems USA, Inc.

CT

Best Service: Canon Medical Systems USA, Inc.

Cardiovascular Ultrasound

Best Customer Satisfaction: Philips North America

Best Service: Philips North America

General Ultrasound

Best System Performance: Philips North America

Best Service: Philips North America

General X-Ray

Best System Performance: Philips North America

Radiation Oncology

Best Customer Satisfaction: Varian Medical Systems

Best System Performance: Varian Medical Systems

Best Service: Varian Medical Systems

Mammography

Best Customer Satisfaction: Hologic, Inc.

Best System Performance: Hologic, Inc.

Best Service: Hologic, Inc.

About IMV, part of Science and Medicine Group
IMV produces an annual series of proprietary ServiceTrak Imaging reports derived from extensive phone interviews with imaging professionals in hospital departments and independent imaging centers in the U.S. Imaging professionals are asked to rate their level of satisfaction with the equipment manufacturers, system performance, and the service received for their imaging equipment. Satisfaction ratings are collected on a 10-point scale, in which 10 = "excellent" and 1 = "very poor." Report analysis is based on the percentage of highly satisfied (%HS) responses that are represented by satisfaction ratings of a 9 or 10 on this scale.
The ServiceTrak Imaging Awards are presented to the manufacturer with the highest %HS in each of three categories, representing the Industry Best of Customer Satisfaction, System Performance, and Service. The Best of Customer Satisfaction award is given to the manufacturer who has the highest %HS responses when asked to rate the likelihood they will purchase again from their current manufacturer. The Best of System Satisfaction award is given to the manufacturer whose customers have the highest %HS responses when asked to rate their overall system performance. The Best of Service award is given to the manufacturer whose customers give the highest %HS responses when asked to rate overall OEM service performance.
The 2020 ServiceTrak Imaging awards are based on interviews conducted in 2020 with respondents in 3,324 imaging locations having 5,211 instruments.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The non-profit organization CISCRP (Center for Information and Study on Clinical Research Participation), hosted AWARE for All – Los Angeles, a free, interactive webinar on November 18th, 2020. The Los Angeles focused program shared critical information about clinical research participation.

LOS ANGELES (PRWEB) DECEMBER 03, 2020
The non-profit organization CISCRP (Center for Information and Study on Clinical Research Participation), hosted AWARE for All – Los Angeles, a free, interactive webinar on November 18th that:

Demystified clinical trials

Revealed what the experience is like for participants

Reviewed the roles and responsibilities of involved medical professionals

Reinforced the critical role that individuals who participate in clinical trials play in advancing new medicines and treatments

Attendees of the webinar were able to submit questions during the program via a secure platform.
The webinar included a facilitated conversation with patients, researchers and health care professionals after an overview presentation given by Dr. Jonathan Jackson, Ph.D., Director of Community Access, Recruitment, and Engagement (CARE) Research Center, Massachusetts General Hospital and the Harvard Medical School. Two health exercises were part of the online program—a memory/brain health exercise offered by Alzheimer's Los Angeles and Reiki offered by WESpark Cancer Support Center. Attendees also had the opportunity to visit local and national health and wellness organizations who provided educational resources in the virtual exhibit alley.
Access the webinar recording: https://www.ciscrp.org/events/aware-for-all/aware-for-all-events/
Dr. Leanne Burnham of City of Hope shared her thoughts on certain factors that contribute to a positive study experience, such as trust in the institution, the team and when there is a patient-physician match and language matched materials that can help study participants feel more comfortable.
Tomma Hargraves, a clinical trial participant, credits her participation with surviving Stage 3 lung cancer 14 years ago. Since then, she has participated in other clinical trials and serves as a patient liaison helping others navigate clinical trials.
"At CISCRP, helping patients and the public learn about the importance of clinical research participation is at the heart of our mission. We're extremely excited to have been able to present this online event with support from a diverse team of stakeholders from the Los Angeles community," said Joan Chambers, Senior Director, CISCRP.
The AWARE for All – Los Angeles supporters include Allergy & Asthma Network, City of Hope, Pancreatic Cancer Action Network, PALS for Health, Alzheimer's LA, Debbie's Dream Foundation, Alliance for a Better Community, Being Alive LA, WeSPARK Cancer Support Center, Providence Clinical Research, Peer Plus, and the AWARE Industry Consortium.
CISCRP has hosted other regionally focused webinars in 2020 including Chicago, Philadelphia and Raleigh. A December 8th webinar is scheduled for Miami. Learn more about these events: https://www.ciscrp.org/events/aware-for-all/aware-for-all-events/
About CISCRP
The Center for Information and Study on Clinical Research Participation (CISCRP) is a 501(c)(3) non-profit organization dedicated to engaging the public and patients as partners in the clinical research process. CISCRP provides free education and outreach to the general public and patient communities. Visit http://www.CISCRP.org for more information or to participate in CISCRP's educational initiatives. For additional questions about AWARE for All, contact awareforall@ciscrp.org or call 877-633-4376.

"We're extremely excited to have been able to present this online event with support from a diverse team of stakeholders from the Los Angeles community," said Joan Chambers, Senior Director, CISCRP.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Ongoing evolution in propensity to pay modeling increases precision in payment plan offers and likelihood of patient acceptance and adherence.

LIVONIA, MICH. (PRWEB) DECEMBER 03, 2020
RevSpring, a leading provider of healthcare financial engagement and payment solutions, today announced a new payment plan optimization score. This new propensity score within RevSpring Predict represents another major step forward in RevSpring's ability to leverage analytics to improve patients' financial journeys, while helping providers collect payments and achieve revenue management goals. This new predictive score identifies both the "sweet spot" for the installment payment amount, as well as the duration of a recommended payment plan.
RevSpring Predict is an advancement in propensity to pay modeling that enhances predictability at more touchpoints throughout the patient payment journey to increase payments. The payment plan optimization score takes it a step further by allowing healthcare providers to present an even more precise payment plan all within their pre-determined guidelines.
"The new payment plan optimization score is the result of increasing sophistication in our use of patient analytics," said April Wilson, vice president of analytics at RevSpring. "We're excited because it increases the likelihood that patients accept and fulfill payment plans RevSpring Predict proposes. And patients using RevSpring's PersonaPay portal will appreciate the flexibility it provides for adjusting their own payment terms within the provider's business rules. Either way, patients and providers win."
Unlike credit score-based models that are one-dimensional and therefore less precise in terms of predicting payment behavior in financially underserved segments, RevSpring Predict—including the new payment plan optimization score—achieves a higher standard of precision because it uses more human context, including behavioral characteristics, the stage of the patient in their healthcare journey, and more. Through iterative modeling and machine learning techniques, RevSpring uses science to create a more flexible and compassionate payment experience for the patient. This means providers can have confidence that they are matching the best payment option to the needs of the patient at the right time—and ultimately improve patient loyalty and satisfaction—while increasing payments.
About RevSpring
RevSpring leads the market in financial communications and payment solutions that inspire patients to pay. The company has built the industry's most comprehensive and impactful suite of patient engagement, OmniChannel communications and payment solutions backed by behavior analysis, propensity-to-pay scoring, contextual messaging, and user experience best practices. Using proprietary data analytics to tailor the engagement from pre-service to post-service, we improve the financial experience and outcomes for providers and their patients. To learn more, visit revspringinc.com/healthcare.

"The new payment plan optimization score...increases the likelihood that patients accept and fulfill payment plans RevSpring Predict proposes," said April Wilson, vice president of analytics at RevSpring.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The patent-pending, self-improvement BringIt challenge platform promotes healthy competition among the brand's followers to increase audience engagement and advocate for the importance of living a healthy, active lifestyle.

BEND, ORE. (PRWEB) DECEMBER 03, 2020
KrowdFit, the only cash-back wellness incentive program in the U.S. and Canada, today announced its new self-improvement fitness challenge platform, BringIt, which gives brands' loyalty marketing teams the ability to engage their customers in customizable health and fitness challenges.
KrowdFit's BringIt platform supports "skill-based" self-improvement fitness challenges designed for brands interested in promoting and advocating the importance of living a healthy, active lifestyle in a unique and engaging way to their social media followers. With BringIt, brands are given the ability to sponsor challenges, where participants compete against each other across various activities including steps, sleep, and physical activity to win e-gift cards to purchase the brand sponsor's merchandise. BringIt participants must install the KrowdFit App for free and then use wearable technology such as Fitbit, Garmin, Apple Watch, Misfit, partner's fitness App, Smartphone, etc. to participate for free.
With the BringIt platform, companies can socially engage their customers in an exciting new way to increase brand awareness, increase customer loyalty, introduce new products/services, and reinforce company values. In addition to promoting healthy competition among the brands' customer base and engaging their followers, brands will receive Activity Reports allowing them to see who their most physically active followers, customers, and use these insights to target those highly active individuals with special offers to purchase new products and/or become brand ambassadors.
"We've all learned during this COVID-19 pandemic that maintaining a healthy immune system and an active lifestyle is critical. KrowdFit's unique self-improvement challenge technology combines fitness tracking with monetary rewards and gives brands the opportunity to reinforce the importance of health and reward their customers for the effort they make to live a healthy, active lifestyle while promoting the brand's healthy values," said Jim Miller, CEO and founder of KrowdFit. "Brands have full reign to customize a BringIt wellness challenge that reinforces their own values and KrowdFit handles the rest, from managing the leaderboard, reward fulfillment, and tax reporting."
BringIt is powered by KrowdFit, a science-backed wellness engagement and incentive platform that has paid out millions in KrowdFit funded cash rewards to its members to-date for engaging in daily wellness activities, such as mindfulness, sleep, steps, meal logging, and physical activity. By using the latest wearable devices, smartphones, and popular diet, fitness, sleep and mindfulness apps, KrowdFit members' activities are automatically logged into the KrowdFit app. Each time an activity is logged, members seamlessly earn entries into one of five different cash giveaways, making them eligible to receive weekly, monthly, and quarterly cash incentives of up to $5,000/ea. or more per winner.
For more information, visit http://www.krowdfit.com/bringit
About KrowdFit
KrowdFit has paid out millions in KrowdFit sponsored cash rewards and is the recognized leader in milestone-driven, wellness incentive, and engagement programs. KrowdFit's mission is to create a healthy revolution by encouraging, recognizing, and rewarding the consistent effort people make to live healthy, active lifestyles. KrowdFit's patent-pending, skill-based, fitness betting, self-improvement challenge platform BringIt has proven to drive very high levels of sustained engagement leading to positive outcomes and long-term, healthy behavioral change. KrowdFit is headquartered in Bend, OR with an in-office in Bellevue, WA. For more information, visit http://www.krowdfit.com.
Media Contact:
Max Borges Agency for KrowdFit
krowdfit@maxborgesagency.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com